zokoogaocijicmkcsgiitiskocrogkmclcyiwidk length 6 343038 page 343038 

<!DOCTYPE html>

<html id="doc" lang="en" class="page-article">
<head id="Head1">
    <!-- charset must appear in the first 1024 bytes of the document -->
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />

<script>
      var SCM = SCM || {};
      if (SCM.AMA && SCM.AMA.DataLayerAsync) {
        SCM.AMA.DataLayerAsync.push("arrSisAffinity", "", "array");
        SCM.AMA.DataLayerAsync.push("SubStatus", "no", "string");
      }

      var googletag = window.googletag || {};
      googletag.cmd = googletag.cmd || [];

          
          if (typeof Storage !== "undefined")
          {
              var targetingParamStr = localStorage.getItem("bcDFPTargetingParams");
              if (targetingParamStr)
              {
                  var targetingParameters = JSON.parse(targetingParamStr);     // set page-level targeting parameters
                  jQuery.each(targetingParameters, function (index, param) {
                      googletag.cmd.push(function () {
                          window.googletag.pubads().setTargeting(param.key, param.value);
                      });
                  });
              }
          }
          
      if (!googletag.pubads) {
        (function () {
          var gads = document.createElement('script');
          var useSSL = 'https:' == document.location.protocol;
          gads.src = (useSSL ? 'https:' : 'http:') +
            '//securepubads.g.doubleclick.net/tag/js/gpt.js';
              gads.setAttribute("async", "");
              gads.setAttribute("defer", "");
          var node = document.getElementsByTagName('script')[0];
          node.parentNode.insertBefore(gads, node);
          })();

        var App = App || {};
        App.Ads = App.Ads || {};
        App.Ads.adPath = App.Ads.adPath || '/6479/' + 'ama.jama';
        App.Ads.Mappings = App.Ads.Mappings || {};
        App.Ads.slots = App.Ads.slots || [];
        App.Ads.fromGoogle = !('yes' === 'yes');

        App.isCollection = App.isCollection || !!document.getElementsByClassName('pg_collection').length;

        
        googletag.cmd.push(function () {

          googletag.pubads()
            .setTargeting('environment', ['newjama'])
            .setTargeting('site', ['ama.jama'])
            .setTargeting('sect', ['scholarly'])
            .setTargeting('sub', ['no'])
            .setTargeting('device', ['cis5550-crawler'])
            .setTargeting('usaphys', ['no'])
            .setTargeting('memberstat', ['no'])
            .setTargeting('pracset', [''])
            .setTargeting('specialty', ['other'])
            .setTargeting('occupation', [''])
            .setTargeting('useraffinity', [''])
            .setTargeting('direct', ['yes'])
            .setTargeting('bot', ['yes'])
            .setTargeting('datacenter', ['no'])
            .setTargeting('selfMPA', [''])
            .setTargeting('selfSpecialty', ['']);

          if (App.isCollection) {
            googletag.pubads().setTargeting('collection', ['']);
          }

          var testParam = getQueryVariable('test');

          if (testParam) {
            googletag.pubads().setTargeting('test', [testParam]);
          }

          function getQueryVariable(variable) {
            var query = window.location.search.substring(1);
            var vars = query.split('&');
            for (var i = 0; i < vars.length; i++) {
              var pair = vars[i].split('=');
              if (decodeURIComponent(pair[0]) == variable) {
                return decodeURIComponent(pair[1]);
              }
            }
          }

          googletag.pubads().disableInitialLoad();
          googletag.enableServices();
        });
      }
</script>


<meta name="viewport" content="width=device-width, initial-scale=1" /><meta name="format-detection" content="telephone=no" /><link rel="shortcut icon" href="//cdn.jamanetwork.com/UI/app/img/favicons/jama/favicon.ico">
<link rel="icon" type="image/png" href="//cdn.jamanetwork.com/UI/app/img/favicons/jama/favicon-192x192.png" sizes="192x192">
<link rel="apple-touch-icon" sizes="180x180" href="//cdn.jamanetwork.com/UI/app/img/favicons/jama/apple-touch-icon-180x180.png">
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
    
    <link rel="stylesheet" href="//cdn.jamanetwork.com/UI/app/dist/app.min.css?v=638488852237037766">
    
    
    
    
    <link href="//cdn.jsdelivr.net/chartist.js/latest/chartist.min.css" type="text/css" rel="stylesheet" />
    

    <meta property="og:title" content="USPSTF Recommendation: Statins for Primary Prevention of Cardiovascular Disease in Adults" />
    <meta property="og:type" content="Article" />
    <meta property="og:url" content="https://jamanetwork.com/journals/jama/fullarticle/2795521" />
    <meta property="og:image" content="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938974/jus220018fa_1660869424.31945.png?Expires=2147483647&amp;Signature=x0OOmQXczAqAURQj7~j~7bE6eTeszKiQYmS-2xzQSNeZ-o0l-D0bMAKLVFP57BXvKrzvBgOYH~RKEEKDeFsRg3lHrFvvAZWpC82L4a4P4GmWOwuEM69NYxlSjPkm3ukYQJfP9YXm~sc2~IYUtf3uwa-NW7T6uh2736FNEl-OGlnhUmIbJXOGyQ3MEMPNpP7kop4HzLbxIJsHU-UNi6kcMnm9iN5mkXyvbaLXGyBe1xvbE6WjlNP9tiuiFTbgcIQ~t-~oo2RLkvxgAfDgYEF~R6CcnGf8w6SkLlYWRNSKr4vfThRbKTL12CK5XEVsNqGs0kAb9FyU6RaqxHV8wxKIDg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" />
    <meta property="og:image" content="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938974/jus220018t1_1660869424.35946.png?Expires=2147483647&amp;Signature=VxBCi2LCwD7-ZVdGj-gzKq46~dshdUewtLZnVCKhjzXGvDeMzkxcSp7SRvzZUr9TQsWC7FzrAx70MhmG07ptE4v5GfEC2ZcLT-iyCimEvlfBZ5s928~iQhBQG-iy4e1ygWoX-CF3yYfvkqPwQcCNfpNTUJ3uXGuCpy3zBtSZvjnACVXQW~nY-ofp5n0i7fN7TvPtG-zQJO~FrlIMmucNeJ1-6PV5cywgrv6gxY3cYzOmAJFq7lE1g77vyZGxk2UgGa6R1ZcGLPf8etrlFcVmIR8dRZPBtKnBrUEARhsAyx3DbdHautIXJkL1gnqE4EzR7BGb57cURV~51Z7pbUGr5g__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" />
    <meta property="og:image" content="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938974/jus220018f1_1660869424.36947.png?Expires=2147483647&amp;Signature=qV88Ql2ZQ~GG-MPhgAD-7AZzTKUQ8DEO~4A2ovBm1E6QyZYORu3j7Vkg62GAEXe9NG87nxc1Ab~n2X2LG~tVwQiIna43boHOP7FH23eROXkW3GdpTQx1NJaIbGwYK72CAICZsPjUQCtw3B07CRu-BSl-T7N4RyuqBJoMsz4Q8cfUvofRPe9AhEcEvb7i~gZUX2g-ayx755Eb9Ex8UPR50U1OEWKOdQM0RgVAZUAGdfRwf~bTMg~YxIXE9X1rRmxPlXopcm~GHb7NeAVUq27Lu9Lr5zjJxN-VH4ROFKo0WMlQf~mD6RAuKKBoIREhMdp6ergUBii0jgtkHEuzraUtiA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" />
    <meta property="og:description" content="This 2022 Recommendation Statement from the US Preventive Services Task Force recommends that for primary prevention of cardiovascular disease (CVD) in adults aged 40-75 years who have ≥1 CVD risk factors, clinicians should prescribe a statin for those with an estimated 10-year CVD risk ≥10% (B..." />
        <meta property="fb:pages" content="87087958340" />
        <meta property="fb:pages" content="122228711814384" />
        <meta property="fb:pages" content="1648414928738217" />
        <meta property="fb:pages" content="117506346528" />
        <meta property="fb:pages" content="97538728726" />
        <meta property="fb:pages" content="114116793520" />
        <meta property="fb:pages" content="100679858757" />
        <meta property="fb:pages" content="759822190741773" />
        <meta property="fb:pages" content="100265333750" />
        <meta property="fb:pages" content="234770525256" />
        <meta property="fb:pages" content="98784919862" />
        <meta property="fb:pages" content="120829458202" />
        <meta property="fb:pages" content="124842870398" />
        <meta property="fb:pages" content="110245330325636" />
        <meta name="twitter:card" content="summary_large_image" />
        <meta name="twitter:site" content="@JAMA_current" />
        <meta name="twitter:image" content="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938974/jus220018fa_1660869424.31945.png?Expires=2147483647&amp;Signature=x0OOmQXczAqAURQj7~j~7bE6eTeszKiQYmS-2xzQSNeZ-o0l-D0bMAKLVFP57BXvKrzvBgOYH~RKEEKDeFsRg3lHrFvvAZWpC82L4a4P4GmWOwuEM69NYxlSjPkm3ukYQJfP9YXm~sc2~IYUtf3uwa-NW7T6uh2736FNEl-OGlnhUmIbJXOGyQ3MEMPNpP7kop4HzLbxIJsHU-UNi6kcMnm9iN5mkXyvbaLXGyBe1xvbE6WjlNP9tiuiFTbgcIQ~t-~oo2RLkvxgAfDgYEF~R6CcnGf8w6SkLlYWRNSKr4vfThRbKTL12CK5XEVsNqGs0kAb9FyU6RaqxHV8wxKIDg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" />




<script type="application/ld+json">
    {
  "@context": "https://schema.org/",
  "@type": "Article",
  "headline": "Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force",
  "author": "US Preventive Services Task Force",
  "url": "https://jamanetwork.com/journals/jama/fullarticle/2795521",
  "datePublished": "2022-08-23",
  "description": "This 2022 Recommendation Statement from the US Preventive Services Task Force recommends that for primary prevention of cardiovascular disease (CVD) in adults aged 40-75 years who have ≥1 CVD risk factors, clinicians should prescribe a statin for those with an estimated 10-year CVD risk ≥10% (B recommendation) and selectively offer a statin for those with an estimated risk of 7.5% to &lt;10% (C recommendation) and concludes that evidence is insufficient to assess the balance of benefits and harms of statin initiation for primary prevention of CVD events and mortality in adults ≥76 years (I statement).",
  "publisher": {
    "@type": "Organization",
    "name": "JAMA Network",
    "logo": {
      "@type": "ImageObject",
      "url": "//cdn.jamanetwork.com/UI/app/img/favicons/jama/favicon.ico"
    }
  },
  "image": [
    "https://cdn.jamanetwork.com/ama/content_public/journal/jama/938974/jus220018fa_1660869424.31945.png?Expires=2147483647&Signature=x0OOmQXczAqAURQj7~j~7bE6eTeszKiQYmS-2xzQSNeZ-o0l-D0bMAKLVFP57BXvKrzvBgOYH~RKEEKDeFsRg3lHrFvvAZWpC82L4a4P4GmWOwuEM69NYxlSjPkm3ukYQJfP9YXm~sc2~IYUtf3uwa-NW7T6uh2736FNEl-OGlnhUmIbJXOGyQ3MEMPNpP7kop4HzLbxIJsHU-UNi6kcMnm9iN5mkXyvbaLXGyBe1xvbE6WjlNP9tiuiFTbgcIQ~t-~oo2RLkvxgAfDgYEF~R6CcnGf8w6SkLlYWRNSKr4vfThRbKTL12CK5XEVsNqGs0kAb9FyU6RaqxHV8wxKIDg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
    "https://cdn.jamanetwork.com/ama/content_public/journal/jama/938974/jus220018t1_1660869424.35946.png?Expires=2147483647&Signature=VxBCi2LCwD7-ZVdGj-gzKq46~dshdUewtLZnVCKhjzXGvDeMzkxcSp7SRvzZUr9TQsWC7FzrAx70MhmG07ptE4v5GfEC2ZcLT-iyCimEvlfBZ5s928~iQhBQG-iy4e1ygWoX-CF3yYfvkqPwQcCNfpNTUJ3uXGuCpy3zBtSZvjnACVXQW~nY-ofp5n0i7fN7TvPtG-zQJO~FrlIMmucNeJ1-6PV5cywgrv6gxY3cYzOmAJFq7lE1g77vyZGxk2UgGa6R1ZcGLPf8etrlFcVmIR8dRZPBtKnBrUEARhsAyx3DbdHautIXJkL1gnqE4EzR7BGb57cURV~51Z7pbUGr5g__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
    "https://cdn.jamanetwork.com/ama/content_public/journal/jama/938974/jus220018f1_1660869424.36947.png?Expires=2147483647&Signature=qV88Ql2ZQ~GG-MPhgAD-7AZzTKUQ8DEO~4A2ovBm1E6QyZYORu3j7Vkg62GAEXe9NG87nxc1Ab~n2X2LG~tVwQiIna43boHOP7FH23eROXkW3GdpTQx1NJaIbGwYK72CAICZsPjUQCtw3B07CRu-BSl-T7N4RyuqBJoMsz4Q8cfUvofRPe9AhEcEvb7i~gZUX2g-ayx755Eb9Ex8UPR50U1OEWKOdQM0RgVAZUAGdfRwf~bTMg~YxIXE9X1rRmxPlXopcm~GHb7NeAVUq27Lu9Lr5zjJxN-VH4ROFKo0WMlQf~mD6RAuKKBoIREhMdp6ergUBii0jgtkHEuzraUtiA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA"
  ],
  "articleSection": [
    "Summary of Recommendations",
    "Importance",
    "USPSTF Assessment of Magnitude of Net Benefit",
    "Practice Considerations",
    "Patient Population Under Consideration",
    "Assessment of Risk",
    "Treatment and Statin Intensity",
    "Implementation",
    "Additional Tools and Resources",
    "Suggestions for Practice Regarding the I Statement",
    "Potential Preventable Burden",
    "Potential Harms",
    "Current Practice",
    "Other Related USPSTF Recommendations",
    "Update of Previous USPSTF Recommendation",
    "Supporting Evidence",
    "Scope of Review",
    "Benefits of Preventive Medication",
    "Harms of Preventive Medication",
    "Response to Public Comment",
    "Research Needs and Gaps",
    "Recommendations of Others",
    "Article Information",
    "References"
  ],
  "keyWords": "hydroxymethylglutaryl-coa reductase inhibitors, cardiovascular diseases, united states preventive services task force, primary prevention of cardiovascular disease, heart disease risk factors, diabetes mellitus, non-insulin-dependent, diabetes mellitus"
}
</script>
<meta name="citation_author" content="US Preventive Services Task Force" /><meta name="citation_author" content="Carol M. Mangione" /><meta name="citation_author_institution" content="University of California, Los Angeles" /><meta name="citation_author" content="Michael J. Barry" /><meta name="citation_author_institution" content="Harvard Medical School, Boston, Massachusetts" /><meta name="citation_author" content="Wanda K. Nicholson" /><meta name="citation_author_institution" content="University of North Carolina at Chapel Hill" /><meta name="citation_author" content="Michael Cabana" /><meta name="citation_author_institution" content="Albert Einstein College of Medicine, New York, New York" /><meta name="citation_author" content="David Chelmow" /><meta name="citation_author_institution" content="Virginia Commonwealth University, Richmond" /><meta name="citation_author" content="Tumaini Rucker Coker" /><meta name="citation_author_institution" content="University of Washington, Seattle" /><meta name="citation_author" content="Esa M. Davis" /><meta name="citation_author_institution" content="University of Pittsburgh, Pittsburgh, Pennsylvania" /><meta name="citation_author" content="Katrina E. Donahue" /><meta name="citation_author_institution" content="University of North Carolina at Chapel Hill" /><meta name="citation_author" content="Carlos Roberto Jaén" /><meta name="citation_author_institution" content="The University of Texas Health Science Center, San Antonio" /><meta name="citation_author" content="Martha Kubik" /><meta name="citation_author_institution" content="George Mason University, Fairfax, Virginia" /><meta name="citation_author" content="Li Li" /><meta name="citation_author_institution" content="University of Virginia, Charlottesville" /><meta name="citation_author" content="Gbenga Ogedegbe" /><meta name="citation_author_institution" content="New York University, New York, New York" /><meta name="citation_author" content="Lori Pbert" /><meta name="citation_author_institution" content="University of Massachusetts Medical School, Worcester" /><meta name="citation_author" content="John M. Ruiz" /><meta name="citation_author_institution" content="University of Arizona, Tucson" /><meta name="citation_author" content="James Stevermer" /><meta name="citation_author_institution" content="University of Missouri, Columbia" /><meta name="citation_author" content="John B. Wong" /><meta name="citation_author_institution" content="Tufts University School of Medicine, Boston, Massachusetts" /><meta name="citation_title" content="Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement" /><meta name="citation_firstpage" content="746" /><meta name="citation_lastpage" content="753" /><meta name="citation_doi" content="10.1001/jama.2022.13044" /><meta name="citation_keyword" content="statins" /><meta name="citation_keyword" content="cardiovascular diseases" /><meta name="citation_keyword" content="united states preventive services task force" /><meta name="citation_keyword" content="primary prevention of cardiovascular disease" /><meta name="citation_keyword" content="heart disease risk factors" /><meta name="citation_keyword" content="diabetes mellitus, type 2" /><meta name="citation_keyword" content="diabetes mellitus" /><meta name="citation_abstract" content="&lt;h3&gt;Importance&lt;/h3&gt;&lt;p&gt;Cardiovascular disease (CVD) is the leading cause of morbidity and death in the US and is the cause of more than 1 of every 4 deaths. Coronary heart disease is the single leading cause of death and accounts for 43% of deaths attributable to CVD in the US. In 2019, an estimated 558 000 deaths were caused by coronary heart disease and 109 000 deaths were caused by ischemic stroke.&lt;/p&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;p&gt;To update its 2016 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a review of the evidence on the benefits and harms of statins for reducing CVD-related morbidity or mortality or all-cause mortality.&lt;/p&gt;&lt;h3&gt;Population&lt;/h3&gt;&lt;p&gt;Adults 40 years or older without a history of known CVD and who do not have signs and symptoms of CVD.&lt;/p&gt;&lt;h3&gt;Evidence Assessment&lt;/h3&gt;&lt;p&gt;The USPSTF concludes with moderate certainty that statin use for the prevention of CVD events and all-cause mortality in adults aged 40 to 75 years with no history of CVD and who have 1 or more CVD risk factors (ie, dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year CVD event risk of 10% or greater has at least a moderate net benefit. The USPSTF concludes with moderate certainty that statin use for the prevention of CVD events and all-cause mortality in adults aged 40 to 75 years with no history of CVD and who have 1 or more of these CVD risk factors and an estimated 10-year CVD event risk of 7.5% to less than 10% has at least a small net benefit. The USPSTF concludes that the evidence is insufficient to determine the balance of benefits and harms of statin use for the primary prevention of CVD events and mortality in adults 76 years or older with no history of CVD.&lt;/p&gt;&lt;h3&gt;Recommendation&lt;/h3&gt;&lt;p&gt;The USPSTF recommends that clinicians prescribe a statin for the primary prevention of CVD for adults aged 40 to 75 years who have 1 or more CVD risk factors (ie, dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year CVD risk of 10% or greater. (B recommendation) The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of CVD for adults aged 40 to 75 years who have 1 or more of these CVD risk factors and an estimated 10-year CVD risk of 7.5% to less than 10%. The likelihood of benefit is smaller in this group than in persons with a 10-year risk of 10% or greater. (C recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of initiating a statin for the primary prevention of CVD events and mortality in adults 76 years or older. (I statement)&lt;/p&gt;" /><meta name="citation_journal_title" content="JAMA" /><meta name="citation_journal_abbrev" content="JAMA" /><meta name="citation_volume" content="328" /><meta name="citation_issue" content="8" /><meta name="citation_publication_date" content="2022/08/23" /><meta name="citation_issn" content="0098-7484" /><meta name="citation_publisher" content="American Medical Association" /><meta name="citation_reference" content="citation_title=Deaths: leading causes for 2017.; citation_author=Heron  M;  citation_journal_title=Natl Vital Stat Rep;  citation_year=2019;  citation_volume=68;  citation_issue=6;  citation_pages=1-77; " /><meta name="citation_reference" content="citation_title=Mortality in the United States, 2018.; citation_author=Xu  J; citation_author=Murphy  SL; citation_author=Kockanek  KD; citation_author=Arias  E;  citation_journal_title=NCHS Data Brief;  citation_year=2020;  citation_issue=355;  citation_pages=1-8; " /><meta name="citation_reference" content="citation_title=Heart disease and stroke statistics—2020 update: a report from the American Heart Association.; citation_author=American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee; citation_author=Virani  SS; citation_author=Alonso  A; citation_author=Benjamin  EJ;  citation_journal_title=Circulation;  citation_year=2020;  citation_volume=141;  citation_issue=9;  citation_pages=e139-e596; " /><meta name="citation_reference" content="citation_title=Heart disease and stroke statistics—2021 update: a report from the American Heart Association.; citation_author=American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee; citation_author=Virani  SS; citation_author=Alonso  A; citation_author=Aparicio  HJ;  citation_journal_title=Circulation;  citation_year=2021;  citation_volume=143;  citation_issue=8;  citation_pages=e254-e743; " /><meta name="citation_reference" content="US Preventive Services Task Force. Procedure Manual. Updated May 2021. Accessed February 3, 2022. https://uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual " /><meta name="citation_reference" content="citation_title=2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.; citation_author=Goff  DC; citation_author=Lloyd-Jones  DM; citation_author=Bennett  G;  citation_journal_title=J Am Coll Cardiol;  citation_year=2014;  citation_volume=63;  citation_issue=25, pt B;  citation_pages=2935-2959; " /><meta name="citation_reference" content="citation_title=An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort.; citation_author=DeFilippis  AP; citation_author=Young  R; citation_author=Carrubba  CJ;  citation_journal_title=Ann Intern Med;  citation_year=2015;  citation_volume=162;  citation_issue=4;  citation_pages=266-275; " /><meta name="citation_reference" content="citation_title=Calibration of the pooled cohort equations for atherosclerotic cardiovascular disease: an update.; citation_author=Cook  NR; citation_author=Ridker  PM;  citation_journal_title=Ann Intern Med;  citation_year=2016;  citation_volume=165;  citation_issue=11;  citation_pages=786-794; " /><meta name="citation_reference" content="citation_title=Accuracy of the atherosclerotic cardiovascular risk equation in a large contemporary, multiethnic population.; citation_author=Rana  JS; citation_author=Tabada  GH; citation_author=Solomon  MD;  citation_journal_title=J Am Coll Cardiol;  citation_year=2016;  citation_volume=67;  citation_issue=18;  citation_pages=2118-2130; " /><meta name="citation_reference" content="citation_title=Accuracy of cardiovascular risk prediction varies by neighborhood socioeconomic position: a retrospective cohort study.; citation_author=Dalton  JE; citation_author=Perzynski  AT; citation_author=Zidar  DA;  citation_journal_title=Ann Intern Med;  citation_year=2017;  citation_volume=167;  citation_issue=7;  citation_pages=456-464; " /><meta name="citation_reference" content="citation_title=Performance of the atherosclerotic cardiovascular disease pooled cohort risk equations by social deprivation status.; citation_author=Colantonio  LD; citation_author=Richman  JS; citation_author=Carson  AP;  citation_journal_title=J Am Heart Assoc;  citation_year=2017;  citation_volume=6;  citation_issue=3; " /><meta name="citation_reference" content="citation_title=Collaboration and shared decision-making between patients and clinicians in preventive health care decisions and US Preventive Services Task Force recommendations.; citation_author=US Preventive Services Task Force;  citation_journal_title=JAMA;  citation_year=2022;  citation_volume=327;  citation_issue=12;  citation_pages=1171-1176; " /><meta name="citation_reference" content="Chou R,Cantor A,Dana T,. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: A Systematic Review for the US Preventive Services Task Force. Evidence Synthesis No. 219. Agency for Healthcare Research and Quality ; 2022. AHRQ publication 22-05291-EF-1. " /><meta name="citation_reference" content="citation_title=Effects of race on statin prescribing for primary prevention with high atherosclerotic cardiovascular disease risk in a large healthcare system.; citation_author=Dorsch  MP; citation_author=Lester  CA; citation_author=Ding  Y; citation_author=Joseph  M; citation_author=Brook  RD;  citation_journal_title=J Am Heart Assoc;  citation_year=2019;  citation_volume=8;  citation_issue=22; " /><meta name="citation_reference" content="citation_title=Vulnerabilities to health disparities and statin use in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study.; citation_author=Schroff  P; citation_author=Gamboa  CM; citation_author=Durant  RW; citation_author=Oikeh  A; citation_author=Richman  JS; citation_author=Safford  MM;  citation_journal_title=J Am Heart Assoc;  citation_year=2017;  citation_volume=6;  citation_issue=9; " /><meta name="citation_reference" content="citation_title=Race-sex differences in statin use and low-density lipoprotein cholesterol control among people with diabetes mellitus in the Reasons for Geographic and Racial Differences in Stroke study.; citation_author=Gamboa  CM; citation_author=Colantonio  LD; citation_author=Brown  TM; citation_author=Carson  AP; citation_author=Safford  MM;  citation_journal_title=J Am Heart Assoc;  citation_year=2017;  citation_volume=6;  citation_issue=5; " /><meta name="citation_reference" content="citation_title=Trends and disparities in statin use and low-density lipoprotein cholesterol levels among US patients with diabetes, 1999-2014.; citation_author=Gu  A; citation_author=Kamat  S; citation_author=Argulian  E;  citation_journal_title=Diabetes Res Clin Pract;  citation_year=2018;  citation_volume=139;  citation_pages=1-10; " /><meta name="citation_reference" content="citation_title=Vital Signs: prevalence of key cardiovascular disease risk factors for Million Hearts 2022—United States, 2011-2016.; citation_author=Wall  HK; citation_author=Ritchey  MD; citation_author=Gillespie  C; citation_author=Omura  JD; citation_author=Jamal  A; citation_author=George  MG;  citation_journal_title=MMWR Morb Mortal Wkly Rep;  citation_year=2018;  citation_volume=67;  citation_issue=35;  citation_pages=983-991; " /><meta name="citation_reference" content="National Center for Health Statistics. Health, United States, 2019: Table 7: Leading Causes of Death and Numbers of Deaths, by Age: United States, 1980 and 2018. Accessed February 3, 2022. https://www.cdc.gov/nchs/data/hus/2019/007-508.pdf " /><meta name="citation_reference" content="citation_title=Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.; citation_author=JUPITER Study Group; citation_author=Ridker  PM; citation_author=Danielson  E; citation_author=Fonseca  FA;  citation_journal_title=N Engl J Med;  citation_year=2008;  citation_volume=359;  citation_issue=21;  citation_pages=2195-2207; " /><meta name="citation_reference" content="citation_title=Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial.; citation_author=Ridker  PM; citation_author=Pradhan  A; citation_author=MacFadyen  JG; citation_author=Libby  P; citation_author=Glynn  RJ;  citation_journal_title=Lancet;  citation_year=2012;  citation_volume=380;  citation_issue=9841;  citation_pages=565-571; " /><meta name="citation_reference" content="citation_title=Incidence of statin use in older adults with and without cardiovascular disease and diabetes mellitus, January 2008-March 2018.; citation_author=Panozzo  CA; citation_author=Curtis  LH; citation_author=Marshall  J;  citation_journal_title=PLoS One;  citation_year=2019;  citation_volume=14;  citation_issue=12; " /><meta name="citation_reference" content="citation_title=Aspirin use to prevent cardiovascular disease: US Preventive Services Task Force recommendation statement.; citation_author=US Preventive Services Task Force;  citation_journal_title=JAMA;  citation_year=2022;  citation_volume=327;  citation_issue=16;  citation_pages=1577-1584; " /><meta name="citation_reference" content="citation_title=Screening for hypertension in adults: US Preventive Services Task Force reaffirmation recommendation statement.; citation_author=US Preventive Services Task Force;  citation_journal_title=JAMA;  citation_year=2021;  citation_volume=325;  citation_issue=16;  citation_pages=1650-1656; " /><meta name="citation_reference" content="citation_title=Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force recommendation statement.; citation_author=US Preventive Services Task Force;  citation_journal_title=JAMA;  citation_year=2021;  citation_volume=326;  citation_issue=8;  citation_pages=736-743; " /><meta name="citation_reference" content="citation_title=Interventions for tobacco smoking cessation in adults, including pregnant persons: US Preventive Services Task Force recommendation statement.; citation_author=US Preventive Services Task Force;  citation_journal_title=JAMA;  citation_year=2021;  citation_volume=325;  citation_issue=3;  citation_pages=265-279; " /><meta name="citation_reference" content="citation_title=Behavioral counseling interventions to promote a healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: US Preventive Services Task Force recommendation statement.; citation_author=US Preventive Services Task Force;  citation_journal_title=JAMA;  citation_year=2020;  citation_volume=324;  citation_issue=20;  citation_pages=2069-2075; " /><meta name="citation_reference" content="citation_title=Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults without cardiovascular risk factors: US Preventive Services Task Force recommendation statement.; citation_author=US Preventive Services Task Force;  citation_journal_title=JAMA;  citation_year=2017;  citation_volume=318;  citation_issue=2;  citation_pages=167-174; " /><meta name="citation_reference" content="citation_title=Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force recommendation statement.; citation_author=US Preventive Services Task Force;  citation_journal_title=JAMA;  citation_year=2018;  citation_volume=320;  citation_issue=11;  citation_pages=1163-1171; " /><meta name="citation_reference" content="citation_title=Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement.; citation_author=US Preventive Services Task Force;  citation_journal_title=JAMA;  citation_year=2016;  citation_volume=316;  citation_issue=19;  citation_pages=1997-2007; " /><meta name="citation_reference" content="citation_title=Statin use for the primary prevention of cardiovascular disease in adults: updated evidence report and systematic review for the US Preventive Services Task Force.; citation_author=Chou  R; citation_author=Cantor  A; citation_author=Dana  T;  citation_journal_title=JAMA;  citation_year=2022; " /><meta name="citation_reference" content="citation_title=Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.; citation_author=PROSPER Study Group; citation_author=Shepherd  J; citation_author=Blauw  GJ; citation_author=Murphy  MB;  citation_journal_title=Lancet;  citation_year=2002;  citation_volume=360;  citation_issue=9346;  citation_pages=1623-1630; " /><meta name="citation_reference" content="citation_title=Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia.; citation_author=West of Scotland Coronary Prevention Study Group; citation_author=Shepherd  J; citation_author=Cobbe  SM; citation_author=Ford  I;  citation_journal_title=N Engl J Med;  citation_year=1995;  citation_volume=333;  citation_issue=20;  citation_pages=1301-1307; " /><meta name="citation_reference" content="citation_title=Effect of statin treatment vs usual care on primary cardiovascular prevention among older adults: the ALLHAT-LLT randomized clinical trial.; citation_author=ALLHAT Collaborative Research Group; citation_author=Han  BH; citation_author=Sutin  D; citation_author=Williamson  JD;  citation_journal_title=JAMA Intern Med;  citation_year=2017;  citation_volume=177;  citation_issue=7;  citation_pages=955-965; " /><meta name="citation_reference" content="citation_title=Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).; citation_author=ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group;  citation_journal_title=JAMA;  citation_year=2002;  citation_volume=288;  citation_issue=23;  citation_pages=2998-3007; " /><meta name="citation_reference" content="citation_title=Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis.; citation_author=Macedo  AF; citation_author=Taylor  FC; citation_author=Casas  JP; citation_author=Adler  A; citation_author=Prieto-Merino  D; citation_author=Ebrahim  S;  citation_journal_title=BMC Med;  citation_year=2014;  citation_volume=12;  citation_issue=51;  citation_pages=51" /><meta name="citation_reference" content="citation_title=Statins and newly diagnosed diabetes.; citation_author=Jick  SS; citation_author=Bradbury  BD;  citation_journal_title=Br J Clin Pharmacol;  citation_year=2004;  citation_volume=58;  citation_issue=3;  citation_pages=303-309; " /><meta name="citation_reference" content="citation_title=Statin use and risk of diabetes mellitus in postmenopausal women in the Women’s Health Initiative.; citation_author=Culver  AL; citation_author=Ockene  IS; citation_author=Balasubramanian  R;  citation_journal_title=Arch Intern Med;  citation_year=2012;  citation_volume=172;  citation_issue=2;  citation_pages=144-152; " /><meta name="citation_reference" content="citation_title=Statin therapy: diabetes mellitus risk and cardiovascular benefit in primary prevention.; citation_author=Porath  A; citation_author=Arbelle  JE; citation_author=Fund  N; citation_author=Cohen  A; citation_author=Mosseri  M;  citation_journal_title=Isr Med Assoc J;  citation_year=2018;  citation_volume=20;  citation_issue=8;  citation_pages=480-485; " /><meta name="citation_reference" content="citation_title=Cholesterol lowering in intermediate-risk persons without cardiovascular disease.; citation_author=HOPE-3 Investigators; citation_author=Yusuf  S; citation_author=Bosch  J; citation_author=Dagenais  G;  citation_journal_title=N Engl J Med;  citation_year=2016;  citation_volume=374;  citation_issue=21;  citation_pages=2021-2031; " /><meta name="citation_reference" content="citation_title=Risk assessment for cardiovascular disease with nontraditional risk factors: US Preventive Services Task Force recommendation statement.; citation_author=US Preventive Services Task Force;  citation_journal_title=JAMA;  citation_year=2018;  citation_volume=320;  citation_issue=3;  citation_pages=272-280; " /><meta name="citation_reference" content="citation_title=2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.; citation_author=Grundy  SM; citation_author=Stone  NJ; citation_author=Bailey  AL;  citation_journal_title=Circulation;  citation_year=2019;  citation_volume=139;  citation_pages=e1082-1143; " /><meta name="citation_reference" content="citation_title=2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.; citation_author=Arnett  DK; citation_author=Blumenthal  RS; citation_author=Albert  MA;  citation_journal_title=Circulation;  citation_year=2019;  citation_volume=140;  citation_issue=11;  citation_pages=e596-e646; " /><meta name="citation_reference" content="Department of Veterans Affairs, Department of Defense. VA/DoD Clinical Practice Guideline for the Management of Dyslipidemia for Cardiovascular Risk Reduction. Published 2014. Accessed February 3, 2022. https://www.healthquality.va.gov/guidelines/CD/lipids/VADoDDyslipidemiaCPG2014.pdf " /><meta name="citation_fulltext_world_readable" content="" /><meta name="citation_pdf_url" content="https://jamanetwork.com/journals/jama/articlepdf/2795521/jama_mangione_2022_us_220018_1660869424.13945.pdf" />

    
        <title>Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement | Cardiology | JAMA | JAMA Network</title>

    <meta name="description" content="This 2022 Recommendation Statement from the US Preventive Services Task Force recommends that for primary prevention of cardiovascular disease (CVD) in">


    <link rel="canonical" href="https://jamanetwork.com/journals/jama/fullarticle/2795521" />









    
    <script src="//cdn.jamanetwork.com/UI/app/dist/head.min.js?v=638488852268208351"></script>
     
     <script src="https://r451.jamanetwork.com/script.js"></script>
        <div class="widget-WidgetLoader widget-instance-AMA_AdTag_HeaderScript">
        
    <meta class="SCM-SharedWidgets-AsyncHeaderAdLoader" data-url="/AMA/AdTag/AMA_AdTag_HeaderScript" data-params="{&quot;parameters&quot;:{&quot;siteName&quot;:&quot;jama&quot;,&quot;siteId&quot;:3,&quot;journalId&quot;:67,&quot;adDisplay&quot;:0,&quot;adSection&quot;:&quot;scholarly&quot;,&quot;adPosition&quot;:&quot;&quot;,&quot;fromGoogle&quot;:false},&quot;dynamicParameters&quot;:{&quot;localParams&quot;:&quot;[REPLACE_WITH_LOCAL]&quot;}}">
 
    </div>
</head>

<body data-sitename="jama" class="pg_article " data-thm="jama">
    
    <script>
        
        var App = App || {};
        App.suppressAds = App.suppressAds || !!document.getElementsByClassName('suppress-ads').length;
        App.suppressGtm = App.suppressGtm || !!document.getElementsByClassName('suppress-gtm').length;
    </script>

    

        <div id="ad-interstitial" class="ad-interstitial">
            <script>
      googletag.cmd.push(function() {
        if (App.suppressAds) { return; }
        App.Ads.slots[13] = googletag.defineOutOfPageSlot(App.Ads.adPath + '/scholarly', 'ad-interstitial')
          .setTargeting('pos', ['interstitial'])
          .addService(googletag.pubads());
        googletag.display('ad-interstitial');
        googletag.pubads().refresh([App.Ads.slots[13]], {changeCorrelator: false});
      });
            </script>
        </div>




    
    <a class="accessible js-skip-to-navigation" href="#skip-to-navigation">[Skip to Navigation]</a>

    <!-- Google Tag Manager --><noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-WNKSNP" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-WNKSNP');</script><!-- End Google Tag Manager -->

    
    
    <span class="hide tagmanagervalue" data-attribute="productName" data-value="JAMA" data-type="string"></span>
    <form method="post" action="./2795521" id="webform" class="m0">
<input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="SMBD0I8/7XWfUX82T1x8+51TZAo+RGmkMXmJH2RUHLiTonPo/9So2V+NBYGH8gjbKMfA47ogVrcDk1Tt3BTvr9RYx5k=" />

<input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="2173C2F0" />
<input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="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" />
        
        <input id="hdnSiteID" type="hidden" value="3" />
        <input id="hdnDomain" type="hidden" value=".jamanetwork.com" />

        
        

        
        

    <section class="master-header">
        


<script type='text/javascript'>
    var App = App || {};
    App.LoginUserInfo = {
        isInstLoggedIn: [0],
        currentSessionId: 'z0ppgabmkqpzeyaczvmeohov'
    };
</script>



<input name="ctl00$ctl00$BodyContent$Header$hfGlobalSearchSiteURL" type="hidden" id="hfGlobalSearchSiteURL" value="https://jamanetwork.com/" />

<input name="ctl00$ctl00$BodyContent$Header$hfAppIsPaidUser" type="hidden" id="hfAppIsPaidUser" value="false" />
<input name="ctl00$ctl00$BodyContent$Header$hfAppIsMember" type="hidden" id="hfAppIsMember" value="false" />
<input name="ctl00$ctl00$BodyContent$Header$hfAppSubscribedTo" type="hidden" id="hfAppSubscribedTo" />
<input name="ctl00$ctl00$BodyContent$Header$hfAppIsIndividual" type="hidden" id="hfAppIsIndividual" value="false" />
<input name="ctl00$ctl00$BodyContent$Header$hfAppHasAccess" type="hidden" id="hfAppHasAccess" value="false" />
<input name="ctl00$ctl00$BodyContent$Header$hfAppIsReferredFromGoogle" type="hidden" id="hfAppIsReferredFromGoogle" value="False" />
<input name="ctl00$ctl00$BodyContent$Header$hfSolrAutoSuggestMinimumCharactersLength" type="hidden" id="hfSolrAutoSuggestMinimumCharactersLength" value="2" />
<input name="ctl00$ctl00$BodyContent$Header$hfSolrJournalName" type="hidden" id="hfSolrJournalName" value="JAMA" />
<input name="ctl00$ctl00$BodyContent$Header$hfSolrJournalID" type="hidden" id="hfSolrJournalID" value="J67" />
<input name="ctl00$ctl00$BodyContent$Header$hfAppIsLucy" type="hidden" id="hfAppIsLucy" value="false" />


<div class="header-wrap">
    <header class="header">
            <div class="widget-GdprCookieBanner widget-instance-GdprCookieBanner">
        <div class="gdpr-cookie-wrapper js-gdpr-banner">
	<div class="gdpr-cookie-body">
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our <a href="https://jamanetwork.com/pages/privacy-policy#cookies">Cookie Policy</a>&nbsp;<span class="pipe">|</span>&nbsp;<a href="javascript:;" class="js-gdpr-cookie-acceptLink at-acceptgdpr">Continue</a>	</div>
            <input id="hdnDomain" type="hidden" value=".jamanetwork.com" />

    <input id="hdnDomainGdpr" type="hidden" value=".jamanetwork.com" />
    <input id="hdnClientIdGdpr" type="hidden" value="3" />

</div> 
    </div>

        <div class="network-bar">
            <a class="jama-network" href="/" title="JAMA Network Home">
                <img alt="JAMA Network Home" class="title-image" width="443" height="52" src="//cdn.jamanetwork.com/UI/app/svg/Jama_Network_Logo.svg">
            </a>
            
        </div>

        <a class="nav-toggler" href="#nav">
            <div class="nav-toggler-indicator">
                <span class="indicator-stroke"></span>
                <span class="indicator-stroke"></span>
                <span class="indicator-stroke"></span>
                <span class="indicator-stroke"></span>
            </div>
            <div class="nav-toggler-site">
                <span id="BodyContent_Header_siteFullNamenav" class="nav-toggler-microsite"><span class='network'>JAMA</span></span>
            </div>
        </a>
        <nav id="nav" class="nav hide" >
            <div class="nav-journal-level sb-nav-journal-level">
                <a href="https://jamanetwork.com/journals/jama" id="BodyContent_Header_rptMicrositeHeaders_aItemResourceList_0" class="home">Home</a><a href="https://jamanetwork.com/journals/jama/newonline" id="BodyContent_Header_rptMicrositeHeaders_aItemResourceList_1" class="new-online">New Online</a><a href="https://jamanetwork.com/journals/jama/currentissue" id="BodyContent_Header_rptMicrositeHeaders_aItemResourceList_2" class="current-issue">Current Issue</a><a href="https://jamanetwork.com/journals/jama/pages/for-authors" id="BodyContent_Header_rptMicrositeHeaders_aItemResourceList_3" class="for-authors">For Authors</a>
            </div>
            <div class="nav-journals">
                    <div class="widget-SelfServeContent widget-instance-HamburgerPublicationMenu">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="HamburgerPublicationMenu" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<style type="text/css">
    .nav-journals {margin-bottom: 1em;}
    .nav-heading {color: #B9B9B9;border-bottom: 1px solid #242424;border-top: 1px solid #242424;font-size: 1.15em;font-weight: 400;margin: 0;padding: .7em .75em;text-transform: uppercase;}
    a.no-bullet:before {content:none !important;}
    .nav-heading {font-size: 1.15em;margin-bottom:0;padding-left: 38px;}
    .nav-journals a.theme-jama {background-color: #242424;border-bottom: 1px solid #fff;border-top: 1px solid #fff;color: #fff;font-size: 1.15em;margin-bottom: 8px;padding: 11px 0 9px 37px;}
    .nav-journals a.theme-jama::before {background: unset;content: "\e91b";display: none;font-family: ama_icons !important;font-size: 1.25em;line-height: 1;}
    .nav-journals a.theme-jama-network-open {border-bottom:0;}
    .nav .widget-instance-HamburgerPublicationMenu a {padding-left: 36px;}
    .fake-ribbon {border-left: 8px solid #BE1E32;}
    .fake-ribbon a:before {content:none;}
    .nav .widget-instance-HamburgerPublicationMenu .fake-ribbon a {padding-left:30px;}
</style>
<h2 class="nav-heading">Journals</h2>
<a href="/journals/jama" class="theme-jama">JAMA</a>
<a href="/journals/jamanetworkopen" class="theme-jama-network-open">JAMA Network Open</a>
<a href="/journals/jamacardiology" class="theme-jama-cardiology">JAMA Cardiology</a>
<a href="/journals/jamadermatology" class="theme-jama-dermatology">JAMA Dermatology</a>
<a href="/journals/jama-health-forum" class="theme-jama-health-forum">JAMA Health Forum</a>
<a href="/journals/jamainternalmedicine" class="theme-jama-internal-medicine">JAMA Internal Medicine</a>
<a href="/journals/jamaneurology" class="theme-jama-neurology">JAMA Neurology</a>
<a href="/journals/jamaoncology" class="theme-jama-oncology">JAMA Oncology</a>
<a href="/journals/jamaophthalmology" class="theme-jama-ophthalmology">JAMA Ophthalmology </a>
<a href="/journals/jamaotolaryngology" class="theme-jama-otolaryngology-head-neck-surgery">JAMA Otolaryngology–Head &amp; Neck Surgery</a>
<a href="/journals/jamapediatrics" class="theme-jama-pediatrics">JAMA Pediatrics</a>
<a href="/journals/jamapsychiatry" class="theme-jama-psychiatry">JAMA Psychiatry</a>
<a href="/journals/jamasurgery" class="theme-jama-surgery">JAMA Surgery</a>
<a href="/journals/archneurpsyc" class="theme-archives-of-neurology-psychiatry-1919-1959-">Archives of Neurology &amp; Psychiatry (1919-1959)</a>
<h2 class="nav-heading">Podcasts</h2>
<a href="/journals/jama/pages/jama-clinical-reviews">Clinical Reviews</a>
<a href="/journals/jama/pages/jama-editors-summary">Editors' Summary</a>
<a href="/journals/jama/pages/jama-medical-news">Medical News</a>
<a href="/journals/jama/pages/jama-author-interviews">Author Interviews</a>
<a href="/pages/audio" class="no-bullet">More</a>


</div>

 
    </div>
    
            </div>
            <div class="nav-network-other">
                <a href="https://edhub.ama-assn.org/jn-learning" id="BodyContent_Header_rptOtherResources_aItemResourceList_0" class="is-b link-jn-learning-cme" target="_blank">JN Learning / CME</a><a href="https://store.jamanetwork.com/index.aspx?productcode=64" id="BodyContent_Header_rptOtherResources_aItemResourceList_1" class="is-b link-subscribe" target="_blank">Subscribe</a><a href="https://careers.jamanetwork.com/" id="BodyContent_Header_rptOtherResources_aItemResourceList_2" class="is-b link-jobs" target="_blank">Jobs</a><a href="https://jamanetwork.com/pages/resources-for-librarians" id="BodyContent_Header_rptOtherResources_aItemResourceList_3" class="is-b link-institutions-librarians">Institutions / Librarians</a><a href="https://jamanetwork.com/pages/reprints-and-permissions" id="BodyContent_Header_rptOtherResources_aItemResourceList_4" class="is-b link-reprints-permissions" rel="nofollow">Reprints &amp; Permissions</a>
            </div>
            <div class="white text-xxs">
                <div class="p05 ml4 mr3 mb1 mt10 flex hamburger-menu-legal">
                    <a href="/pages/conditions-of-use" class="p0" rel="nofollow">Terms of Use</a>
                    <span class="pl1 pr1">| </span>
                    <a href="/pages/privacy-policy" class="p0" rel="nofollow">Privacy Policy</a>
                    <span class="pl1 pr1">| </span>
                    <a href="/pages/accessibility-statement" class="p0" rel="nofollow">Accessibility Statement</a>
                </div>
                <div class="ta-c">
                    <span class="pb1">2024 American Medical Association. All Rights Reserved</span>
                </div>
            </div>
        </nav>

        

        
        <a class="toolbar-search-trigger is-b" data-mobile-tog-target=".site-search"></a>

        
        <div id="site-search" role="search" class="site-search">
            <div class="site-search-bar">
                
                <div role="search">
                    <select name="ctl00$ctl00$BodyContent$Header$ddlForSearch" id="BodyContent_Header_ddlForSearch" Name="dropDownList" class="cs-select cs-skin-border" title="Search Site Selector" role="options" aria-labelledby="searchLabel">
	<option value="J*">Search All</option>
	<option value="3">JAMA</option>
	<option value="214">JAMA Network Open</option>
	<option value="192">JAMA Cardiology</option>
	<option value="12">JAMA Dermatology</option>
	<option value="261">JAMA Forum Archive</option>
	<option value="193">JAMA Health Forum</option>
	<option value="15">JAMA Internal Medicine</option>
	<option value="16">JAMA Neurology</option>
	<option value="159">JAMA Oncology</option>
	<option value="17">JAMA Ophthalmology</option>
	<option value="18">JAMA Otolaryngology–Head &amp; Neck Surgery</option>
	<option value="19">JAMA Pediatrics</option>
	<option value="14">JAMA Psychiatry</option>
	<option value="20">JAMA Surgery</option>
	<option value="23">Archives of Neurology &amp; Psychiatry</option>

</select>
                </div>
                
                <div class="search-input-container">
                    <input type="search" name="textbox" autocomplete="off" role="textbox" id="search-term" aria-labelledby="searchLabel" class="search-term at-microsite-search-term" placeholder="Enter Search Term" maxlength="255" title="Enter Search Term">
                  
                    <ul id="umbrellaSiteAutoCompleteResults" class="term-list hidden"></ul>
                    
                    <label style="display:none" for="umbrellaSiteSearchInputHint" id="searchLabel">Input Search Term</label>
                      <input class="searchTerm search-input" name="textbox" role="textbox" type="text" id="umbrellaSiteSearchInputHint" aria-labelledby="searchLabel" title="Input Search Term" autocomplete="off">
                </div>
                <!-- /.search-input-container -->
                
                <a name="button" role="button" class="search-button is-b" alt="search button" href="javascript:;"></a>
            </div>
        </div>
        
        <div id="BodyContent_Header_GlobalSignIn_auth" class="auth">
            <a class="auth--trigger is-b is-a" href="javascript:;">
                <span id="BodyContent_Header_GlobalSignIn_spnUserFullName" class="user-full-name">Sign In</span>
            </a>

            <div class="auth--dropdown js-signIn-dropdown">
                
                <div class="auth--option auth--ind">
                    
                    <div id="BodyContent_Header_GlobalSignIn_divUserFullName" class="auth--ind-user"></div>                    
                    
                    <div id="BodyContent_Header_GlobalSignIn_divIndSignIn" class="auth--ind-auth">
                        <div class="auth--title">Individual Sign In</div>
                        <a href="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2795521" id="BodyContent_Header_GlobalSignIn_oauthSignInLink" rel="nofollow" class="auth--ind-sign-in">Sign in</a><a href="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2795521" id="BodyContent_Header_GlobalSignIn_oauthSignUpLink" rel="nofollow" class="auth--ind-create">Create an Account</a>
                    </div>
                </div>

                
                <div id="BodyContent_Header_GlobalSignIn_divInstSignIn" class="auth--option auth--inst">

                    
                    
                    <div class="auth--inst-auth">
                        <div class="auth--title">Access through your institution</div>
                        <a href="/signinshibboleth?returnUrl=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2795521" id="BodyContent_Header_GlobalSignIn_institutionSignIn" rel="nofollow" class="auth--shib">Sign In</a>
                    </div>
                    </div>
 
                                               
                <div id="BodyContent_Header_GlobalSignIn_divPurchaseOptions" class="auth--option auth--purchase">
                    <div class="auth--title">Purchase Options:</div>
                    
                    <a id="BodyContent_Header_GlobalSignIn_lnkSubscribeJournal" class="auth--subscribe" rel="nofollow" href="https://store.jamanetwork.com/index.aspx?productcode=64">Subscribe to the JAMA journal</a>
                </div>

                
                

                
            </div>
        </div>




    </header>
</div>


<div class="editors-choice-header">
</div>

<div id="BodyContent_Header_divAds" class="header-ad-wrap sb-background-primary-dark">
        <div class="leader-ad desktop-only">
            
                <div class="widget-WidgetLoader widget-instance-AMA_AdTag_LeaderboardAd">
        
    <div class="SCM-SharedWidgets-AsyncAdLoader" data-url="/AMA/AdTag/AMA_AdTag_LeaderboardAd" data-params="{&quot;parameters&quot;:{&quot;siteName&quot;:&quot;jama&quot;,&quot;siteId&quot;:3,&quot;journalId&quot;:67,&quot;adDisplay&quot;:1,&quot;adSection&quot;:&quot;scholarly&quot;,&quot;adPosition&quot;:&quot;atf&quot;,&quot;fromGoogle&quot;:false},&quot;dynamicParameters&quot;:{&quot;localParams&quot;:&quot;[REPLACE_WITH_LOCAL]&quot;}}"></div>
 
    </div>

        </div>
    </div>

<!-- /.header-ad-wrap -->


    </section>


    <section class="master-main">
        
    <div class="social-share hide" data-share-journal="JAMA_current" data-share-title="USPSTF Recommendation: Statins for Primary Prevention of Cardiovascular Disease in Adults"></div>

        <div class="widget-UserContentAccessWrite widget-instance-AMA_LocalStorage_Article">
        <div class="SCM-SharedWidgets-LocalStorage-UserContentAccessWrite" data-values='{"id":"2795521","type":"Article","date":"5/5/2024 10:05:40 AM"}'></div>
 
    </div>
    <div class="widget-ArticleToggleView widget-instance-AMA_ArticleToggleView">
        
    <div class="widget-ArticleFullView widget-instance-AMA_ArticleFullView">
        
<script>
    (function () {
        var bodyElem = document.querySelector('body');
        var className = 'split-screen';

        if (bodyElem.classList) {
            bodyElem.classList.add(className);
        } else {
            el.className += ' ' + className;
        }
    })();
</script>


<div id="resources-panel" class="resources-panel">
                <span class="hide tagmanagervalue" data-attribute="template" data-value="splitscreen" data-type="string"></span>


    <div class="tab-nav">
        <a class="tab-nav-trigger tab-nav-full-text tablet-down" href="#full-text-tab">
            <i class="icon-full_text"><span class="sr-t">full text icon</span></i>
            <div class="tab-nav-tab-name">Full Text</div>
        </a>
        <a class="tab-nav-trigger tab-nav-contents target-tab-active" href="#contents-tab">
            <i class="icon-contents"><span class="sr-t">contents icon</span></i>
            <div class="tab-nav-tab-name">Contents</div>
        </a>
        <a class="tab-nav-trigger tab-nav-figure-table" href="#figure-table-tab">
            <i class="icon-figures"><span class="sr-t">figure icon</span></i>
            <div class="tab-nav-tab-name">Figures / <br> Tables</div>
        </a>
        <a class="tab-nav-trigger tab-nav-multimedia" href="#multimedia-tab">
            <i class="icon-multimedia"><span class="sr-t">multimedia icon</span></i>
            <div class="tab-nav-tab-name">Multimedia</div>
        </a>
        <a class="tab-nav-trigger tab-nav-supplemental" href="#supplemental-tab">
            <i class="icon-attach"><span class="sr-t">attach icon</span></i>
            <div class="tab-nav-tab-name">Supplemental <br> Content</div>
        </a>
        <a class="tab-nav-trigger tab-nav-references" href="#references-tab">
            <i class="icon-references"><span class="sr-t">references icon</span></i>
            <div class="tab-nav-tab-name">References</div>
        </a>
        <a class="tab-nav-trigger tab-nav-related" href="#related-tab">
            <i class="icon-related"><span class="sr-t">related icon</span></i>
            <div class="tab-nav-tab-name">Related</div>
        </a>
        <a class="tab-nav-trigger tab-nav-comments" href="#comments-tab">
            <i class="icon-user-comments"><span class="sr-t">comments icon</span></i>
            <div class="tab-nav-tab-name">Comments</div>
        </a>
    </div>



    <div class="resource-tabs">
        <div id="contents-tab" class="resource-tab js-resource-tab contents-tab tab-active">
            <div class="contents-tab-contents">
            <a id="pdf-link" class="toolbar-tool toolbar-pdf al-link pdfaccess" data-article-id="2795521" data-article-url="/journals/jama/articlepdf/2795521/jama_mangione_2022_us_220018_1660869424.13945.pdf" data-ajax-url="/Content/CheckPdfAccess"><span class="toolbar-pdf-text"><span class="toolbar-link-text-extra">Download </span><span class="toolbar-link-text">PDF</span></span>
            </a>
    <div class="widget-ArticleJumpLinks widget-instance-AMA_ArticleJumpLinks_Widget">
            <a href="#top" class="section-jump-link contents-tab-jump-link top-of-article" data-tab-toggle=".tab-nav-full-text">Top of Article</a>
    <ul class="section-jump-links bullet ml2 pl1">
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#248566950" data-tab-toggle=".tab-nav-full-text">Abstract</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#248566956" data-tab-toggle=".tab-nav-full-text">Summary of Recommendations</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#248566959" data-tab-toggle=".tab-nav-full-text">Importance</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#248566961" data-tab-toggle=".tab-nav-full-text">USPSTF Assessment of Magnitude of Net Benefit</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#248566968" data-tab-toggle=".tab-nav-full-text">Practice Considerations</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#248566991" data-tab-toggle=".tab-nav-full-text">Update of Previous USPSTF Recommendation</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#248566993" data-tab-toggle=".tab-nav-full-text">Supporting Evidence</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#248567010" data-tab-toggle=".tab-nav-full-text">Research Needs and Gaps</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#248567013" data-tab-toggle=".tab-nav-full-text">Recommendations of Others</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#248567016" data-tab-toggle=".tab-nav-full-text">Article Information</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#248567017" data-tab-toggle=".tab-nav-full-text">References</a></li>
    </ul>
 
    </div>
    <div class="widget-SelfServeContent widget-instance-AMA_Contents_Tab_SelfServe">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="v2_article_content_tab" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="bc_right_rail_article_promo"><!-- Content Goes Here --></div>


</div>

 
    </div>

            </div>
            <div class="contents-tab-ad">
                <div id="split-screen-contab"></div>
            </div>
        </div>

        
        <div id="figure-table-tab" class="resource-tab js-resource-tab figure-table-tab need-jobs-ad">
    <div class="widget-ArticleFiguresAndTables widget-instance-AMA_Article_Figures_Tab">
        <div class="figure-table-wrapper inline thm-bd-top"><div class="inline-graphic"><a id="jus220018fa" class="figure-anchor"> </a><a href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938974/jus220018fa_1660869424.31945.png?Expires=1717537474&amp;Signature=Xywrc19m9PGmnAd-w5tfM-2gEHh~8UbYtysDWmPvg~D-laC51LHBbDhU-wx64AWMXYUWg7eGiXoJAd0xDYaHAx4eOiuwXd1bKNbndUs~BFydzRSYGTlYpSQbaoWHaP7wLycaOad0Y1vbgqLK7TnEusO3DVkBXFdllEoTeUrfvl5oA0Fm2cLHjVSDQ9Z1RxVn~ALiIK8KB9frSe9yOtITwFS0RXJkdTMZtFtx3v6FqhY70BwY5FLvnyZR8muCcHL0BnXmmqA0KKiLqEij2kWi2fyggpkbtBmAMi5qQyiJBAGtKFP7SLWrgxxitdWIo9b-qTKmRgb-VO3VFZkoJpFU7g__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" path-from-xml="jus220018fa" rel="nofollow"><img data-original="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938974/m_jus220018fa_1660869424.31945.png?Expires=1717537474&amp;Signature=O35I8xM063i3uY~x9Gx1i0lMUGb6WRaXhnh5STPXR4ww3~P4ddiOWiJjmw5BS7zhwO1tyIGpLVyLcKni-hw8PGgkiQolCvJEuIXOELvwZFFs7iy7tY0usukUEtSd6XAk7ZnkrHL~AFj31JtaBSlbM~Feg3L0zoMChVuYdAFbK0tyWecr9KXeGhvDWmoywH-xCWSQ4EYwMrNqm17vMtrClUKDc~H8KfgXVE0dLRQpPFwkQ0~H~QyNO6LNetf-uU3rFrQVM4OF2OxjiGIHuMzQwxZuRDAHsRkB5Uik~7cR10zV5I9Vq7AbxwK0VYALlD9vdsnk-Qw0-YEGeJ-7U9aorA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" alt="USPSTF indicates US Preventive Services Task Force." class="content-img lazy" path-from-xml="jus220018fa" /></a></div><div class="figure-caption clip-last-child"><p class="para">USPSTF indicates US Preventive Services Task Force.</p></div></div><div class="figure-table-wrapper thm-bd-top"><div class="figure-label">Figure.  Clinician Summary: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults</div><a id="jus220018f1" class="figure-table-anchor"> </a><div class="figure-table-links right"><a class="view-large figure-table-link is-b desktop-only" path-from-xml="jus220018f1" href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938974/jus220018f1_1660869424.36947.png?Expires=1717537474&amp;Signature=1Ldbt8aAEfEqQT6AcXoTQOr3SbrJnwNgMhch5YnXclEncNq-FeK903SklLm6Grx6zAENTjV~SI4r1GOH00tFmRShFAnkYJeIZ85ng0NMl84AoytzqKxXzyF~yoiFjgOikCkf2uXp4GLuIcf4MqzlUkQRaK27RwzOpwhBkM7LR1S-mqed~1Jwvb5W8n818n8EgauWJ8x-dmgRb23bmVmB7jkVglL7OPEmeN5pz5XV1XfwJAkqt9L6EJ~rCot0cPzyHX-TubHq5awePxkaCypOMTXpfwa4KwVv74TG7o-VeZGreqyuS1bjXOX5XjKgGPSwgBkXspXO1ijK4jeWf5nIMQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" rel="nofollow"><span class="view-large-text">View Large</span></a><a class="download-ppt figure-table-link is-b stats-download-figure-table" path-from-xml="jus220018f1" href="/downloadimage.aspx?image=https://cdn.jamanetwork.com/ama/content_public/journal/jama/938974/jus220018f1_1660869424.36947.png?Expires=1717537474&Signature=1Ldbt8aAEfEqQT6AcXoTQOr3SbrJnwNgMhch5YnXclEncNq-FeK903SklLm6Grx6zAENTjV~SI4r1GOH00tFmRShFAnkYJeIZ85ng0NMl84AoytzqKxXzyF~yoiFjgOikCkf2uXp4GLuIcf4MqzlUkQRaK27RwzOpwhBkM7LR1S-mqed~1Jwvb5W8n818n8EgauWJ8x-dmgRb23bmVmB7jkVglL7OPEmeN5pz5XV1XfwJAkqt9L6EJ~rCot0cPzyHX-TubHq5awePxkaCypOMTXpfwa4KwVv74TG7o-VeZGreqyuS1bjXOX5XjKgGPSwgBkXspXO1ijK4jeWf5nIMQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=248566967&ar=2795521&imagename=&siteId=3" rel="nofollow"><span class="download-ppt-text">Download</span></a><a class="figure-table-twitter figure-table-link figure-table-social addthis_button_twitter is-b" rel="nofollow"><span class="share-text"> </span></a><a class="figure-table-facebook figure-table-link figure-table-social addthis_button_facebook is-b" rel="nofollow"><span class="share-text"> </span></a></div><div class="figure-table cf cb"><div class="figure-table-image"><a href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938974/jus220018f1_1660869424.36947.png?Expires=1717537474&amp;Signature=1Ldbt8aAEfEqQT6AcXoTQOr3SbrJnwNgMhch5YnXclEncNq-FeK903SklLm6Grx6zAENTjV~SI4r1GOH00tFmRShFAnkYJeIZ85ng0NMl84AoytzqKxXzyF~yoiFjgOikCkf2uXp4GLuIcf4MqzlUkQRaK27RwzOpwhBkM7LR1S-mqed~1Jwvb5W8n818n8EgauWJ8x-dmgRb23bmVmB7jkVglL7OPEmeN5pz5XV1XfwJAkqt9L6EJ~rCot0cPzyHX-TubHq5awePxkaCypOMTXpfwa4KwVv74TG7o-VeZGreqyuS1bjXOX5XjKgGPSwgBkXspXO1ijK4jeWf5nIMQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" path-from-xml="jus220018f1" rel="nofollow"><img data-original="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938974/m_jus220018f1_1660869424.36947.png?Expires=1717537474&amp;Signature=I4xWT5K-g~pB18kArC2S4HeOw7a7zBzvAD5Kqrqt-~ribTGwK5E4zwr3knu5pk5o~6lH~kNnoD~98JL4nDzfk2HR127xX3BnnIX~iN7Yvl3tfaPcALLZFYAintvIX0l-bNSanwqnOIcwP584O7o1LVUCpQISodkQ5MF9VZtKT9zBZTO9jVSrejUc90QylJhNgM84hF5UyoKzsZLQ5YFOl-k4vL60U8f0k39cOkk6VrCpaI4Qci2dZNlfvV9lSwDhMDGKtXtdx5VnmfcBi0YrEJPKgkveuQJ~cOQyXrvFNIglN44MmpXW7hm67QKYV~OZT5-kx~DLCFAovyxwCZhoaw__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" alt="Clinician Summary: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults" class="content-img lazy" path-from-xml="jus220018f1" /></a></div></div><div class="figure-caption clip-last-child"><p class="para">USPSTF indicates US Preventive Services Task Force</p></div></div> 
    </div>
    <div class="widget-ArticleFiguresAndTables widget-instance-AMA_Article_Tables_Tab">
        <div class="figure-table-wrapper thm-bd-top"><div class="table-label">Table.  Summary of USPSTF Rationale</div><a class="figure-table-anchor" id="jus220018t1"> </a><div class="figure-table-links right"><a class="view-large figure-table-link is-b desktop-only" path-from-xml="jus220018t1" href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938974/jus220018t1_1660869424.35946.png?Expires=1717537474&amp;Signature=pSx5UoGTWO9ICTBsz81H0hu90uGdawQCQS2KBUT0FoSzECXgh1sP5c-wgU33pBJMlZBEzftA7l0ty~56M7Q-HW2ETHuiyqbxcmBDs0mHqa4fwdP~kJgNh12E4dCxIWLfkF75h9aAQ2LNeuQ4e-XSNud0X1ZMJS8FKkk~e1O40PgYM7IFcQB1zbWwA~O70zHI7fENsa9Xl0HG5dwn7kGPJSlp~rpuU12k7ko9J9Nn7G6myJe6Ru6Wnz1rbVuB4Fj9hzcgRhZTChDdcsAAaI2ZYcOvSH-BvFpkSVBdRJequI1tMqPOIcP4l0O8TEdHd9gIZVZt0cqChwmjO3KRY0gb6A__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" rel="nofollow"><span class="view-large-text">View Large</span></a><a class="download-ppt figure-table-link is-b stats-download-figure-table" path-from-xml="jus220018t1" href="/downloadimage.aspx?image=https://cdn.jamanetwork.com/ama/content_public/journal/jama/938974/jus220018t1_1660869424.35946.png?Expires=1717537474&Signature=pSx5UoGTWO9ICTBsz81H0hu90uGdawQCQS2KBUT0FoSzECXgh1sP5c-wgU33pBJMlZBEzftA7l0ty~56M7Q-HW2ETHuiyqbxcmBDs0mHqa4fwdP~kJgNh12E4dCxIWLfkF75h9aAQ2LNeuQ4e-XSNud0X1ZMJS8FKkk~e1O40PgYM7IFcQB1zbWwA~O70zHI7fENsa9Xl0HG5dwn7kGPJSlp~rpuU12k7ko9J9Nn7G6myJe6Ru6Wnz1rbVuB4Fj9hzcgRhZTChDdcsAAaI2ZYcOvSH-BvFpkSVBdRJequI1tMqPOIcP4l0O8TEdHd9gIZVZt0cqChwmjO3KRY0gb6A__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=248566966&ar=2795521&imagename=&siteId=3" rel="nofollow"><span class="download-ppt-text">Download</span></a><a class="figure-table-twitter figure-table-link figure-table-social addthis_button_twitter is-b" rel="nofollow"><span class="share-text"> </span></a><a class="figure-table-facebook figure-table-link figure-table-social addthis_button_facebook is-b" rel="nofollow"><span class="share-text"> </span></a></div><div class="figure-table cf cb"><div class="figure-table-image"><a href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938974/jus220018t1_1660869424.35946.png?Expires=1717537474&amp;Signature=pSx5UoGTWO9ICTBsz81H0hu90uGdawQCQS2KBUT0FoSzECXgh1sP5c-wgU33pBJMlZBEzftA7l0ty~56M7Q-HW2ETHuiyqbxcmBDs0mHqa4fwdP~kJgNh12E4dCxIWLfkF75h9aAQ2LNeuQ4e-XSNud0X1ZMJS8FKkk~e1O40PgYM7IFcQB1zbWwA~O70zHI7fENsa9Xl0HG5dwn7kGPJSlp~rpuU12k7ko9J9Nn7G6myJe6Ru6Wnz1rbVuB4Fj9hzcgRhZTChDdcsAAaI2ZYcOvSH-BvFpkSVBdRJequI1tMqPOIcP4l0O8TEdHd9gIZVZt0cqChwmjO3KRY0gb6A__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" path-from-xml="jus220018t1" rel="nofollow"><img data-original="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938974/m_jus220018t1_1660869424.35946.png?Expires=1717537474&amp;Signature=JLvXGdf9~pYhHB8yucxRk0gy2E-FChkCy3Zw-GxS~O7zCnuZ9EM6un4ePSqRBZwlDQarE9aWOKeirOK4EMIUDr8~uztmL2Qb9XWzjb7Xu9FGYbB-piM1R7o6DrMe4-w49uGN77BmzoHr6Oy2xv-hTifsL0DIWxDSsosPoUGk56mugiN7ReM6bDejtQ9GObOB9JxX0cQFhjc317yBJGyd1H41i7k0ezi~HS~OBkDl32nUcjwjMGOu5a0o~qdocVVJDNDH0KEApW16QFrJzEGLSCX93x~cmufU0K1xGdcd6TUgc8H9909jTRHkfyDVAYiQMmrhkZbMJgWPSkgEXTepRA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" alt="Summary of USPSTF Rationale" class="content-img lazy" path-from-xml="jus220018t1" /></a></div></div><div class="table-caption"></div></div> 
    </div>

        </div>

        
        <div id="multimedia-tab" class="resource-tab js-resource-tab multimedia-tab need-jobs-ad">
    <div class="widget-MultimediaInfo widget-instance-AMAv2MultimediaContent">
        

        <div class="multimedia-item audio ">
                    <div class="audio-group-duration">
            Audio (25:31)
        </div>
        <div><a class="audio-title" href="https://jamanetwork.com/learning/audio-player/18717724" target="_blank" aria-label="Linked Multimedia Button"><div class="multimedia-title">USPSTF Recommendation: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults</div></a></div>
        <a class="audio-anchor"></a>
    <div class="widget-AudioPlayer widget-instance-AMA_MultimediaInfo_PlatformAudioPlayer_MultimediaInfo">
            <div class="audio-element-wrapper js-audio-element-wrapper">
                            <a class="audio-anchor" id="101001jama202211315"></a>
        <div id="audio-player-wrapper" class="js-audio-player-wrapper audio-player-wrapper">
            <audio class="js-audio-player" id="audio-player" type="audio/mp3" preload="none" src=https://traffic.libsyn.com/secure/jamaauthorinterviews/uspstf_recommendation_statin_use_for_the_primary_prevention_of_cardiovascular_disease_in_adults.mp3></audio>
            <div class="display-elements">
                <div class="audio-controls">
                    <a id="backward" class="js-btn-backward audio-back" href="javascript:;" aria-label="Back Button">
                        <img src="//cdn.jamanetwork.com/UI/app/svg/multimedia/Backward_15.svg" alt="Backward 15" />
                    </a>
                    <a id="play-pause" class="js-play-pause audio-play" href="javascript:;" aria-label="Play Button">
                        <img src="//cdn.jamanetwork.com/UI/app/svg/multimedia/Play.svg" alt="Play" />
                    </a>
                    <a id="play-pause" class="js-play-pause audio-pause" href="javascript:;" aria-label="Pause Button">
                        <img src="//cdn.jamanetwork.com/UI/app/svg/multimedia/Pause.svg" alt="Pause" />
                    </a>
                    <a id="forward" class="js-btn-forward audio-forward" href="javascript:;" aria-label="Fast Forward Button">
                        <img src="//cdn.jamanetwork.com/UI/app/svg/multimedia/Forward_15.svg" alt="Forward 15" />
                    </a>
                </div>
                <div class="js-progressBar-clickable progressBar-clickable">
                    <div class="js-progressBar progressBar">
                        <div class="js-loading-animation">
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                        </div>
                        <div class="js-timeBar timeBar thm-bg-col sb-background-pc" tabindex="0" aria-label="Progress Bar"></div>
                    </div>
                </div>
                <div class="audio-speed">
                    <a id="speed-1x" class="js-btn-speed" play-speed=1 href="javascript:;" aria-label="Speed Control Button">1x</a>
                </div>
                <div class="audio-time">
                    <span id="time" class="js-time js-timeAudioCurrent">0:00</span>
                    <span> / </span>
                    <span class="js-initialTime">0:00</span>
                    <span class="js-duration hide"></span>
                </div>
            </div>
        </div>
            <div class="linked-content-urls-wrapper">
                            <span><a class="thm-col sb-pc linked-content" target="_blank" href="https://jamanetwork.com/journals/jama/pages/jama-author-interviews" aria-label="Subscribe To Podcast Button">Subscribe to Podcast</a></span>

            </div>
        
    </div>
 
    </div>

        </div>

            <span class="hide tagmanagervalue" data-attribute="arrRelatedAudio" data-value="10.1001/jama.2022.11315" data-type="array"></span>





 
    </div>

        </div>

        
        <div id="supplemental-tab" class="resource-tab js-resource-tab supplemental-tab need-jobs-ad">
    <div class="widget-ArticleDataSupplements widget-instance-AMA_Data_Supplements_Tab">
            <div class="supplement">
        <a id="note-JUS220018-1" href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938974/jus220018supp1_prod_1660869424.14948.pdf?Expires=1717899211&amp;Signature=IfMNeBiFQ9cRFJZqaZdj2~HTCfS8eUISyBL8awsxHjb2VV95AjUmcHrAutEKgygqhxwAhscPH7n9JgZNY2UabAF61WQMkrRtlCw8TOycLvsxVA1OblDdK1AQjr7kjjFV0VOXOtjN7NoDXbagbsP4Wn6zeYdyFRjYYYMobUmXNKRfW4vOV8JOw204bKtpQxslYIQQWLOls2o2Ur9ub2M3EasxbUPLL13VZXahoXaMXq-qTsT2BjzGFjEWMlZzAU1VUhzrnoqn5lkMw9Gd~Ri365mSgwjkjeQpgux3BoAGrCepNSbZoPzGLZyEA3HDg7S1dbYoo5kPq7zzQMVqUoJYOg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" class="supplement-link supplement-download stats-supplement-download" rel=&quot;nofollow&quot;>
            <div class="pdf supplement-type"></div>
                <div class="supplement-title"><span class="title-label">Supplement.</span><p class="para">eFigure. US Preventive Services Task Force (USPSTF) Grades and Levels of Evidence</p></div>
        </a>        
    </div>

 
    </div>

        </div>

        
        <div id="references-tab" class="resource-tab js-resource-tab references-tab need-jobs-ad">
            <div class="references-wrap">
    <div class="widget-SectionDisplay widget-instance-AMA_References_Tab">
        
<div class="references"><div class="reference"><a class="reference-number" id="jus220018r1">1.</a><div class="reference-content">Heron
         M﻿.  Deaths: leading causes for 2017. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Natl Vital Stat Rep</i>. 2019;68(6):1-77.<a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32501203" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Deaths%3A%20leading%20causes%20for%202017.&amp;author=M%20Heron&amp;publication_year=2019&amp;journal=Natl%20Vital%20Stat%20Rep&amp;volume=68&amp;pages=1-77" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jus220018r2">2.</a><div class="reference-content">Xu
         J﻿, Murphy
         SL﻿, Kockanek
         KD﻿, Arias
         E﻿.  Mortality in the United States, 2018. ﻿ <i xmlns:helper="urn:XsltStringHelper"> NCHS Data Brief</i>. 2020;(355):1-8.<a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32487294" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Mortality%20in%20the%20United%20States%2C%202018.&amp;author=J%20Xu&amp;author=SL%20Murphy&amp;author=KD%20Kockanek&amp;author=E%20Arias&amp;publication_year=2020&amp;journal=NCHS%20Data%20Brief&amp;volume=&amp;pages=1-8" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jus220018r3">3.</a><div class="reference-content">Virani
         SS﻿, Alonso
         A﻿, Benjamin
         EJ﻿, 
     et al; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee.  Heart disease and stroke statistics—2020 update: a report from the American Heart Association. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Circulation</i>. 2020;141(9):e139-e596. doi:<a href="http://dx.doi.org/10.1161/CIR.0000000000000757">10.1161/CIR.0000000000000757</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/31992061" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Heart%20disease%20and%20stroke%20statistics%E2%80%942020%20update%3A%20a%20report%20from%20the%20American%20Heart%20Association.&amp;author=SS%20Virani&amp;author=A%20Alonso&amp;author=EJ%20Benjamin&amp;publication_year=2020&amp;journal=Circulation&amp;volume=141&amp;pages=e139-e596" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1161/CIR.0000000000000757" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1161/CIR.0000000000000757" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r4">4.</a><div class="reference-content">Virani
         SS﻿, Alonso
         A﻿, Aparicio
         HJ﻿, 
     et al; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee.  Heart disease and stroke statistics—2021 update: a report from the American Heart Association. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Circulation</i>. 2021;143(8):e254-e743. doi:<a href="http://dx.doi.org/10.1161/CIR.0000000000000950">10.1161/CIR.0000000000000950</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/33501848" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Heart%20disease%20and%20stroke%20statistics%E2%80%942021%20update%3A%20a%20report%20from%20the%20American%20Heart%20Association.&amp;author=SS%20Virani&amp;author=A%20Alonso&amp;author=HJ%20Aparicio&amp;publication_year=2021&amp;journal=Circulation&amp;volume=143&amp;pages=e254-e743" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1161/CIR.0000000000000950" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1161/CIR.0000000000000950" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r5">5.</a><div class="reference-content">US Preventive Services Task Force. Procedure Manual. Updated May 2021. Accessed February 3, 2022. <a href="https://uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual">https://uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual</a></div></div><div class="reference"><a class="reference-number" id="jus220018r6">6.</a><div class="reference-content">Goff
         DC
         Jr﻿, Lloyd-Jones
         DM﻿, Bennett
         G﻿, 
     et al.  2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Am Coll Cardiol</i>. 2014;63(25, pt B):2935-2959. doi:<a href="http://dx.doi.org/10.1016/j.jacc.2013.11.005">10.1016/j.jacc.2013.11.005</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/24239921" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=2013%20ACC%2FAHA%20guideline%20on%20the%20assessment%20of%20cardiovascular%20risk%3A%20a%20report%20of%20the%20American%20College%20of%20Cardiology%2FAmerican%20Heart%20Association%20Task%20Force%20on%20Practice%20Guidelines.&amp;author=DC%20Goff&amp;author=DM%20Lloyd-Jones&amp;author=G%20Bennett&amp;publication_year=2014&amp;journal=J%20Am%20Coll%20Cardiol&amp;volume=63&amp;pages=2935-2959" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/j.jacc.2013.11.005" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/j.jacc.2013.11.005" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r7">7.</a><div class="reference-content">DeFilippis
         AP﻿, Young
         R﻿, Carrubba
         CJ﻿, 
     et al.  An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Ann Intern Med</i>. 2015;162(4):266-275. doi:<a href="http://dx.doi.org/10.7326/M14-1281">10.7326/M14-1281</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/25686167" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=An%20analysis%20of%20calibration%20and%20discrimination%20among%20multiple%20cardiovascular%20risk%20scores%20in%20a%20modern%20multiethnic%20cohort.&amp;author=AP%20DeFilippis&amp;author=R%20Young&amp;author=CJ%20Carrubba&amp;publication_year=2015&amp;journal=Ann%20Intern%20Med&amp;volume=162&amp;pages=266-275" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.7326/M14-1281" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.7326/M14-1281" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r8">8.</a><div class="reference-content">Cook
         NR﻿, Ridker
         PM﻿.  Calibration of the pooled cohort equations for atherosclerotic cardiovascular disease: an update. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Ann Intern Med</i>. 2016;165(11):786-794. doi:<a href="http://dx.doi.org/10.7326/M16-1739">10.7326/M16-1739</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/27723890" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Calibration%20of%20the%20pooled%20cohort%20equations%20for%20atherosclerotic%20cardiovascular%20disease%3A%20an%20update.&amp;author=NR%20Cook&amp;author=PM%20Ridker&amp;publication_year=2016&amp;journal=Ann%20Intern%20Med&amp;volume=165&amp;pages=786-794" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.7326/M16-1739" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.7326/M16-1739" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r9">9.</a><div class="reference-content">Rana
         JS﻿, Tabada
         GH﻿, Solomon
         MD﻿, 
     et al.  Accuracy of the atherosclerotic cardiovascular risk equation in a large contemporary, multiethnic population. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Am Coll Cardiol</i>. 2016;67(18):2118-2130. doi:<a href="http://dx.doi.org/10.1016/j.jacc.2016.02.055">10.1016/j.jacc.2016.02.055</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/27151343" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Accuracy%20of%20the%20atherosclerotic%20cardiovascular%20risk%20equation%20in%20a%20large%20contemporary%2C%20multiethnic%20population.&amp;author=JS%20Rana&amp;author=GH%20Tabada&amp;author=MD%20Solomon&amp;publication_year=2016&amp;journal=J%20Am%20Coll%20Cardiol&amp;volume=67&amp;pages=2118-2130" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/j.jacc.2016.02.055" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/j.jacc.2016.02.055" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r10">10.</a><div class="reference-content">Dalton
         JE﻿, Perzynski
         AT﻿, Zidar
         DA﻿, 
     et al.  Accuracy of cardiovascular risk prediction varies by neighborhood socioeconomic position: a retrospective cohort study. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Ann Intern Med</i>. 2017;167(7):456-464. doi:<a href="http://dx.doi.org/10.7326/M16-2543">10.7326/M16-2543</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/28847012" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Accuracy%20of%20cardiovascular%20risk%20prediction%20varies%20by%20neighborhood%20socioeconomic%20position%3A%20a%20retrospective%20cohort%20study.&amp;author=JE%20Dalton&amp;author=AT%20Perzynski&amp;author=DA%20Zidar&amp;publication_year=2017&amp;journal=Ann%20Intern%20Med&amp;volume=167&amp;pages=456-464" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.7326/M16-2543" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.7326/M16-2543" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r11">11.</a><div class="reference-content">Colantonio
         LD﻿, Richman
         JS﻿, Carson
         AP﻿, 
     et al.  Performance of the atherosclerotic cardiovascular disease pooled cohort risk equations by social deprivation status. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Am Heart Assoc</i>. 2017;6(3):e005676. doi:<a href="http://dx.doi.org/10.1161/JAHA.117.005676">10.1161/JAHA.117.005676</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/28314800" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Performance%20of%20the%20atherosclerotic%20cardiovascular%20disease%20pooled%20cohort%20risk%20equations%20by%20social%20deprivation%20status.&amp;author=LD%20Colantonio&amp;author=JS%20Richman&amp;author=AP%20Carson&amp;publication_year=2017&amp;journal=J%20Am%20Heart%20Assoc&amp;volume=6&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1161/JAHA.117.005676" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1161/JAHA.117.005676" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r12">12.</a><div class="reference-content">US Preventive Services Task Force.  Collaboration and shared decision-making between patients and clinicians in preventive health care decisions and US Preventive Services Task Force recommendations. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2022;327(12):1171-1176. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2022.3267">10.1001/jama.2022.3267</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/35315879" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Collaboration%20and%20shared%20decision-making%20between%20patients%20and%20clinicians%20in%20preventive%20health%20care%20decisions%20and%20US%20Preventive%20Services%20Task%20Force%20recommendations.&amp;publication_year=2022&amp;journal=JAMA&amp;volume=327&amp;pages=1171-1176" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2022.3267" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2022.3267" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r13">13.</a><div class="reference-content">Chou
         R﻿, Cantor
         A﻿, Dana
         T﻿, 
     et al. <i xmlns:helper="urn:XsltStringHelper"> Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: A Systematic Review for the US Preventive Services Task Force. Evidence Synthesis No. 219</i>.  Agency for Healthcare Research and Quality; 2022. AHRQ publication 22-05291-EF-1.</div></div><div class="reference"><a class="reference-number" id="jus220018r14">14.</a><div class="reference-content">Dorsch
         MP﻿, Lester
         CA﻿, Ding
         Y﻿, Joseph
         M﻿, Brook
         RD﻿.  Effects of race on statin prescribing for primary prevention with high atherosclerotic cardiovascular disease risk in a large healthcare system. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Am Heart Assoc</i>. 2019;8(22):e014709. doi:<a href="http://dx.doi.org/10.1161/JAHA.119.014709">10.1161/JAHA.119.014709</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/31707943" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Effects%20of%20race%20on%20statin%20prescribing%20for%20primary%20prevention%20with%20high%20atherosclerotic%20cardiovascular%20disease%20risk%20in%20a%20large%20healthcare%20system.&amp;author=MP%20Dorsch&amp;author=CA%20Lester&amp;author=Y%20Ding&amp;author=M%20Joseph&amp;author=RD%20Brook&amp;publication_year=2019&amp;journal=J%20Am%20Heart%20Assoc&amp;volume=8&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1161/JAHA.119.014709" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1161/JAHA.119.014709" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r15">15.</a><div class="reference-content">Schroff
         P﻿, Gamboa
         CM﻿, Durant
         RW﻿, Oikeh
         A﻿, Richman
         JS﻿, Safford
         MM﻿.  Vulnerabilities to health disparities and statin use in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Am Heart Assoc</i>. 2017;6(9):e005449. doi:<a href="http://dx.doi.org/10.1161/JAHA.116.005449">10.1161/JAHA.116.005449</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/28847913" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Vulnerabilities%20to%20health%20disparities%20and%20statin%20use%20in%20the%20REGARDS%20%28Reasons%20for%20Geographic%20and%20Racial%20Differences%20in%20Stroke%29%20study.&amp;author=P%20Schroff&amp;author=CM%20Gamboa&amp;author=RW%20Durant&amp;author=A%20Oikeh&amp;author=JS%20Richman&amp;author=MM%20Safford&amp;publication_year=2017&amp;journal=J%20Am%20Heart%20Assoc&amp;volume=6&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1161/JAHA.116.005449" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1161/JAHA.116.005449" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r16">16.</a><div class="reference-content">Gamboa
         CM﻿, Colantonio
         LD﻿, Brown
         TM﻿, Carson
         AP﻿, Safford
         MM﻿.  Race-sex differences in statin use and low-density lipoprotein cholesterol control among people with diabetes mellitus in the Reasons for Geographic and Racial Differences in Stroke study. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Am Heart Assoc</i>. 2017;6(5):e004264. doi:<a href="http://dx.doi.org/10.1161/JAHA.116.004264">10.1161/JAHA.116.004264</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/28490523" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Race-sex%20differences%20in%20statin%20use%20and%20low-density%20lipoprotein%20cholesterol%20control%20among%20people%20with%20diabetes%20mellitus%20in%20the%20Reasons%20for%20Geographic%20and%20Racial%20Differences%20in%20Stroke%20study.&amp;author=CM%20Gamboa&amp;author=LD%20Colantonio&amp;author=TM%20Brown&amp;author=AP%20Carson&amp;author=MM%20Safford&amp;publication_year=2017&amp;journal=J%20Am%20Heart%20Assoc&amp;volume=6&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1161/JAHA.116.004264" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1161/JAHA.116.004264" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r17">17.</a><div class="reference-content">Gu
         A﻿, Kamat
         S﻿, Argulian
         E﻿.  Trends and disparities in statin use and low-density lipoprotein cholesterol levels among US patients with diabetes, 1999-2014. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetes Res Clin Pract</i>. 2018;139:1-10. doi:<a href="http://dx.doi.org/10.1016/j.diabres.2018.02.019">10.1016/j.diabres.2018.02.019</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/29476887" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Trends%20and%20disparities%20in%20statin%20use%20and%20low-density%20lipoprotein%20cholesterol%20levels%20among%20US%20patients%20with%20diabetes%2C%201999-2014.&amp;author=A%20Gu&amp;author=S%20Kamat&amp;author=E%20Argulian&amp;publication_year=2018&amp;journal=Diabetes%20Res%20Clin%20Pract&amp;volume=139&amp;pages=1-10" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/j.diabres.2018.02.019" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/j.diabres.2018.02.019" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r18">18.</a><div class="reference-content">Wall
         HK﻿, Ritchey
         MD﻿, Gillespie
         C﻿, Omura
         JD﻿, Jamal
         A﻿, George
         MG﻿.  Vital Signs: prevalence of key cardiovascular disease risk factors for Million Hearts 2022—United States, 2011-2016. ﻿ <i xmlns:helper="urn:XsltStringHelper"> MMWR Morb Mortal Wkly Rep</i>. 2018;67(35):983-991. doi:<a href="http://dx.doi.org/10.15585/mmwr.mm6735a4">10.15585/mmwr.mm6735a4</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/30188885" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Vital%20Signs%3A%20prevalence%20of%20key%20cardiovascular%20disease%20risk%20factors%20for%20Million%20Hearts%202022%E2%80%94United%20States%2C%202011-2016.&amp;author=HK%20Wall&amp;author=MD%20Ritchey&amp;author=C%20Gillespie&amp;author=JD%20Omura&amp;author=A%20Jamal&amp;author=MG%20George&amp;publication_year=2018&amp;journal=MMWR%20Morb%20Mortal%20Wkly%20Rep&amp;volume=67&amp;pages=983-991" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.15585/mmwr.mm6735a4" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.15585/mmwr.mm6735a4" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r19">19.</a><div class="reference-content">National Center for Health Statistics. Health, United States, 2019: Table 7: Leading Causes of Death and Numbers of Deaths, by Age: United States, 1980 and 2018. Accessed February 3, 2022. <a href="https://www.cdc.gov/nchs/data/hus/2019/007-508.pdf">https://www.cdc.gov/nchs/data/hus/2019/007-508.pdf</a></div></div><div class="reference"><a class="reference-number" id="jus220018r20">20.</a><div class="reference-content">Ridker
         PM﻿, Danielson
         E﻿, Fonseca
         FA﻿, 
     et al; JUPITER Study Group.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. ﻿ <i xmlns:helper="urn:XsltStringHelper"> N Engl J Med</i>. 2008;359(21):2195-2207. doi:<a href="http://dx.doi.org/10.1056/NEJMoa0807646">10.1056/NEJMoa0807646</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/18997196" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Rosuvastatin%20to%20prevent%20vascular%20events%20in%20men%20and%20women%20with%20elevated%20C-reactive%20protein.&amp;author=PM%20Ridker&amp;author=E%20Danielson&amp;author=FA%20Fonseca&amp;publication_year=2008&amp;journal=N%20Engl%20J%20Med&amp;volume=359&amp;pages=2195-2207" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1056/NEJMoa0807646" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1056/NEJMoa0807646" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r21">21.</a><div class="reference-content">Ridker
         PM﻿, Pradhan
         A﻿, MacFadyen
         JG﻿, Libby
         P﻿, Glynn
         RJ﻿.  Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet</i>. 2012;380(9841):565-571. doi:<a href="http://dx.doi.org/10.1016/S0140-6736(12)61190-8">10.1016/S0140-6736(12)61190-8</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/22883507" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Cardiovascular%20benefits%20and%20diabetes%20risks%20of%20statin%20therapy%20in%20primary%20prevention%3A%20an%20analysis%20from%20the%20JUPITER%20trial.&amp;author=PM%20Ridker&amp;author=A%20Pradhan&amp;author=JG%20MacFadyen&amp;author=P%20Libby&amp;author=RJ%20Glynn&amp;publication_year=2012&amp;journal=Lancet&amp;volume=380&amp;pages=565-571" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S0140-6736(12)61190-8" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S0140-6736(12)61190-8" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r22">22.</a><div class="reference-content">Panozzo
         CA﻿, Curtis
         LH﻿, Marshall
         J﻿, 
     et al.  Incidence of statin use in older adults with and without cardiovascular disease and diabetes mellitus, January 2008-March 2018. ﻿ <i xmlns:helper="urn:XsltStringHelper"> PLoS One</i>. 2019;14(12):e0223515. doi:<a href="http://dx.doi.org/10.1371/journal.pone.0223515">10.1371/journal.pone.0223515</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/31805056" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Incidence%20of%20statin%20use%20in%20older%20adults%20with%20and%20without%20cardiovascular%20disease%20and%20diabetes%20mellitus%2C%20January%202008-March%202018.&amp;author=CA%20Panozzo&amp;author=LH%20Curtis&amp;author=J%20Marshall&amp;publication_year=2019&amp;journal=PLoS%20One&amp;volume=14&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1371/journal.pone.0223515" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1371/journal.pone.0223515" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r23">23.</a><div class="reference-content">US Preventive Services Task Force.  Aspirin use to prevent cardiovascular disease: US Preventive Services Task Force recommendation statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2022;327(16):1577-1584. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2022.4983">10.1001/jama.2022.4983</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/35471505" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Aspirin%20use%20to%20prevent%20cardiovascular%20disease%3A%20US%20Preventive%20Services%20Task%20Force%20recommendation%20statement.&amp;publication_year=2022&amp;journal=JAMA&amp;volume=327&amp;pages=1577-1584" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2022.4983" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2022.4983" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r24">24.</a><div class="reference-content">US Preventive Services Task Force.  Screening for hypertension in adults: US Preventive Services Task Force reaffirmation recommendation statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2021;325(16):1650-1656. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2021.4987">10.1001/jama.2021.4987</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/33904861" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Screening%20for%20hypertension%20in%20adults%3A%20US%20Preventive%20Services%20Task%20Force%20reaffirmation%20recommendation%20statement.&amp;publication_year=2021&amp;journal=JAMA&amp;volume=325&amp;pages=1650-1656" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2021.4987" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2021.4987" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r25">25.</a><div class="reference-content">US Preventive Services Task Force.  Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force recommendation statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2021;326(8):736-743. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2021.12531">10.1001/jama.2021.12531</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/34427594" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Screening%20for%20prediabetes%20and%20type%202%20diabetes%3A%20US%20Preventive%20Services%20Task%20Force%20recommendation%20statement.&amp;publication_year=2021&amp;journal=JAMA&amp;volume=326&amp;pages=736-743" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2021.12531" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2021.12531" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r26">26.</a><div class="reference-content">US Preventive Services Task Force.  Interventions for tobacco smoking cessation in adults, including pregnant persons: US Preventive Services Task Force recommendation statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2021;325(3):265-279. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2020.25019">10.1001/jama.2020.25019</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/33464343" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Interventions%20for%20tobacco%20smoking%20cessation%20in%20adults%2C%20including%20pregnant%20persons%3A%20US%20Preventive%20Services%20Task%20Force%20recommendation%20statement.&amp;publication_year=2021&amp;journal=JAMA&amp;volume=325&amp;pages=265-279" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2020.25019" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2020.25019" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r27">27.</a><div class="reference-content">US Preventive Services Task Force.  Behavioral counseling interventions to promote a healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: US Preventive Services Task Force recommendation statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2020;324(20):2069-2075. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2020.21749">10.1001/jama.2020.21749</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/33231670" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Behavioral%20counseling%20interventions%20to%20promote%20a%20healthy%20diet%20and%20physical%20activity%20for%20cardiovascular%20disease%20prevention%20in%20adults%20with%20cardiovascular%20risk%20factors%3A%20US%20Preventive%20Services%20Task%20Force%20recommendation%20statement.&amp;publication_year=2020&amp;journal=JAMA&amp;volume=324&amp;pages=2069-2075" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2020.21749" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2020.21749" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r28">28.</a><div class="reference-content">US Preventive Services Task Force.  Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults without cardiovascular risk factors: US Preventive Services Task Force recommendation statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2017;318(2):167-174. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2017.7171">10.1001/jama.2017.7171</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/28697260" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Behavioral%20counseling%20to%20promote%20a%20healthful%20diet%20and%20physical%20activity%20for%20cardiovascular%20disease%20prevention%20in%20adults%20without%20cardiovascular%20risk%20factors%3A%20US%20Preventive%20Services%20Task%20Force%20recommendation%20statement.&amp;publication_year=2017&amp;journal=JAMA&amp;volume=318&amp;pages=167-174" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2017.7171" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2017.7171" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r29">29.</a><div class="reference-content">US Preventive Services Task Force.  Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force recommendation statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2018;320(11):1163-1171. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2018.13022">10.1001/jama.2018.13022</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/30326502" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Behavioral%20weight%20loss%20interventions%20to%20prevent%20obesity-related%20morbidity%20and%20mortality%20in%20adults%3A%20US%20Preventive%20Services%20Task%20Force%20recommendation%20statement.&amp;publication_year=2018&amp;journal=JAMA&amp;volume=320&amp;pages=1163-1171" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2018.13022" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2018.13022" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r30">30.</a><div class="reference-content">US Preventive Services Task Force.  Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2016;316(19):1997-2007. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2016.15450">10.1001/jama.2016.15450</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/27838723" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Statin%20use%20for%20the%20primary%20prevention%20of%20cardiovascular%20disease%20in%20adults%3A%20US%20Preventive%20Services%20Task%20Force%20recommendation%20statement.&amp;publication_year=2016&amp;journal=JAMA&amp;volume=316&amp;pages=1997-2007" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2016.15450" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2016.15450" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r31">31.</a><div class="reference-content">Chou
         R﻿, Cantor
         A﻿, Dana
         T﻿, 
     et al.  Statin use for the primary prevention of cardiovascular disease in adults: updated evidence report and systematic review for the US Preventive Services Task Force. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. Published August 23, 2022. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2022.12138">10.1001/jama.2022.12138</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Statin%20use%20for%20the%20primary%20prevention%20of%20cardiovascular%20disease%20in%20adults%3A%20updated%20evidence%20report%20and%20systematic%20review%20for%20the%20US%20Preventive%20Services%20Task%20Force.&amp;author=R%20Chou&amp;author=A%20Cantor&amp;author=T%20Dana&amp;publication_year=2022&amp;journal=JAMA&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jus220018r32">32.</a><div class="reference-content">Shepherd
         J﻿, Blauw
         GJ﻿, Murphy
         MB﻿, 
     et al; PROSPER Study Group.  Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet</i>. 2002;360(9346):1623-1630. doi:<a href="http://dx.doi.org/10.1016/S0140-6736(02)11600-X">10.1016/S0140-6736(02)11600-X</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/12457784" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Pravastatin%20in%20elderly%20individuals%20at%20risk%20of%20vascular%20disease%20%28PROSPER%29%3A%20a%20randomised%20controlled%20trial.&amp;author=J%20Shepherd&amp;author=GJ%20Blauw&amp;author=MB%20Murphy&amp;publication_year=2002&amp;journal=Lancet&amp;volume=360&amp;pages=1623-1630" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S0140-6736(02)11600-X" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S0140-6736(02)11600-X" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r33">33.</a><div class="reference-content">Shepherd
         J﻿, Cobbe
         SM﻿, Ford
         I﻿, 
     et al; West of Scotland Coronary Prevention Study Group.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. ﻿ <i xmlns:helper="urn:XsltStringHelper"> N Engl J Med</i>. 1995;333(20):1301-1307. doi:<a href="http://dx.doi.org/10.1056/NEJM199511163332001">10.1056/NEJM199511163332001</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/7566020" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Prevention%20of%20coronary%20heart%20disease%20with%20pravastatin%20in%20men%20with%20hypercholesterolemia.&amp;author=J%20Shepherd&amp;author=SM%20Cobbe&amp;author=I%20Ford&amp;publication_year=1995&amp;journal=N%20Engl%20J%20Med&amp;volume=333&amp;pages=1301-1307" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1056/NEJM199511163332001" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1056/NEJM199511163332001" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r34">34.</a><div class="reference-content">Han
         BH﻿, Sutin
         D﻿, Williamson
         JD﻿, 
     et al; ALLHAT Collaborative Research Group.  Effect of statin treatment vs usual care on primary cardiovascular prevention among older adults: the ALLHAT-LLT randomized clinical trial. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA Intern Med</i>. 2017;177(7):955-965. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jamainternmed.2017.1442">10.1001/jamainternmed.2017.1442</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/28531241" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20statin%20treatment%20vs%20usual%20care%20on%20primary%20cardiovascular%20prevention%20among%20older%20adults%3A%20the%20ALLHAT-LLT%20randomized%20clinical%20trial.&amp;author=BH%20Han&amp;author=D%20Sutin&amp;author=JD%20Williamson&amp;publication_year=2017&amp;journal=JAMA%20Intern%20Med&amp;volume=177&amp;pages=955-965" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jamainternmed.2017.1442" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jamainternmed.2017.1442" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r35">35.</a><div class="reference-content">ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.  Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2002;288(23):2998-3007. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.288.23.2998">10.1001/jama.288.23.2998</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/12479764" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Major%20outcomes%20in%20moderately%20hypercholesterolemic%2C%20hypertensive%20patients%20randomized%20to%20pravastatin%20vs%20usual%20care%3A%20the%20Antihypertensive%20and%20Lipid-Lowering%20Treatment%20to%20Prevent%20Heart%20Attack%20Trial%20%28ALLHAT-LLT%29.&amp;publication_year=2002&amp;journal=JAMA&amp;volume=288&amp;pages=2998-3007" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.288.23.2998" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.288.23.2998" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r36">36.</a><div class="reference-content">Macedo
         AF﻿, Taylor
         FC﻿, Casas
         JP﻿, Adler
         A﻿, Prieto-Merino
         D﻿, Ebrahim
         S﻿.  Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis. ﻿ <i xmlns:helper="urn:XsltStringHelper"> BMC Med</i>. 2014;12(51):51. doi:<a href="http://dx.doi.org/10.1186/1741-7015-12-51">10.1186/1741-7015-12-51</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/24655568" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Unintended%20effects%20of%20statins%20from%20observational%20studies%20in%20the%20general%20population%3A%20systematic%20review%20and%20meta-analysis.&amp;author=AF%20Macedo&amp;author=FC%20Taylor&amp;author=JP%20Casas&amp;author=A%20Adler&amp;author=D%20Prieto-Merino&amp;author=S%20Ebrahim&amp;publication_year=2014&amp;journal=BMC%20Med&amp;volume=12&amp;pages=51" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1186/1741-7015-12-51" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1186/1741-7015-12-51" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r37">37.</a><div class="reference-content">Jick
         SS﻿, Bradbury
         BD﻿.  Statins and newly diagnosed diabetes. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Br J Clin Pharmacol</i>. 2004;58(3):303-309. doi:<a href="http://dx.doi.org/10.1111/j.1365-2125.2004.02142.x">10.1111/j.1365-2125.2004.02142.x</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/15327590" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Statins%20and%20newly%20diagnosed%20diabetes.&amp;author=SS%20Jick&amp;author=BD%20Bradbury&amp;publication_year=2004&amp;journal=Br%20J%20Clin%20Pharmacol&amp;volume=58&amp;pages=303-309" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1111/bcp.2004.58.issue-3" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1111/bcp.2004.58.issue-3" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r38">38.</a><div class="reference-content">Culver
         AL﻿, Ockene
         IS﻿, Balasubramanian
         R﻿, 
     et al.  Statin use and risk of diabetes mellitus in postmenopausal women in the Women’s Health Initiative. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Arch Intern Med</i>. 2012;172(2):144-152. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/archinternmed.2011.625">10.1001/archinternmed.2011.625</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/22231607" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Statin%20use%20and%20risk%20of%20diabetes%20mellitus%20in%20postmenopausal%20women%20in%20the%20Women%E2%80%99s%20Health%20Initiative.&amp;author=AL%20Culver&amp;author=IS%20Ockene&amp;author=R%20Balasubramanian&amp;publication_year=2012&amp;journal=Arch%20Intern%20Med&amp;volume=172&amp;pages=144-152" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/archinternmed.2011.625" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/archinternmed.2011.625" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r39">39.</a><div class="reference-content">Porath
         A﻿, Arbelle
         JE﻿, Fund
         N﻿, Cohen
         A﻿, Mosseri
         M﻿.  Statin therapy: diabetes mellitus risk and cardiovascular benefit in primary prevention. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Isr Med Assoc J</i>. 2018;20(8):480-485.<a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/30084572" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Statin%20therapy%3A%20diabetes%20mellitus%20risk%20and%20cardiovascular%20benefit%20in%20primary%20prevention.&amp;author=A%20Porath&amp;author=JE%20Arbelle&amp;author=N%20Fund&amp;author=A%20Cohen&amp;author=M%20Mosseri&amp;publication_year=2018&amp;journal=Isr%20Med%20Assoc%20J&amp;volume=20&amp;pages=480-485" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jus220018r40">40.</a><div class="reference-content">Yusuf
         S﻿, Bosch
         J﻿, Dagenais
         G﻿, 
     et al; HOPE-3 Investigators.  Cholesterol lowering in intermediate-risk persons without cardiovascular disease. ﻿ <i xmlns:helper="urn:XsltStringHelper"> N Engl J Med</i>. 2016;374(21):2021-2031. doi:<a href="http://dx.doi.org/10.1056/NEJMoa1600176">10.1056/NEJMoa1600176</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/27040132" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Cholesterol%20lowering%20in%20intermediate-risk%20persons%20without%20cardiovascular%20disease.&amp;author=S%20Yusuf&amp;author=J%20Bosch&amp;author=G%20Dagenais&amp;publication_year=2016&amp;journal=N%20Engl%20J%20Med&amp;volume=374&amp;pages=2021-2031" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1056/NEJMoa1600176" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1056/NEJMoa1600176" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r41">41.</a><div class="reference-content">US Preventive Services Task Force.  Risk assessment for cardiovascular disease with nontraditional risk factors: US Preventive Services Task Force recommendation statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2018;320(3):272-280. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2018.8359">10.1001/jama.2018.8359</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/29998297" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Risk%20assessment%20for%20cardiovascular%20disease%20with%20nontraditional%20risk%20factors%3A%20US%20Preventive%20Services%20Task%20Force%20recommendation%20statement.&amp;publication_year=2018&amp;journal=JAMA&amp;volume=320&amp;pages=272-280" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2018.8359" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2018.8359" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r42">42.</a><div class="reference-content">Grundy
         SM﻿, Stone
         NJ﻿, Bailey
         AL﻿, 
     et al.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Circulation</i>. 2019;139:e1082–1143.  doi:<a href="http://dx.doi.org/10.1161/CIR.0000000000000625">10.1161/CIR.0000000000000625</a>﻿ <a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/30879355" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=2018%20AHA%2FACC%2FAACVPR%2FAAPA%2FABC%2FACPM%2FADA%2FAGS%2FAPhA%2FASPC%2FNLA%2FPCNA%20guideline%20on%20the%20management%20of%20blood%20cholesterol%3A%20a%20report%20of%20the%20American%20College%20of%20Cardiology%2FAmerican%20Heart%20Association%20Task%20Force%20on%20Clinical%20Practice%20Guidelines.&amp;author=SM%20Grundy&amp;author=NJ%20Stone&amp;author=AL%20Bailey&amp;publication_year=2019&amp;journal=Circulation&amp;volume=139&amp;pages=e1082-1143" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1161/CIR.0000000000000625" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1161/CIR.0000000000000625" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r43">43.</a><div class="reference-content">Arnett
         DK﻿, Blumenthal
         RS﻿, Albert
         MA﻿, 
     et al.  2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Circulation</i>. 2019;140(11):e596-e646. doi:<a href="http://dx.doi.org/10.1161/CIR.0000000000000678">10.1161/CIR.0000000000000678</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/30879355" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=2019%20ACC%2FAHA%20guideline%20on%20the%20primary%20prevention%20of%20cardiovascular%20disease%3A%20a%20report%20of%20the%20American%20College%20of%20Cardiology%2FAmerican%20Heart%20Association%20Task%20Force%20on%20Clinical%20Practice%20Guidelines.&amp;author=DK%20Arnett&amp;author=RS%20Blumenthal&amp;author=MA%20Albert&amp;publication_year=2019&amp;journal=Circulation&amp;volume=140&amp;pages=e596-e646" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1161/CIR.0000000000000678" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1161/CIR.0000000000000678" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r44">44.</a><div class="reference-content">Department of Veterans Affairs, Department of Defense. VA/DoD Clinical Practice Guideline for the Management of Dyslipidemia for Cardiovascular Risk Reduction. Published 2014. Accessed February 3, 2022. <a href="https://www.healthquality.va.gov/guidelines/CD/lipids/VADoDDyslipidemiaCPG2014.pdf">https://www.healthquality.va.gov/guidelines/CD/lipids/VADoDDyslipidemiaCPG2014.pdf</a></div></div></div> 
    </div>

            </div>
        </div>

        
        <div id="related-tab" class="resource-tab js-resource-tab related-tab need-jobs-ad">
    <div class="widget-ArticleLinks widget-instance-AMA_See_Also_Related_Content">
        
    <ul class="article-links related-content">

            <li class="article-link related-article odd">
                <a href="https://jamanetwork.com/journals/jama/fullarticle/2795522" class="td-n">
                        <div class="related-article-title">USPSTF Review: Statins for Primary Prevention of Cardiovascular Disease in Adults</div>
                                            <div class="related-journal-name">JAMA</div>
                    <div class="related-article-type">US Preventive Services Task Force</div>
                    <div class="related-article-date">August 23, 2022</div>
                    <div class="related-article-excerpt">This systematic review to support the 2022 US Preventive Services Task Force Recommendation Statement on statin use for prevention of cardiovascular disease (CVD) summarizes published evidence on the benefits and harms of statin use for the primary prevention of CVD in adults at increased CVD risk but without prior CVD events.</div>
                    <div class="related-article-authors">Roger Chou, MD; Amy Cantor, MD, MPH; Tracy Dana, MLS; Jesse Wagner, MA; Azrah Y. Ahmed, BA; Rongwei Fu, PhD; Maros Ferencik, MD, PhD, MCR</div>
                </a>
            </li>
            <li class="article-link related-article even">
                <a href="https://jamanetwork.com/journals/jama/fullarticle/2795551" class="td-n">
                        <div class="related-article-title">Statin Recommendations for Primary Prevention</div>
                                            <div class="related-journal-name">JAMA</div>
                    <div class="related-article-type">Editorial</div>
                    <div class="related-article-date">August 23, 2022</div>
                    <div class="related-article-excerpt"></div>
                    <div class="related-article-authors">Ann Marie Navar, MD, PhD; Eric D. Peterson, MD, MPH</div>
                </a>
            </li>
            <li class="article-link related-article odd">
                <a href="https://jamanetwork.com/journals/jama/fullarticle/2795526" class="td-n">
                        <div class="related-article-title">Patient Information: Statins for the Prevention of Cardiovascular Disease</div>
                                            <div class="related-journal-name">JAMA</div>
                    <div class="related-article-type">JAMA Patient Page</div>
                    <div class="related-article-date">August 23, 2022</div>
                    <div class="related-article-excerpt">This JAMA Patient Page summarizes the US Preventive Services Task Force’s recent recommendations on using statins for primary prevention of cardiovascular disease in adults.</div>
                    <div class="related-article-authors">Jill Jin, MD, MPH</div>
                </a>
            </li>
            <li class="article-link related-article even">
                <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2795560" class="td-n">
                        <div class="related-article-title">Statins and Primary Atherosclerotic Cardiovascular Disease Prevention</div>
                                            <div class="related-journal-name">JAMA Network Open</div>
                    <div class="related-article-type">Editorial</div>
                    <div class="related-article-date">August 23, 2022</div>
                    <div class="related-article-excerpt"></div>
                    <div class="related-article-authors">Salim S. Virani, MD, PhD</div>
                </a>
            </li>
            <li class="article-link related-article odd">
                <a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2795661" class="td-n">
                        <div class="related-article-title">Statins for Primary Cardiovascular Disease Prevention</div>
                                            <div class="related-journal-name">JAMA Internal Medicine</div>
                    <div class="related-article-type">Editorial</div>
                    <div class="related-article-date">October 1, 2022</div>
                    <div class="related-article-excerpt"></div>
                    <div class="related-article-authors">Anand R. Habib, MD, MPhil; Mitchell H. Katz, MD; Rita F. Redberg, MD, MSc</div>
                </a>
            </li>
            <li class="article-link related-article even">
                <a href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2795619" class="td-n">
                        <div class="related-article-title">Statin Usage in Primary Prevention—Comparing USPSTF With AHA/ACC</div>
                                            <div class="related-journal-name">JAMA Cardiology</div>
                    <div class="related-article-type">Editorial</div>
                    <div class="related-article-date">October 1, 2022</div>
                    <div class="related-article-excerpt">This Editorial compares the US Preventive Services Task Force (USPSTF) recommendations with the American Heart Association/American College of Cardiology (AHA/ACC)/multisociety guidelines on statin usage in primary prevention.</div>
                    <div class="related-article-authors">Neil J. Stone, MD; Philip Greenland, MD; Scott M. Grundy, MD, PHD</div>
                </a>
            </li>
    </ul>
 
    </div>
    <div class="widget-EditorsChoice widget-instance-AMA_EditorsChoice_Links">
        
 
    </div>
    <div class="widget-RelatedTopics widget-instance-AMA_Related_Topics">
        
        <div class="related-topics-block">
            <h4 class="related-topics-heading topic-suggestions-heading sb-sc">
See More About            </h4>
            <div class="related-topics topic-suggestions">
    <a href="https://jamanetwork.com/collections/5548/cardiology" id="item_Link" class="related-topic topic-suggestion no-wrap sb-anchor-light">Cardiology</a>    <a href="https://jamanetwork.com/collections/5721/dyslipidemia" id="item_Link_1" class="related-topic topic-suggestion no-wrap sb-anchor-light">Dyslipidemia</a>    <a href="https://jamanetwork.com/collections/5614/clinical-pharmacy-and-pharmacology" id="item_Link_2" class="related-topic topic-suggestion no-wrap sb-anchor-light">Clinical Pharmacy and Pharmacology</a>    <a href="https://jamanetwork.com/collections/42101/cardiovascular-risk-factors" id="item_Link_3" class="related-topic topic-suggestion no-wrap sb-anchor-light">Cardiovascular Risk Factors</a>    <a href="https://jamanetwork.com/collections/5672/guidelines" id="item_Link_4" class="related-topic topic-suggestion no-wrap sb-anchor-light">Guidelines</a>    <a href="https://jamanetwork.com/collections/44068/united-states-preventive-services-task-force" id="item_Link_5" class="related-topic topic-suggestion no-wrap sb-anchor-light">United States Preventive Services Task Force</a>            </div>
        </div>
 
    </div>
                <div class="ymal--footer">
    <div class="widget-WidgetLoader widget-instance-AMA_PersonalizedContent_SplitScreenView_Footer">
        <div class="SCM-SharedWidgets-AsyncWidgetLoader" data-url="/Personalization/PersonalizedContent/AMA_PersonalizedContent_SplitScreenView_Footer" data-params="{&quot;parameters&quot;:{&quot;resourceIdToExclude&quot;:2795521,&quot;resourceTypeToExclude&quot;:3},&quot;dynamicParameters&quot;:{&quot;localParams&quot;:&quot;[REPLACE_WITH_LOCAL]&quot;}}"></div>
 
    </div>

                </div>
                <hr />
                <div class="manage-interest">
                    <h4><a href="#" class="manage-interests-link-no-access thm-col-sec">Select Your Interests</a></h4>
    <div class="widget-ManageCollectionInterests widget-instance-ManageCollectionInterests_SplitScreen">
        <div class="manage-interests-modal reveal-modal small modal" data-reveal>
<div class="manage-interests--header">
    <div class="widget-SelfServeContent widget-instance-AMA_ManageInterests_Header">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="AllSitesManageInterestsHeader" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<style>
    h4 {
    font-size: 20px !important;
    }
</style>
<h4>Select Your Interests</h4>
<p>Customize your JAMA Network experience by selecting one or more topics from the list below.</p>


</div>

 
    </div>

</div><div class="manage-interests--categories">
    <ul class="category-list">
            <li><span class="category-list-item " data-categoryid="46425">Academic Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5489">Acid Base, Electrolytes, Fluids</span></li>
            <li><span class="category-list-item " data-categoryid="5504">Allergy and Clinical Immunology</span></li>
            <li><span class="category-list-item " data-categoryid="46447">American Indian or Alaska Natives</span></li>
            <li><span class="category-list-item " data-categoryid="5510">Anesthesiology</span></li>
            <li><span class="category-list-item " data-categoryid="42143">Anticoagulation</span></li>
            <li><span class="category-list-item " data-categoryid="6261">Art and Images in Psychiatry</span></li>
            <li><span class="category-list-item " data-categoryid="44024">Artificial Intelligence</span></li>
            <li><span class="category-list-item " data-categoryid="42097">Assisted Reproduction</span></li>
            <li><span class="category-list-item " data-categoryid="42099">Bleeding and Transfusion</span></li>
            <li><span class="category-list-item " data-categoryid="5548">Cardiology</span></li>
            <li><span class="category-list-item " data-categoryid="44036">Caring for the Critically Ill Patient</span></li>
            <li><span class="category-list-item " data-categoryid="6255">Challenges in Clinical Electrocardiography</span></li>
            <li><span class="category-list-item " data-categoryid="46435">Climate and Health</span></li>
            <li><span class="category-list-item " data-categoryid="46448">Climate Change</span></li>
            <li><span class="category-list-item " data-categoryid="44038">Clinical Challenge</span></li>
            <li><span class="category-list-item " data-categoryid="5589">Clinical Decision Support</span></li>
            <li><span class="category-list-item " data-categoryid="44039">Clinical Implications of Basic Neuroscience</span></li>
            <li><span class="category-list-item " data-categoryid="5614">Clinical Pharmacy and Pharmacology</span></li>
            <li><span class="category-list-item " data-categoryid="5575">Complementary and Alternative Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="44040">Consensus Statements</span></li>
            <li><span class="category-list-item " data-categoryid="46099">Coronavirus (COVID-19)</span></li>
            <li><span class="category-list-item " data-categoryid="5584">Critical Care Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="46325">Cultural Competency</span></li>
            <li><span class="category-list-item " data-categoryid="44019">Dental Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5598">Dermatology</span></li>
            <li><span class="category-list-item " data-categoryid="44011">Diabetes and Endocrinology</span></li>
            <li><span class="category-list-item " data-categoryid="46320">Diagnostic Test Interpretation</span></li>
            <li><span class="category-list-item " data-categoryid="42054">Drug Development</span></li>
            <li><span class="category-list-item " data-categoryid="5620">Electronic Health Records</span></li>
            <li><span class="category-list-item " data-categoryid="5621">Emergency Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5819">End of Life, Hospice, Palliative Care</span></li>
            <li><span class="category-list-item " data-categoryid="42107">Environmental Health</span></li>
            <li><span class="category-list-item " data-categoryid="46387">Equity, Diversity, and Inclusion</span></li>
            <li><span class="category-list-item " data-categoryid="42108">Ethics</span></li>
            <li><span class="category-list-item " data-categoryid="5644">Facial Plastic Surgery</span></li>
            <li><span class="category-list-item " data-categoryid="44012">Gastroenterology and Hepatology</span></li>
            <li><span class="category-list-item " data-categoryid="5664">Genetics and Genomics</span></li>
            <li><span class="category-list-item " data-categoryid="44041">Genomics and Precision Health</span></li>
            <li><span class="category-list-item " data-categoryid="5668">Geriatrics</span></li>
            <li><span class="category-list-item " data-categoryid="5670">Global Health</span></li>
            <li><span class="category-list-item " data-categoryid="46427">Guide to Statistics and Methods</span></li>
            <li><span class="category-list-item " data-categoryid="5672">Guidelines</span></li>
            <li><span class="category-list-item " data-categoryid="5674">Hair Disorders</span></li>
            <li><span class="category-list-item " data-categoryid="42113">Health Care Delivery Models</span></li>
            <li><span class="category-list-item " data-categoryid="42114">Health Care Economics, Insurance, Payment</span></li>
            <li><span class="category-list-item " data-categoryid="42116">Health Care Quality</span></li>
            <li><span class="category-list-item " data-categoryid="5680">Health Care Reform</span></li>
            <li><span class="category-list-item " data-categoryid="5830">Health Care Safety</span></li>
            <li><span class="category-list-item " data-categoryid="5682">Health Care Workforce</span></li>
            <li><span class="category-list-item " data-categoryid="5679">Health Disparities</span></li>
            <li><span class="category-list-item " data-categoryid="46328">Health Inequities</span></li>
            <li><span class="category-list-item " data-categoryid="44020">Health Policy</span></li>
            <li><span class="category-list-item " data-categoryid="46451">Health Systems Science</span></li>
            <li><span class="category-list-item " data-categoryid="5688">Hematology</span></li>
            <li><span class="category-list-item " data-categoryid="5692">History of Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5514">Humanities</span></li>
            <li><span class="category-list-item " data-categoryid="5697">Hypertension</span></li>
            <li><span class="category-list-item " data-categoryid="44043">Images in Neurology</span></li>
            <li><span class="category-list-item " data-categoryid="45887">Implementation Science</span></li>
            <li><span class="category-list-item " data-categoryid="5702">Infectious Diseases</span></li>
            <li><span class="category-list-item " data-categoryid="44044">Innovations in Health Care Delivery</span></li>
            <li><span class="category-list-item " data-categoryid="44070">JAMA Infographic</span></li>
            <li><span class="category-list-item " data-categoryid="5716">Law and Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="45308">Leading Change</span></li>
            <li><span class="category-list-item " data-categoryid="44045">Less is More</span></li>
            <li><span class="category-list-item " data-categoryid="46327">LGBTQIA Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5720">Lifestyle Behaviors</span></li>
            <li><span class="category-list-item " data-categoryid="45311">Medical Coding</span></li>
            <li><span class="category-list-item " data-categoryid="5738">Medical Devices and Equipment</span></li>
            <li><span class="category-list-item " data-categoryid="44023">Medical Education</span></li>
            <li><span class="category-list-item " data-categoryid="5739">Medical Education and Training</span></li>
            <li><span class="category-list-item " data-categoryid="5713">Medical Journals and Publishing</span></li>
            <li><span class="category-list-item " data-categoryid="5746">Melanoma</span></li>
            <li><span class="category-list-item " data-categoryid="44025">Mobile Health and Telemedicine</span></li>
            <li><span class="category-list-item " data-categoryid="5766">Narrative Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5769">Nephrology</span></li>
            <li><span class="category-list-item " data-categoryid="5777">Neurology</span></li>
            <li><span class="category-list-item " data-categoryid="44052">Neuroscience and Psychiatry</span></li>
            <li><span class="category-list-item " data-categoryid="44053">Notable Notes</span></li>
            <li><span class="category-list-item " data-categoryid="5787">Nursing</span></li>
            <li><span class="category-list-item " data-categoryid="5788">Nutrition</span></li>
            <li><span class="category-list-item " data-categoryid="44027">Nutrition, Obesity, Exercise</span></li>
            <li><span class="category-list-item " data-categoryid="5791">Obesity</span></li>
            <li><span class="category-list-item " data-categoryid="44013">Obstetrics and Gynecology</span></li>
            <li><span class="category-list-item " data-categoryid="5796">Occupational Health</span></li>
            <li><span class="category-list-item " data-categoryid="5801">Oncology</span></li>
            <li><span class="category-list-item " data-categoryid="5804">Ophthalmology</span></li>
            <li><span class="category-list-item " data-categoryid="5808">Orthopedics</span></li>
            <li><span class="category-list-item " data-categoryid="5811">Otolaryngology</span></li>
            <li><span class="category-list-item " data-categoryid="44028">Pain Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="46446">Palliative Care</span></li>
            <li><span class="category-list-item " data-categoryid="44029">Pathology and Laboratory Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="45306">Patient Care</span></li>
            <li><span class="category-list-item " data-categoryid="6258">Patient Information</span></li>
            <li><span class="category-list-item " data-categoryid="5843">Pediatrics</span></li>
            <li><span class="category-list-item " data-categoryid="44060">Performance Improvement</span></li>
            <li><span class="category-list-item " data-categoryid="45315">Performance Measures</span></li>
            <li><span class="category-list-item " data-categoryid="42050">Perioperative Care and Consultation</span></li>
            <li><span class="category-list-item " data-categoryid="42125">Pharmacoeconomics</span></li>
            <li><span class="category-list-item " data-categoryid="42126">Pharmacoepidemiology</span></li>
            <li><span class="category-list-item " data-categoryid="5851">Pharmacogenetics</span></li>
            <li><span class="category-list-item " data-categoryid="44030">Pharmacy and Clinical Pharmacology</span></li>
            <li><span class="category-list-item " data-categoryid="5856">Physical Medicine and Rehabilitation</span></li>
            <li><span class="category-list-item " data-categoryid="42059">Physical Therapy</span></li>
            <li><span class="category-list-item " data-categoryid="45313">Physician Leadership</span></li>
            <li><span class="category-list-item " data-categoryid="44061">Poetry</span></li>
            <li><span class="category-list-item " data-categoryid="45316">Population Health</span></li>
            <li><span class="category-list-item " data-categoryid="46445">Primary Care</span></li>
            <li><span class="category-list-item " data-categoryid="45309">Professional Well-being</span></li>
            <li><span class="category-list-item " data-categoryid="44064">Professionalism</span></li>
            <li><span class="category-list-item " data-categoryid="5871">Psychiatry and Behavioral Health</span></li>
            <li><span class="category-list-item " data-categoryid="42128">Public Health</span></li>
            <li><span class="category-list-item " data-categoryid="5877">Pulmonary Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="42129">Radiology</span></li>
            <li><span class="category-list-item " data-categoryid="42058">Regulatory Agencies</span></li>
            <li><span class="category-list-item " data-categoryid="46443">Reproductive Health</span></li>
            <li><span class="category-list-item " data-categoryid="5916">Research, Methods, Statistics</span></li>
            <li><span class="category-list-item " data-categoryid="42142">Resuscitation</span></li>
            <li><span class="category-list-item " data-categoryid="5896">Rheumatology</span></li>
            <li><span class="category-list-item " data-categoryid="46326">Risk Management</span></li>
            <li><span class="category-list-item " data-categoryid="38802">Scientific Discovery and the Future of Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5833">Shared Decision Making and Communication</span></li>
            <li><span class="category-list-item " data-categoryid="5912">Sleep Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5915">Sports Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5533">Stem Cell Transplantation</span></li>
            <li><span class="category-list-item " data-categoryid="5921">Substance Use and Addiction Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5923">Surgery</span></li>
            <li><span class="category-list-item " data-categoryid="44065">Surgical Innovation</span></li>
            <li><span class="category-list-item " data-categoryid="44066">Surgical Pearls</span></li>
            <li><span class="category-list-item " data-categoryid="44067">Teachable Moment</span></li>
            <li><span class="category-list-item " data-categoryid="45310">Technology and Finance</span></li>
            <li><span class="category-list-item " data-categoryid="44034">The Art of JAMA</span></li>
            <li><span class="category-list-item " data-categoryid="44037">The Arts and Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="6257">The Rational Clinical Examination</span></li>
            <li><span class="category-list-item " data-categoryid="5936">Tobacco and e-Cigarettes</span></li>
            <li><span class="category-list-item " data-categoryid="5938">Toxicology</span></li>
            <li><span class="category-list-item " data-categoryid="46433">Translational Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="42136">Trauma and Injury</span></li>
            <li><span class="category-list-item " data-categoryid="5942">Treatment Adherence</span></li>
            <li><span class="category-list-item " data-categoryid="46323">Ultrasonography</span></li>
            <li><span class="category-list-item " data-categoryid="5947">Urology</span></li>
            <li><span class="category-list-item " data-categoryid="44069">Users&#39; Guide to the Medical Literature</span></li>
            <li><span class="category-list-item " data-categoryid="5950">Vaccination</span></li>
            <li><span class="category-list-item " data-categoryid="5955">Venous Thromboembolism</span></li>
            <li><span class="category-list-item " data-categoryid="45312">Veterans Health</span></li>
            <li><span class="category-list-item " data-categoryid="5957">Violence</span></li>
            <li><span class="category-list-item " data-categoryid="42139">Women&#39;s Health</span></li>
            <li><span class="category-list-item " data-categoryid="45307">Workflow and Process</span></li>
            <li><span class="category-list-item " data-categoryid="42140">Wound Care, Infection, Healing</span></li>
    </ul>
</div>

    
<div class="manage-interests--save-preferences">
    <div class="save-preferences-btn thm-bg ">
        <span class="save-preferences-btn-text fw-b">Save Preferences</span>
    </div>
</div>
<div class="manage-interests--privacy-terms"> <a class="manage-interests--privacy-terms-color" href="/pages/privacy-policy">Privacy Policy</a> | <a class="manage-interests--privacy-terms-color" href="/pages/terms-of-use">Terms of Use</a></div>

    
    <a class="close-reveal-modal icon-close"></a>
</div> 
    </div>

                </div>
                <h4 class="thm-col-sec" align="center">
                    Others Also Liked
                </h4>
                <div id="trendmd-suggestions"></div>

        </div>


        
        <div id="comments-tab" class="resource-tab js-resource-tab comments-tab js-comments-tab single-comment-view">



        </div>
    </div>
</div>

<a id="skip-to-navigation" href="#" tabindex="-1"></a>
<div id="content-panel" class="content-panel">
    <a id="top"></a>

    <div id="full-text-tab" class="resource-tab js-resource-tab full-text-tab">
    <div class="widget-ArticleLinks widget-instance-AMA_ErrataArticleLinks_FullText">
         
    </div>
    <div class="widget-ArticleLinks widget-instance-AMA_ArticleLinks_ToErrata_FullText">
        
 
    </div>
    <div class="widget-ArticleNavLinks widget-instance-AMA_ArticleNavLinks">
                <a class="toc-link btn" href="https://jamanetwork.com/journals/jama/issue/328/8">This Issue</a>
 
    </div>



            <div class="article-metrics-wrapper" id="divArticleLevelMetrics">
    <div class="widget-ArticleLevelMetrics widget-instance-AMA_ArticleMetrics">
        

    <div class="artmet-condensed-wrap clearfix">
        <div class="artmet-condensed-stats clearfix">
                <div class="artmet-item artmet-views">
                    <span class="artmet-text sb-sc">Views</span>
                    <span class="artmet-number sb-sc">250,731</span>
                </div>
                                <div class="artmet-item artmet-citations">
                            <a class="artmet-citations-link" href="https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=silverchair&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000855063100022&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL" target="_blank">
                                <span class="artmet-text">Citations</span>
                                <span class="artmet-number">88</span>
                            </a>
                    </div>
                                <div class="artmet-item artmet-altmetric">
    <div class="widget-AltmetricLink widget-instance-AMAv2_ArticleLevelMetrics_AltmetricLinkSummary">
            <!-- Altmetrics -->
    <div id="altmetricEmbedId" class='altmetric-embed' data-link-target="_blank" data-badge-type="text" data-hide-no-mentions="false" data-doi="10.1001/jama.2022.13044"
     
        
        ></div>
 
    </div>

                    </div>

        </div>

        <div class="artmet-modal-trigger-wrap">
            <a rel="nofollow" class="artmet-modal-trigger" data-article-id="2795521"><i class="icon-metrics"></i><span>View Metrics</span></a>
        </div>
    </div>

 
    </div>

            </div>
        <ul class="toolbar">
            <li class="toolbar-pdf-wrap toolbar-tool-wrap">
            <a id="pdf-link" class="toolbar-tool toolbar-pdf al-link pdfaccess" data-article-id="2795521" data-article-url="/journals/jama/articlepdf/2795521/jama_mangione_2022_us_220018_1660869424.13945.pdf" data-ajax-url="/Content/CheckPdfAccess"><span class="toolbar-pdf-text"><span class="toolbar-link-text-extra">Download </span><span class="toolbar-link-text">PDF</span></span>
            </a>

            </li>
            <li class="toolbar-share-wrap toolbar-tool-wrap">
                <div class="toolbar-tool">
                    <a class="st-custom-button addthis_button_twitter is-b toolbar-twitter toolbar-share"
                       data-network="twitter"
                       data-title=""
                       data-url=""
                       data-email-subject=""
                       rel="nofollow"
                       href="javascript:;">
                        <span class="share-text">X</span>
                    </a>
                    <a class="st-custom-button addthis_button_facebook is-b toolbar-facebook toolbar-share"
                       data-network="facebook"
                       data-title=""
                       data-url=""
                       data-email-subject=""
                       rel="nofollow"
                       href="javascript:;">
                        <span class="share-text">Facebook</span>
                    </a>
                    <a class="toolbar-share-more-link is-a" rel="nofollow"><span class="icon icon-carrot_down social-arrow"></span><span class="more-text-wrap">More</span></a>
                    <div class="toolbar-share-more">
                        <a class="st-custom-button addthis_button_linkedin is-b toolbar-linkedin toolbar-share"
                           data-network="linkedin"
                           data-title=""
                           data-url=""
                           data-email-subject=""
                           rel="nofollow"
                           href="javascript:;">
                            <span class="share-text">LinkedIn</span>
                        </a>
                    </div>
                </div>
            </li>
    <li class="toolbar-cme-wrap toolbar-tool-wrap">
                <a class="toolbar-tool toolbar-cme is-b jama-active-cme-button" rel="nofollow" href="https://edhub.ama-assn.org/jn-learning/module/2795521">CME &amp; MOC</a>

    </li>







            <li class="toolbar-citation-wrap toolbar-tool-wrap">
    <div class="widget-ToolboxGetCitation widget-instance-AMA_Get_Citation">
        
        <a class="toolbar-tool toolbar-citation is-b stats-citation" rel="nofollow" data-reveal-id="get-citation" data-reveal>
            <span class="toolbar-link-text">Cite</span>
            <span class="toolbar-link-text-extra">This</span>
        </a>
    <div id="get-citation" class="reveal-modal get-citation" data-reveal>
        <h3 class="get-citation-title">Citation</h3>
        <p class="get-citation-citation">US Preventive Services Task Force. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults<span class="subtitle"><span class="colon-for-citation-subtitle">: </span>US Preventive Services Task Force Recommendation Statement</span>. <em>JAMA.</em> 2022;328(8):746–753. doi:10.1001/jama.2022.13044</p>
        <h4 class="get-citation-download-heading">Manage citations:</h4>
        <div class="get-citation-types">
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2795521&amp;resourceType=3&amp;citationFormat=0">Ris (Zotero)</a>
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2795521&amp;resourceType=3&amp;citationFormat=1">EndNote</a>
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2795521&amp;resourceType=3&amp;citationFormat=2">BibTex</a>
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2795521&amp;resourceType=3&amp;citationFormat=3">Medlars</a>
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2795521&amp;resourceType=3&amp;citationFormat=0">ProCite</a>
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2795521&amp;resourceType=3&amp;citationFormat=3">RefWorks</a>
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2795521&amp;resourceType=3&amp;citationFormat=0">Reference Manager</a>
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2795521&amp;resourceType=3&amp;citationFormat=0">Mendeley</a>
        </div>

        <p class="get-citation-copyright">&#169; 2024 </p>
        <a class="close-reveal-modal icon-close" rel="nofollow"></a>
    </div>


 
    </div>

            </li>
            <li class="toolbar-permissions-wrap toolbar-tool-wrap">
    <div class="widget-ToolboxPermissions widget-instance-AMA_Get_Permissions">
            <a href="http://s100.copyright.com/AppDispatchServlet?publisherName=AMA&amp;publication=0098-7484&amp;title=Statin+Use+for+the+Primary+Prevention+of+Cardiovascular+Disease+in+Adults%3a+US+Preventive+Services+Task+Force+Recommendation+Statement&amp;publicationDate=2022-08-23&amp;volumeNum=328&amp;issueNum=8&amp;author=US+Preventive+Services+Task+Force%3b+Mangione%2c+Carol+M.&amp;startPage=746&amp;endPage=753&amp;contentId=10.1001%2fjama.2022.13044&amp;oa=&amp;orderBeanReset=True" rel="nofollow" id="PermissionsLink" class="toolbar-tool toolbar-permissions is-b" target="_blank"><span class="toolbar-link-text">Permissions</span></a>
 
    </div>

            </li>
        </ul>

    <div class="widget-ArticleTopInfo widget-instance-AMA_ArticleTop_Info_Widget">
        

    <div class="meta-access-type free-access is-b"></div>


            <span class="hide tagmanagervalue" data-attribute="articleId" data-value="2795521" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="arrArticleAuthor" data-value="US%20Preventive%20Services%20Task%20Force" data-type="array"></span>
            <span class="hide tagmanagervalue" data-attribute="articleDOI" data-value="10.1001/jama.2022.13044" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="articleTitle" data-value="Statin Use for the Primary Prevention of Cardiovascular Disease in Adults&lt;span class=&quot;subtitle&quot;&gt;&lt;span class=&quot;colon-for-citation-subtitle&quot;&gt;: &lt;/span&gt;US Preventive Services Task Force Recommendation Statement&lt;/span&gt;" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="type" data-value="US Preventive Services Task Force" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="thematicLabel" data-value="Recommendation Statement" data-type="array"></span>
            <span class="hide tagmanagervalue" data-attribute="issueVolume" data-value="328" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="issueNo" data-value="8" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="publishDate" data-value="August 23, 2022" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="topics" data-value="Cardiology, Dyslipidemia, Clinical Pharmacy and Pharmacology, Cardiovascular Risk Factors, Guidelines, United States Preventive Services Task Force" data-type="array"></span>
            <span class="hide tagmanagervalue" data-attribute="topicCode" data-value="5548, 5721, 5614, 42101, 5672, 44068" data-type="array"></span>
            <span class="hide tagmanagervalue" data-attribute="category" data-value="Research" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="journalClub" data-value="No" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="contentStatus" data-value="Free" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="articlePubState" data-value="Final" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="contentMedium" data-value="Article" data-type="string"></span>


        <div class="meta-article-type-wrap">
            <div class="meta-article-type thm-col">US Preventive Services Task Force </div>
                <div class="meta-super-class">Recommendation Statement</div>
        </div>
        <div class="meta-date"><span class="ppub"><span class="month">August </span><span class="day">23/30, </span><span class="year">2022</span></span></div>
        <div class="meta-article-title-wrap">
            
            <h1 class="meta-article-title ">Statin Use for the Primary Prevention of Cardiovascular Disease in Adults<span class="subtitle"><span class="colon-for-citation-subtitle">: </span>US Preventive Services Task Force Recommendation Statement</span></h1>

            
        </div>
            <div class="meta-authors">
                US Preventive Services Task Force<sup></sup>
            </div>
            <div class="meta-author">
                <a class="meta-articleinfo-jumplink no-affiliations section-jump-link scroll-to" data-tab-toggle=".tab-nav-full-text" href="#248567016">Article Information</a>
            </div>
        <div class="meta-citation-wrap">
            <span class="meta-citation-journal-name">JAMA. </span><span class="meta-citation"> 2022;328(8):746-753. doi:10.1001/jama.2022.13044</span>
        </div>

 
    </div>
    <div class="widget-EditorsChoice widget-instance-AMA_EditorsChoice_Links">
        
 
    </div>
    <div class="widget-LinkedContentToolbar widget-instance-AMA_LinkedContentToolbar">
        
<div class="linked-content-toolbar">
    
    <div class="hidden js-search-open-multimedia-by-default" showContentByDefault="False"></div>
    <div class="linked-content-controls">
        <a class="linked-content-trigger td-n stats-graphical-abstract" href="#graphical-abstract-tab">
            <i class="icon-visual-abstract"><span class="sr-t">visual abstract icon</span></i>
            <div class="trigger-text d-ib va-m ta-l fw-5">Visual <div>Abstract</div></div>
        </a>
        <a class="linked-content-trigger td-n stats-editorial-comment" href="#editorial-comment-tab">
            <i class="icon-document"><span class="sr-t">editorial comment icon</span></i>
            <div class="trigger-text d-ib va-m ta-l fw-5">Editorial <div>Comment</div></div>
        </a>
        <a class="linked-content-trigger td-n stats-related-articles" href="#related-articles-tab">
            <i class="icon-related"><span class="sr-t">related articles icon</span></i>
            <div class="trigger-text d-ib va-m ta-l fw-5">Related <div>Articles</div></div>
        </a>
        <a class="linked-content-trigger td-n stats-author-interviews" href="#author-interviews-tab">
            <i class="icon-author_interview"><span class="sr-t">author interview icon</span></i>
            <div class="trigger-text d-ib va-m ta-l fw-5">Interviews</div>
        </a>
        <a class="linked-content-trigger td-n stats-more-multimedia" href="#more-multimedia-tab">
            <i class="icon-multimedia"><span class="sr-t">multimedia icon</span></i>
            <div class="trigger-text d-ib va-m ta-l fw-5">Multimedia</div>
        </a>
        <a class="linked-content-trigger td-n stats-listen-to-this-article" href="#listen-to-this-article-tab">
            <i class="icon-audio"><span class="sr-t">audio icon</span></i>
            <div class="trigger-text d-ib va-m ta-l fw-5">Listen to <div>this article</div></div>
        </a>
    </div>

    
<div class="linked-content-tabs">
    <div id="graphical-abstract-tab" class="linked-content-tab graphical-abstract-tab">
    <div class="widget-SectionDisplay widget-instance-AMA_GraphicalAbstract_Tab">
        
 
    </div>

    </div>

    
    <div id="editorial-comment-tab" class="linked-content-tab editorial-comment-tab">
    <div class="widget-ArticleLinks widget-instance-AMA_LinkedContentToolbar_EditorialComments">
        
    <ul class="article-abstract-links related-abstract-content">
            <li class="article-link related-abstract-article">

                    <a class="related-article-title" href="https://jamanetwork.com/journals/jama/fullarticle/2795551">
                            <div class="related-article-type">Editorial</div>
                        <div class="related-article-title sb-tc">Statin Recommendations for Primary Prevention</div>
                    </a>
                    <div class="related-article-authors">Ann Marie Navar, MD, PhD; Eric D. Peterson, MD, MPH</div>
                                    <div class="related-article-journal-name">JAMA</div>
            </li>
            <li class="article-link related-abstract-article">

                    <a class="related-article-title" href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2795560">
                            <div class="related-article-type">Editorial</div>
                        <div class="related-article-title sb-tc">Statins and Primary Atherosclerotic Cardiovascular Disease Prevention</div>
                    </a>
                    <div class="related-article-authors">Salim S. Virani, MD, PhD</div>
                                    <div class="related-article-journal-name">JAMA Network Open</div>
            </li>
            <li class="article-link related-abstract-article">

                    <a class="related-article-title" href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2795661">
                            <div class="related-article-type">Editorial</div>
                        <div class="related-article-title sb-tc">Statins for Primary Cardiovascular Disease Prevention</div>
                    </a>
                    <div class="related-article-authors">Anand R. Habib, MD, MPhil; Mitchell H. Katz, MD; Rita F. Redberg, MD, MSc</div>
                                    <div class="related-article-journal-name">JAMA Internal Medicine</div>
            </li>
            <li class="article-link related-abstract-article">

                    <a class="related-article-title" href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2795619">
                            <div class="related-article-type">Editorial</div>
                        <div class="related-article-title sb-tc">Statin Usage in Primary Prevention—Comparing USPSTF With AHA/ACC</div>
                    </a>
                    <div class="related-article-authors">Neil J. Stone, MD; Philip Greenland, MD; Scott M. Grundy, MD, PHD</div>
                                    <div class="related-article-journal-name">JAMA Cardiology</div>
            </li>
    </ul>
 
    </div>

    </div>

    
    <div id="related-articles-tab" class="linked-content-tab related-article-tab">
    <div class="widget-ArticleLinks widget-instance-AMA_LinkedContentToolbar_RelatedArticle">
        
    <ul class="article-abstract-links related-abstract-content">
            <li class="article-link related-abstract-article">

                    <a class="related-article-title" href="https://jamanetwork.com/journals/jama/fullarticle/2795522">
                            <div class="related-article-type">US Preventive Services Task Force</div>
                        <div class="related-article-title sb-tc">USPSTF Review: Statins for Primary Prevention of Cardiovascular Disease in Adults</div>
                    </a>
                    <div class="related-article-authors">Roger Chou, MD; Amy Cantor, MD, MPH; Tracy Dana, MLS; Jesse Wagner, MA; Azrah Y. Ahmed, BA; Rongwei Fu, PhD; Maros Ferencik, MD, PhD, MCR</div>
                                    <div class="related-article-journal-name">JAMA</div>
            </li>
            <li class="article-link related-abstract-article">

                    <a class="related-article-title" href="https://jamanetwork.com/journals/jama/fullarticle/2795526">
                            <div class="related-article-type">JAMA Patient Page</div>
                        <div class="related-article-title sb-tc">Patient Information: Statins for the Prevention of Cardiovascular Disease</div>
                    </a>
                    <div class="related-article-authors">Jill Jin, MD, MPH</div>
                                    <div class="related-article-journal-name">JAMA</div>
            </li>
    </ul>
 
    </div>
    <div class="widget-ArticleLinks widget-instance-AMA_LinkedContentToolbar_RelatedEditorsChoices">
        
 
    </div>

    </div>

    
    <div id="author-interviews-tab" class="linked-content-tab linked-author-interviews-tab">
    <div class="widget-AudioPlayer widget-instance-AMA_LinkedContentToolbar_PlatformAudioPlayer_AuthorInterviews">
                <div class="audio-border-top  thm-bg-col sb-background-pc"></div>
    <div class="audio-element-wrapper js-audio-element-wrapper">
            <div class="audio-group-duration">
                Audio  (25:31)
            </div>
                    <div><a class="audio-title" href="https://jamanetwork.com/learning/audio-player/18717724" target="_blank" aria-label="Linked Multimedia Button">USPSTF Recommendation: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults</a></div>
                <div id="audio-player-wrapper" class="js-audio-player-wrapper audio-player-wrapper">
            <audio class="js-audio-player" id="audio-player" type="audio/mp3" preload="none" src=https://traffic.libsyn.com/secure/jamaauthorinterviews/uspstf_recommendation_statin_use_for_the_primary_prevention_of_cardiovascular_disease_in_adults.mp3></audio>
            <div class="display-elements">
                <div class="audio-controls">
                    <a id="backward" class="js-btn-backward audio-back" href="javascript:;" aria-label="Back Button">
                        <img src="//cdn.jamanetwork.com/UI/app/svg/multimedia/Backward_15.svg" alt="Backward 15" />
                    </a>
                    <a id="play-pause" class="js-play-pause audio-play" href="javascript:;" aria-label="Play Button">
                        <img src="//cdn.jamanetwork.com/UI/app/svg/multimedia/Play.svg" alt="Play" />
                    </a>
                    <a id="play-pause" class="js-play-pause audio-pause" href="javascript:;" aria-label="Pause Button">
                        <img src="//cdn.jamanetwork.com/UI/app/svg/multimedia/Pause.svg" alt="Pause" />
                    </a>
                    <a id="forward" class="js-btn-forward audio-forward" href="javascript:;" aria-label="Fast Forward Button">
                        <img src="//cdn.jamanetwork.com/UI/app/svg/multimedia/Forward_15.svg" alt="Forward 15" />
                    </a>
                </div>
                <div class="js-progressBar-clickable progressBar-clickable">
                    <div class="js-progressBar progressBar">
                        <div class="js-loading-animation">
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                        </div>
                        <div class="js-timeBar timeBar thm-bg-col sb-background-pc" tabindex="0" aria-label="Progress Bar"></div>
                    </div>
                </div>
                <div class="audio-speed">
                    <a id="speed-1x" class="js-btn-speed" play-speed=1 href="javascript:;" aria-label="Speed Control Button">1x</a>
                </div>
                <div class="audio-time">
                    <span id="time" class="js-time js-timeAudioCurrent">0:00</span>
                    <span> / </span>
                    <span class="js-initialTime">0:00</span>
                    <span class="js-duration hide"></span>
                </div>
            </div>
        </div>
            <div class="linked-content-urls-wrapper">
                            <span><a class="thm-col sb-pc linked-content" target="_blank" href="https://jamanetwork.com/journals/jama/pages/jama-author-interviews" aria-label="Subscribe To Podcast Button">Subscribe to Podcast</a></span>

            </div>
        
    </div>
 
    </div>
    <div class="widget-MultimediaInfo widget-instance-AMA_LinkedContentToolbar_AuthorInterviews">
        





 
    </div>

    </div>

    
    <div id="listen-to-this-article-tab" class="linked-content-tab linked-listen-to-this-article-tab">
    <div class="widget-AudioPlayer widget-instance-AMA_LinkedContentToolbar_PlatformAudioPlayer_ListenToThisArticle">
         
    </div>

    </div>

    
    <div id="more-multimedia-tab" class="linked-content-tab more-multimedia-tab">
    <div class="widget-MultimediaInfo widget-instance-AMA_LinkedContentToolbar_MoreMultimedia">
        





 
    </div>

    </div>
</div>
</div> 
    </div>

            <div class="widget-ArticleFulltext widget-instance-AMA_Article_FullText_Widget">
        <div class="article-full-text" data-userHasAccess="True">
    

            <a class="article-section-id-anchor" id="248566950"></a>
                        <div class="h3 cb section-type-abstract decorated-hed ">

                            <div class="heading-text thm-col sb-sc">
                                Abstract
                            </div>
                        </div>
<p><strong>Importance</strong> 
    <span>Cardiovascular disease (CVD) is the leading cause of morbidity and death in the US and is the cause of more than 1 of every 4 deaths. Coronary heart disease is the single leading cause of death and accounts for 43% of deaths attributable to CVD in the US. In 2019, an estimated 558 000 deaths were caused by coronary heart disease and 109 000 deaths were caused by ischemic stroke.</span></p><p><strong>Objective</strong> 
    <span>To update its 2016 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a review of the evidence on the benefits and harms of statins for reducing CVD-related morbidity or mortality or all-cause mortality.</span></p><p><strong>Population</strong> 
    <span>Adults 40 years or older without a history of known CVD and who do not have signs and symptoms of CVD.</span></p><p><strong>Evidence Assessment</strong> 
    <span>The USPSTF concludes with moderate certainty that statin use for the prevention of CVD events and all-cause mortality in adults aged 40 to 75 years with no history of CVD and who have 1 or more CVD risk factors (ie, dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year CVD event risk of 10% or greater has at least a moderate net benefit. The USPSTF concludes with moderate certainty that statin use for the prevention of CVD events and all-cause mortality in adults aged 40 to 75 years with no history of CVD and who have 1 or more of these CVD risk factors and an estimated 10-year CVD event risk of 7.5% to less than 10% has at least a small net benefit. The USPSTF concludes that the evidence is insufficient to determine the balance of benefits and harms of statin use for the primary prevention of CVD events and mortality in adults 76 years or older with no history of CVD.</span></p><p><strong>Recommendation</strong> 
    <span>The USPSTF recommends that clinicians prescribe a statin for the primary prevention of CVD for adults aged 40 to 75 years who have 1 or more CVD risk factors (ie, dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year CVD risk of 10% or greater. (B recommendation) The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of CVD for adults aged 40 to 75 years who have 1 or more of these CVD risk factors and an estimated 10-year CVD risk of 7.5% to less than 10%. The likelihood of benefit is smaller in this group than in persons with a 10-year risk of 10% or greater. (C recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of initiating a statin for the primary prevention of CVD events and mortality in adults 76 years or older. (I statement)</span></p>            <div class="movable-ad-target bta"> </div>
            <a class="article-section-id-anchor" id="248566956"></a>
                        <div class="h3 cb section-type-section  ">

                            <div class="heading-text thm-col sb-sc">
                                Summary of Recommendations
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248566958"></a>
<p class="para">See the Summary of Recommendation Figure.</p>            <a class="article-section-id-anchor" id="248566959"></a>
                        <div class="h3 cb section-type-section  ">

                            <div class="heading-text thm-col sb-sc">
                                Importance
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248566960"></a>
<p class="para">Cardiovascular disease (CVD) is the leading cause of morbidity and death in the US, resulting in more than 1 of every 4 deaths.<sup><a href="#jus220018r1" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">1</a></sup> Coronary heart disease is the single leading cause of death and accounts for 43% of deaths attributable to CVD in the US.<sup><a href="#jus220018r2" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">2</a></sup><sup>,<a href="#jus220018r3" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">3</a></sup> In 2019, an estimated 558 000 deaths were caused by coronary heart disease and 109 000 deaths were caused by ischemic stroke. Men have a higher overall prevalence of and mortality from CVD, although women experience higher mortality from certain cardiovascular events, such as stroke. On average, men experience CVD events earlier in life compared with women. The prevalence of CVD also differs by race and ethnicity. Among both sexes, Black adults have the highest prevalence of CVD.<sup><a href="#jus220018r4" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">4</a></sup></p>            <a class="article-section-id-anchor" id="248566961"></a>
                        <div class="h3 cb section-type-section  ">

                            <div class="heading-text thm-col sb-sc">
                                USPSTF Assessment of Magnitude of Net Benefit
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248566962"></a>
<p class="para">The US Preventive Services Task Force (USPSTF) concludes with moderate certainty that statin use for the prevention of CVD events and all-cause mortality in adults aged 40 to 75 years with no history of CVD and who have 1 or more CVD risk factors (ie, dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year CVD event risk of 10% or greater has at least a <strong>moderate net benefit</strong>.</p>            <a class="article-section-id-anchor" id="248566963"></a>
<p class="para">The USPSTF concludes with moderate certainty that statin use for the prevention of CVD events and all-cause mortality in adults aged 40 to 75 years with no history of CVD and who have 1 or more CVD risk factors (ie, dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year CVD event risk of 7.5% to less than 10% has at least a <strong>small net benefit</strong>. The decision to initiate therapy should depend on individual patient preference for a potential small benefit relative to the potential harms and inconvenience of taking a daily medication.</p>            <a class="article-section-id-anchor" id="248566964"></a>
<p class="para">The USPSTF concludes that the <strong>evidence is insufficient</strong> to determine the balance of benefits and harms of statin use for the primary prevention of CVD events and mortality in adults 76 years or older with no history of CVD.</p>            <a class="article-section-id-anchor" id="248566965"></a>
<p class="para">See the <a href="#jus220018t1" class="table-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Table</a> for more information on the USPSTF recommendation rationale and assessment and the eFigure in the <a class="supplement-link section-jump-link" data-tab-toggle=".tab-nav-supplemental" href="#note-JUS220018-1">Supplement</a> for information on the recommendation grade. See the <a href="#jus220018f1" class="figure-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Figure</a> for a summary of the recommendation for clinicians. For more details on the methods the USPSTF uses to determine the net benefit, see the USPSTF Procedure Manual.<sup><a href="#jus220018r5" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">5</a></sup></p>            <a class="article-section-id-anchor" id="248566968"></a>
                        <div class="h3 cb section-type-section  ">

                            <div class="heading-text thm-col sb-sc">
                                Practice Considerations
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248566969"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Patient Population Under Consideration
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248566970"></a>
<p class="para">These recommendations apply to adults 40 years or older without a history of known CVD and who do not have signs and symptoms of CVD. These recommendations do not apply to adults with a low-density lipoprotein cholesterol (LDL-C) level greater than 190 mg/dL (4.92 mmol/L) or known familial hypercholesterolemia. These populations are at very high risk for CVD, and considerations on the use of statins in these populations can be found in other organizations’ guidelines.</p>            <a class="article-section-id-anchor" id="248566971"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Assessment of Risk
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248566972"></a>
<p class="para">The American College of Cardiology/American Heart Association (ACC/AHA) Pooled Cohort Equations may be used to estimate 10-year risk of CVD. The ACC/AHA risk estimator is, to date, the only US-based CVD risk prediction tool that has published external validation studies in other US-based populations.<sup><a href="#jus220018r6" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">6</a></sup> The estimator has separate equations based on sex and for Black persons and non-Black persons, which include the risk factors of age, cholesterol levels, systolic blood pressure level, antihypertension treatment, presence of diabetes, and smoking status, and focuses on hard clinical outcomes (myocardial infarction and death from coronary heart disease; ischemic stroke and stroke-related death) as the outcomes of interest. Age is one of the strongest risk factors for CVD, and the 10-year CVD event risk estimated by the ACC/AHA risk estimator is heavily influenced by increasing age. The risk prediction equations generally show higher risk for Black persons than White persons.<sup><a href="#jus220018r6" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">6</a></sup> The USPSTF recognizes that race is a social construct, and it is an imperfect proxy for social determinants of health and the effects of structural racism. Concerns about calibration of the Pooled Cohort Equations exist, with many external validation studies showing overprediction in broad populations (men and women across racial and ethnic groups).<sup><a href="#jus220018r7" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">7</a></sup><sup>-<a href="#jus220018r7" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">9</a></sup> Limited evidence also suggests underprediction in disadvantaged communities<sup><a href="#jus220018r10" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">10</a></sup><sup>,<a href="#jus220018r11" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">11</a></sup> that could lead to underutilization of preventive therapies. Clinicians should recognize that predictions of 10-year CVD events using the Pooled Cohort Equations are estimates.</p>            <a class="article-section-id-anchor" id="248566973"></a>
<p class="para">The likelihood that a patient will benefit from statin use depends on their absolute risk of having a future CVD event, a risk estimation that, as noted above, is imprecise based on the currently available risk estimation tools. The higher a person’s 10-year risk of a CVD event, the greater the chance of benefit from statin use. Thus, the expected benefit of statin therapy for persons with a 10-year CVD risk of 10% or greater exceeds the expected benefit for persons with a 10-year CVD risk of 7.5% to less than 10%. Clinicians should discuss with patients the potential risk of having a CVD event and the expected benefits and harms of statin use. For patients with an estimated 10-year CVD risk of 10% or greater and who smoke or have dyslipidemia, diabetes, or hypertension, the USPSTF recommends that clinicians prescribe a statin once the rationale has been explained and the patient agrees to take a statin.<sup><a href="#jus220018r12" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">12</a></sup> For patients with an estimated 10-year CVD risk of 7.5% to less than 10% (and who have ≥1 of the risk factors noted above), clinicians may selectively offer a statin, taking patient values and preferences into account. Patients in this estimated risk range who place a higher value on the potential benefits than on the potential harms and inconvenience of taking a daily medication may choose to initiate a statin.</p>            <a class="article-section-id-anchor" id="248566974"></a>
<p class="para">Given that participants in clinical trials of statin therapy were enrolled based on the presence of 1 or more CVD risk factors, and that the magnitude of benefit of statin use is proportional to a person’s estimated 10-year CVD risk, the USPSTF recommends that clinicians evaluate both the presence of CVD risk factors (ie, dyslipidemia, diabetes, hypertension, or smoking) as well as estimated 10-year risk of CVD in determining which persons should initiate use of statins.</p>            <a class="article-section-id-anchor" id="248566975"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Treatment and Statin Intensity
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248566976"></a>
<p class="para">There are limited data directly comparing the effects of different statin intensities on health outcomes. A majority of the trials reviewed by the USPSTF used moderate-intensity statin therapy.<sup><a href="#jus220018r13" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">13</a></sup> Based on available evidence, use of moderate-intensity statin therapy seems reasonable for the primary prevention of CVD in most persons.</p>            <a class="article-section-id-anchor" id="248566977"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Implementation
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248566978"></a>
<p class="para">Several studies have reported inequities in statin use based on demographic and socioeconomic factors such as race and ethnicity, sex, area poverty level, and income level. Some studies found that Black adults have a decreased likelihood of being prescribed a statin<sup><a href="#jus220018r14" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">14</a></sup> and statin use<sup><a href="#jus220018r15" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">15</a></sup> compared with White adults. Having no health insurance was also associated with decreased likelihood of statin use, as was having multiple vulnerabilities (defined as age 65 years or older, being a woman, being Black, area poverty level of 10% or greater, or no health insurance).<sup><a href="#jus220018r15" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">15</a></sup> Older age, having health insurance, and higher income were associated with an increased likelihood of statin use.<sup><a href="#jus220018r16" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">16</a></sup><sup>,<a href="#jus220018r17" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">17</a></sup> Data from the 2013-2014 National Health and Nutrition Examination Survey found that among persons eligible for statin use, statin use was higher among non-Hispanic White (58.3%) persons compared with non-Hispanic Asian (49.2%), non-Hispanic Black (44.3%), or Hispanic (33.7%) persons.<sup><a href="#jus220018r18" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">18</a></sup> It is essential to equitably improve statin use in both women and men of all races and ethnicities, regardless of socioeconomic level or health insurance status, to achieve the full benefits of statin use, and especially among Black adults and Hispanic adults, who have the highest prevalence of CVD<sup><a href="#jus220018r4" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">4</a></sup> and the lowest use of statins, respectively.</p>            <a class="article-section-id-anchor" id="248566979"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Additional Tools and Resources
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248566980"></a>
<p class="para">The Centers for Disease Control and Prevention provides information about cholesterol-lowering medications, including statins (<a href="https://www.cdc.gov/cholesterol/treating_cholesterol.htm">https://www.cdc.gov/cholesterol/treating_cholesterol.htm</a>), and resources for clinicians (<a href="https://www.cdc.gov/cholesterol/educational_materials.htm">https://www.cdc.gov/cholesterol/educational_materials.htm</a>).</p>            <a class="article-section-id-anchor" id="248566981"></a>
<p class="para">Million Hearts, a national initiative from the US Department of Health and Human Services to prevent myocardial infarctions and strokes, provides information on statins (<a href="https://millionhearts.hhs.gov/learn-prevent/scoop-on-statins.html">https://millionhearts.hhs.gov/learn-prevent/scoop-on-statins.html</a>).</p>            <a class="article-section-id-anchor" id="248566982"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Suggestions for Practice Regarding the I Statement
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248566983"></a>
                        <div class="h5 cb section-type-section  ">

                            <div class="heading-text ">
                                Potential Preventable Burden
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248566984"></a>
<p class="para">According to the National Center for Health Statistics, heart disease and cerebrovascular disease were respectively the first and fourth leading causes of death in adults 65 years or older in 2018, although data were not reported separately for adults older than 75 years.<sup><a href="#jus220018r19" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">19</a></sup> However, trial data on the benefits of statin use in persons older than 75 years are limited,<sup><a href="#jus220018r13" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">13</a></sup> and the available evidence is insufficient to recommend for or against initiating statin use for the primary prevention of CVD in this age group.</p>            <a class="article-section-id-anchor" id="248566985"></a>
                        <div class="h5 cb section-type-section  ">

                            <div class="heading-text ">
                                Potential Harms
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248566986"></a>
<p class="para">Evidence on the potential harms of statin use for the primary prevention of CVD events specifically in adults 76 years or older is limited. Evidence from trials in the general adult population shows that statins are not associated with an increased risk of myalgia, elevated alanine aminotransferase level, or cognitive harms compared with placebo.<sup><a href="#jus220018r13" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">13</a></sup> Almost all trials did not find an association between statin use and incidence of diabetes; 1 trial, JUPITER (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin), found that high-intensity statin therapy was associated with increased risk of diabetes,<sup><a href="#jus220018r20" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">20</a></sup> although a subsequent analysis found that this increased risk was limited to participants with diabetes risk factors at baseline (metabolic syndrome, impaired fasting glucose, body mass index ≥30 [calculated as weight in kilograms divided by square of height in meters], or hemoglobin A<sub>1c</sub> level &gt;6%).<sup><a href="#jus220018r21" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">21</a></sup></p>            <a class="article-section-id-anchor" id="248566987"></a>
                        <div class="h5 cb section-type-section  ">

                            <div class="heading-text ">
                                Current Practice
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248566988"></a>
<p class="para">Data on statin use for the primary prevention of CVD in persons 76 years or older are limited. One study estimated that 10.7 million adults 75 years or older were taking a statin in 2013 to 2014, although it did not distinguish between statin use for primary vs secondary prevention.<sup><a href="#jus220018r18" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">18</a></sup> A second study reported that among adults 75 years or older without a history of CVD, those with diabetes had rates of statin use more than 2 times higher than among those without diabetes (76.1 and 34.5 initiators per 1000 person-years, respectively). This study did not report the prevalence of statin use.<sup><a href="#jus220018r22" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">22</a></sup></p>            <a class="article-section-id-anchor" id="248566989"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Other Related USPSTF Recommendations
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248566990"></a>
<p class="para">The USPSTF has made several recommendations related to the prevention of CVD in adults, including aspirin use to prevent CVD,<sup><a href="#jus220018r23" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">23</a></sup> screening for high blood pressure,<sup><a href="#jus220018r24" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">24</a></sup> screening for prediabetes and type 2 diabetes,<sup><a href="#jus220018r25" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">25</a></sup> interventions for tobacco smoking cessation,<sup><a href="#jus220018r26" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">26</a></sup> behavioral counseling to promote a healthy diet and physical activity for CVD prevention in adults (with and without cardiovascular risk factors),<sup><a href="#jus220018r27" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">27</a></sup><sup>,<a href="#jus220018r28" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">28</a></sup> and behavioral interventions to prevent obesity-related morbidity and mortality in adults.<sup><a href="#jus220018r29" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">29</a></sup></p>            <a class="article-section-id-anchor" id="248566991"></a>
                        <div class="h3 cb section-type-section  ">

                            <div class="heading-text thm-col sb-sc">
                                Update of Previous USPSTF Recommendation
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248566992"></a>
<p class="para">This recommendation replaces the 2016 USPSTF recommendation on statin use for the primary prevention of CVD and is generally consistent with that recommendation.<sup><a href="#jus220018r30" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">30</a></sup> In 2016, the USPSTF recommended that adults without a history of CVD (ie, symptomatic coronary artery disease or ischemic stroke) use a low- to moderate-dose statin for the prevention of CVD events and mortality when all of the following criteria are met: (1) they are aged 40 to 75 years; (2) they have 1 or more CVD risk factors (ie, dyslipidemia, diabetes, hypertension, or smoking); and (3) they have a calculated 10-year risk of a cardiovascular event of 10% or greater. The USPSTF also recommended that clinicians may choose to offer a low- to moderate-dose statin to adults without a history of CVD who meet criteria 1 and 2 above and have a calculated 10-year risk of a cardiovascular event of 7.5% to less than 10%. The USPSTF concluded that the evidence was insufficient to assess the balance of benefits and harms of initiating statin use for the primary prevention of CVD events and mortality in adults 76 years or older.<sup><a href="#jus220018r30" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">30</a></sup></p>            <a class="article-section-id-anchor" id="248566993"></a>
                        <div class="h3 cb section-type-section  ">

                            <div class="heading-text thm-col sb-sc">
                                Supporting Evidence
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248566994"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Scope of Review
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248566995"></a>
<p class="para">To update its 2016 recommendation statement, the USPSTF commissioned a systematic review<sup><a href="#jus220018r13" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">13</a></sup><sup>,<a href="#jus220018r31" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">31</a></sup> of the evidence on the benefits and harms of statins in reducing CVD-related morbidity or mortality or all-cause mortality. The evidence review also investigated whether the benefits or harms of statin treatment vary in populations of interest defined by demographic, clinical, or socioeconomic characteristics, by statin intensity, or by titration of statin therapy to a target LDL-C level vs use of a fixed statin dose.</p>            <a class="article-section-id-anchor" id="248566996"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Benefits of Preventive Medication
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248566997"></a>
<p class="para">The USPSTF reviewed 22 trials that reported on the benefits of statin use for primary prevention. Mean duration of follow-up was 3.3 years. Mean age of study participants ranged from 52 to 66 years in all trials except for 1, PROSPER (Prospective Study of Pravastatin in the Elderly at Risk), which enrolled persons aged 70 to 82 years (mean age, 75 years).<sup><a href="#jus220018r32" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">32</a></sup> Among the trials that used a fixed statin dose, most (12/16) used a moderate-intensity statin, as defined by ACC/AHA criteria. Fifteen trials reported race and ethnicity; White persons were the most common group in 14 of those trials, representing 41% to 99% of the study population. The proportion of Black participants, reported in 5 trials, ranged from less than 1% to 37%. Data for other races and ethnicities were limited. All trials enrolled persons with at least 1 cardiovascular risk factor, and a few required the presence of multiple cardiovascular risk factors at baseline. The most common risk factors were dyslipidemia (which was variably defined), diabetes, and hypertension.<sup><a href="#jus220018r13" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">13</a></sup><sup>,<a href="#jus220018r31" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">31</a></sup></p>            <a class="article-section-id-anchor" id="248566998"></a>
<p class="para">In pooled analyses, statin therapy was associated with decreased risk of all-cause mortality (18 trials; n = 85 816; relative risk [RR], 0.92 [95% CI, 0.87 to 0.98]; absolute risk difference [ARD], −0.35%), fatal or nonfatal stroke (15 trials; n = 76 610; RR, 0.78 [95% CI, 0.68 to 0.90]; ARD, −0.39%), and fatal or nonfatal myocardial infarction (12 trials; n = 76 498; RR, 0.67 [95% CI, 0.60 to 0.75]; ARD, −0.89%). In several trials, primary outcome was reported as a composite of CVD events, with the exact components of this end point varying across trials. In a pooled analysis of 15 trials, statin therapy was also associated with a decreased risk of composite cardiovascular outcomes (n = 74 390; RR, 0.72 [95% CI, 0.64 to 0.81]; ARD, −1.28%).<sup><a href="#jus220018r13" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">13</a></sup><sup>,<a href="#jus220018r31" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">31</a></sup></p>            <a class="article-section-id-anchor" id="248566999"></a>
<p class="para">Twelve trials (n = 75 138) reported on cardiovascular mortality. Only 1 trial, WOSCOPS (West of Scotland Coronary Prevention Study; n = 6595), reported a statistically significant difference between statin and placebo in risk of cardiovascular mortality (RR, 0.68 at 6 years [95% CI, 0.48 to 0.98]; ARD, −0.70% [95% CI, −1.36% to −0.05%]).<sup><a href="#jus220018r33" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">33</a></sup> In pooled analyses of all 12 trials, statin therapy was associated with a slight reduction in cardiovascular mortality risk at 2 to 6 years that was not statistically significant (RR, 0.91 [95% CI, 0.81 to 1.02]; ARD, −0.13%; [95% CI, −0.25% to −0.02%]).<sup><a href="#jus220018r13" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">13</a></sup><sup>,<a href="#jus220018r31" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">31</a></sup></p>            <a class="article-section-id-anchor" id="248567000"></a>
<p class="para">Evidence on the benefits of statins in persons 75 years or older is limited. As noted, most trials had a mean participant age in the 50s and 60s; only 1 trial, PROSPER (n = 3239 for primary prevention), had a study population with a mean age of 75 years.<sup><a href="#jus220018r32" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">32</a></sup> One additional trial, ALLHAT-LLT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial–Lipid Lowering Trial), reported stratified results for the age group 75 years or older (in addition to other age groups).<sup><a href="#jus220018r34" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">34</a></sup><sup>,<a href="#jus220018r35" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">35</a></sup> The primary prevention data from PROSPER found no decrease in all-cause mortality (RR, 1.07 [95% CI, 0.86 to 1.35]), risk of stroke (RR, 1.03 [95% CI, 0.73 to 1.45]), or in a composite cardiovascular outcome (RR, 0.94 [95% CI, 0.78 to 1.14]) among persons taking a statin compared with placebo.<sup><a href="#jus220018r32" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">32</a></sup> In the ALLHAT-LLT primary prevention population, statin therapy was associated with higher risk of all-cause and cardiovascular mortality in persons 75 years or older than in those aged 65 to 74 years (hazard ratio, 1.36 [95% CI, 0.98 to 1.89] vs 1.05 [95% CI, 0.82 to 1.33], respectively, for all-cause mortality; RR, 1.39 [95% CI, 0.85 to 2.25] vs 0.99 [95% CI, 0.71 to 1.39], respectively, for cardiovascular mortality), but estimates for the age group 75 years or older were imprecise and the difference was not statistically significant.<sup><a href="#jus220018r34" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">34</a></sup><sup>,<a href="#jus220018r35" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">35</a></sup> However, ALLHAT-LLT had several limitations, including its open-label design, high loss to follow-up, and high crossover from the usual care treatment group. This trial reported a small differential in LDL-C–lowering effect between the statin therapy group and usual care group and showed no benefit of statin use overall.</p>            <a class="article-section-id-anchor" id="248567001"></a>
<p class="para">In stratified analyses, the relative benefits of statin therapy did not appear to differ across a variety of demographic and clinical variables, including age (with the caveat that data are limited for persons older than 75 years), sex, and race and ethnicity, or the presence or absence of specific risk factors such as hypertension or diabetes. No trials reported how benefits of statin therapy vary according to socioeconomic characteristics.<sup><a href="#jus220018r13" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">13</a></sup><sup>,<a href="#jus220018r31" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">31</a></sup></p>            <a class="article-section-id-anchor" id="248567002"></a>
<p class="para">No study directly compared treatment with statins titrated to attain a target cholesterol level vs fixed-dose treatment strategies. There were also limited data directly comparing the effects of different statin intensities on health outcomes. Across-study comparisons did not indicate differences in outcomes based on dose titration vs fixed-dose statin therapy or based on statin intensity. As noted, most trials used a moderate-intensity statin.<sup><a href="#jus220018r13" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">13</a></sup><sup>,<a href="#jus220018r31" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">31</a></sup></p>            <a class="article-section-id-anchor" id="248567003"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Harms of Preventive Medication
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248567004"></a>
<p class="para">The USPSTF reviewed 19 trials (n = 75 005) and 3 observational studies (n = 417 523) that reported on the harms of statin therapy in adults without a history of a CVD event. In pooled analyses of trial data, statin therapy was not associated with increased risk of study withdrawal due to adverse events or serious adverse events.<sup><a href="#jus220018r13" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">13</a></sup><sup>,<a href="#jus220018r31" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">31</a></sup> Although observational studies have reported an association between statin use and muscle pain,<sup><a href="#jus220018r36" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">36</a></sup> a pooled analysis of 9 trials (n = 46 388) found no increased risk of myalgia with statin therapy compared with placebo.<sup><a href="#jus220018r13" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">13</a></sup><sup>,<a href="#jus220018r31" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">31</a></sup> Trials also did not find an association between statin therapy and myopathy or rhabdomyolysis, although these events were uncommon, so the estimates of relative risk are imprecise.<sup><a href="#jus220018r13" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">13</a></sup><sup>,<a href="#jus220018r31" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">31</a></sup></p>            <a class="article-section-id-anchor" id="248567005"></a>
<p class="para">Twelve trials (n = 55 358) reported no difference between statin therapy and placebo in risk of elevation in aminotransferase levels, and pooled analyses of 13 trials (n = 71 733) found no difference between statin therapy and placebo or no statin in risk of any cancer.<sup><a href="#jus220018r13" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">13</a></sup><sup>,<a href="#jus220018r31" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">31</a></sup></p>            <a class="article-section-id-anchor" id="248567006"></a>
<p class="para">Six trials (n = 59 083) and 3 observational studies (n = 417 523) reported on risk of new-onset diabetes with statin therapy. Based on a pooled analysis of 6 trials, there was no difference between statins and placebo or no statin in risk of diabetes (RR, 1.04 [95% CI, 0.92 to 1.19]; <i>I<sup>2</sup></i> = 52%; ARD, 0.00% [95% CI, −0.00% to 0.01%]).<sup><a href="#jus220018r12" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">12</a></sup> One trial of high-intensity statin therapy (JUPITER) reported an increased risk of diabetes with statin use (3.0% vs 2.4%; RR, 1.25 [95% CI, 1.05 to 1.49])<sup><a href="#jus220018r20" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">20</a></sup> that was subsequently found to be limited to study participants with 1 or more diabetes risk factors (metabolic syndrome, impaired fasting glucose, body mass index ≥30, or hemoglobin A<sub>1c</sub> level &gt;6%) at baseline.<sup><a href="#jus220018r21" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">21</a></sup> Cohort studies reported mixed findings. One case-control study found no association between statin use and risk of diabetes,<sup><a href="#jus220018r37" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">37</a></sup> an analysis from the Women’s Health Initiative found an increased risk (adjusted hazard ratio, 1.48 [95% CI, 1.38 to 1.59]),<sup><a href="#jus220018r38" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">38</a></sup> and a third cohort reported mixed findings that varied by 10-year cardiovascular mortality risk (based on the SCORE instrument) and adherence to statin therapy.<sup><a href="#jus220018r39" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">39</a></sup></p>            <a class="article-section-id-anchor" id="248567007"></a>
<p class="para">Evidence on the association between statins and renal or cognitive harms is very limited but does not indicate increased risk.<sup><a href="#jus220018r13" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">13</a></sup><sup>,<a href="#jus220018r31" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">31</a></sup> In 1 trial, statin therapy was associated with increased risk of cataract surgery, which was unanticipated and not a predetermined outcome of the trial (3.8% vs 3.1%; RR, 1.24 [95% CI, 1.03 to 1.49]; ARD, 0.73%).<sup><a href="#jus220018r40" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">40</a></sup> Other trials did not note or report on this outcome.</p>            <a class="article-section-id-anchor" id="248567008"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Response to Public Comment
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248567009"></a>
<p class="para">A draft version of this recommendation statement was posted for public comment on the USPSTF website from February 22 to March 21, 2022. Some comments sought clarification on why the USPSTF is recommending that both presence of a CVD risk factor and estimated 10-year CVD risk be used when considering initiation of a statin. As noted in the Practice Considerations section, statin trial inclusion criteria required the presence of 1 or more CVD risk factors. Additionally, the magnitude of the benefits of statin use is proportional to a person’s CVD risk level; thus, the USPSTF concluded that a 10-year CVD risk of 7.5% to less than 10% provides at least a small net benefit and a 10-year CVD risk of 10% or greater provides at least a moderate net benefit. Some comments sought clarification on whether coronary artery calcium score could be used as a criterion for statin use. The USPSTF addressed the use of coronary artery calcium score for CVD risk assessment in a separate recommendation.<sup><a href="#jus220018r41" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">41</a></sup> Some comments sought clarification on whether persons 76 years or older who are already taking a statin should continue its use. The USPSTF reiterates that this recommendation is about initiating a statin for the primary prevention of CVD events and mortality; in adults 76 years or older, the evidence is insufficient to assess the balance of benefits and harms of initiating statins. Some comments expressed concerns about the accuracy of the Pooled Cohort Equations across populations. The USPSTF understands these concerns and calls for more research on improving the accuracy of CVD risk prediction in all racial and ethnic and socioeconomic groups in the Research Needs and Gaps section. In addition, the USPSTF wants to clarify that these recommendations do not pertain to adults with familial hypercholesterolemia or an LDL-C level greater than 190 mg/dL (4.92 mmol/L). Considerations for statin use in these populations can be found in other organizations’ guidelines and resources on management of these conditions.</p>            <a class="article-section-id-anchor" id="248567010"></a>
                        <div class="h3 cb section-type-section  ">

                            <div class="heading-text thm-col sb-sc">
                                Research Needs and Gaps
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248567011"></a>
<p class="para">More studies are needed that address the following.</p>            <a class="article-section-id-anchor" id="248567012"></a>
<p class="para"><ul class="bullet"><li><p class="para">Improving the accuracy of CVD risk prediction in all racial and ethnic and socioeconomic groups.</p></li><li><p class="para">The balance of benefits and harms of initiating statin use for the primary prevention of cardiovascular events in adults 76 years or older.</p></li><li><p class="para">The efficacy and safety of long-term statin use in adults younger than 40 years, and to determine the effects of earlier vs delayed initiation of statin use, particularly in persons with an estimated high long-term (longer than 10 years [eg, lifetime]) risk of CVD.</p></li><li><p class="para">The causes of disparities in statin use and effective methods to reduce disparities.</p></li><li><p class="para">Trials that directly compare statin therapy titrated to target lipid levels vs fixed-dose therapy to inform optimal dosing strategies. Trials that directly compare higher- vs lower-intensity statin therapy and are powered to assess clinical outcomes are also needed.</p></li><li><p class="para">Definitively determining whether statin therapy is associated with increased risk of diabetes in primary prevention populations.</p></li><li><p class="para">The role of patient preferences in decisions to prescribe statins for persons across the spectrum of CVD risk.</p></li></ul></p>            <a class="article-section-id-anchor" id="248567013"></a>
                        <div class="h3 cb section-type-section  ">

                            <div class="heading-text thm-col sb-sc">
                                Recommendations of Others
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248567014"></a>
<p class="para">The 2018 and 2019 ACC/AHA guidelines define cardiovascular risk categories as high (10-year risk of cardiovascular events ≥20%), intermediate (10-year risk of cardiovascular events ≥7.5% to &lt;20%), and borderline (10-year risk of cardiovascular events 5% to &lt;7.5%).<sup><a href="#jus220018r42" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">42</a></sup><sup>,<a href="#jus220018r43" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">43</a></sup> The guidelines recommend initiation of statin therapy in persons at intermediate or high risk and a risk discussion for persons at borderline risk, and recommend consideration of risk enhancers to refine risk assessments based on the Pooled Cohort Equations and inform decision-making for persons at intermediate and borderline risk.<sup><a href="#jus220018r42" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">42</a></sup><sup>,<a href="#jus220018r43" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">43</a></sup> These risk enhancers include family history of early coronary heart disease, presence of chronic kidney disease, metabolic syndrome, preeclampsia, premature menopause, inflammatory diseases, HIV, and South Asian ancestry.<sup><a href="#jus220018r42" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">42</a></sup><sup>,<a href="#jus220018r43" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">43</a></sup></p>            <a class="article-section-id-anchor" id="248567015"></a>
<p class="para">The 2014 US Department of Veterans Affairs/US Department of Defense Clinical Practice Guideline recommends initiation of a moderate-dose statin in persons with an estimated 10-year cardiovascular risk of 12% or greater and shared decision-making for persons with an estimated 10-year cardiovascular risk of 6% to 12%.<sup><a href="#jus220018r44" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">44</a></sup></p>            <a class="article-section-id-anchor" id="248567016"></a>
                        <div class="h3 cb section-type-acknowledgements  has-back-to-top">
                                <a href="#top" class="section-jump-link back-to-top" data-tab-toggle=".tab-nav-full-text">Back to top</a>

                            <div class="heading-text thm-col sb-sc">
                                Article Information
                            </div>
                        </div>
<p class="authorInfoSection"><strong>Corresponding Author:</strong> Carol M. Mangione, MD, MSPH, David Geffen School of Medicine, University of California, Los Angeles, 10940 Wilshire Blvd, Ste 700, Los Angeles, CA 90024 (<a href="mailto:chair@uspstf.net" target="_blank">chair@uspstf.net</a>)</p><p class="para"><strong>Accepted for Publication:</strong> July 13, 2022.</p><p class="paranonbyline-authors-end"><strong>The US Preventive Services Task Force (USPSTF) members:</strong> Carol M. Mangione, MD, MSPH; Michael J. Barry, MD; Wanda K. Nicholson, MD, MPH, MBA; Michael Cabana, MD, MA, MPH; David Chelmow, MD; Tumaini Rucker Coker, MD, MBA; Esa M. Davis, MD, MPH; Katrina E. Donahue, MD, MPH; Carlos Roberto Jaén, MD, PhD, MS; Martha Kubik, PhD, RN; Li Li, MD, PhD, MPH; Gbenga Ogedegbe, MD, MPH; Lori Pbert, PhD; John M. Ruiz, PhD; James Stevermer, MD, MSPH; John B. Wong, MD.</p><p class="paranonbyline-affils-end"><strong>Affiliations of The US Preventive Services Task Force (USPSTF) members: </strong>University of California, Los Angeles (Mangione); Harvard Medical School, Boston, Massachusetts (Barry); University of North Carolina at Chapel Hill (Nicholson); Albert Einstein College of Medicine, New York, New York (Cabana); Virginia Commonwealth University, Richmond (Chelmow); University of Washington, Seattle (Coker); University of Pittsburgh, Pittsburgh, Pennsylvania (Davis); University of North Carolina at Chapel Hill (Donahue); The University of Texas Health Science Center, San Antonio (Jaén); George Mason University, Fairfax, Virginia (Kubik); University of Virginia, Charlottesville (Li); New York University, New York, New York (Ogedegbe); University of Massachusetts Medical School, Worcester (Pbert); University of Arizona, Tucson (Ruiz); University of Missouri, Columbia (Stevermer); Tufts University School of Medicine, Boston, Massachusetts (Wong).</p><p class="paraauthor-contributions"><strong>Author Contributions</strong>: Dr Mangione had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.  The USPSTF members contributed equally to the recommendation statement.</p><p class="parafinancial-disclosure"><strong>Conflict of Interest Disclosures: </strong>Authors followed the policy regarding conflicts of interest described at <a href="https://www.uspreventiveservicestaskforce.org/Page/Name/conflict-of-interest-disclosures">https://www.uspreventiveservicestaskforce.org/Page/Name/conflict-of-interest-disclosures</a>. All members of the USPSTF receive travel reimbursement and an honorarium for participating in USPSTF meetings.</p><p class="parafunding-statement"><strong>Funding/Support:</strong> The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.</p><p class="para"><strong>Role of the Funder/Sponsor:</strong> AHRQ staff assisted in the following: development and review of the research plan, commission of the systematic evidence review from an Evidence-based Practice Center, coordination of expert review and public comment of the draft evidence report and draft recommendation statement, and the writing and preparation of the final recommendation statement and its submission for publication. AHRQ staff had no role in the approval of the final recommendation statement or the decision to submit for publication.</p><p class="para"><strong>Disclaimer:</strong> Recommendations made by the USPSTF are independent of the US government. They should not be construed as an official position of AHRQ or the US Department of Health and Human Services.</p><p class="para"><strong>Additional Contributions:</strong> We thank Howard Tracer, MD (AHRQ), who contributed to the writing of the manuscript, and Lisa Nicolella, MA (AHRQ), who assisted with coordination and editing.</p><p class="para"><strong>Additional Information:</strong> The US Preventive Services Task Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients without obvious related signs or symptoms. It bases its recommendations on the evidence of both the benefits and harms of the service and an assessment of the balance. The USPSTF does not consider the costs of providing a service in this assessment. The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision-making to the specific patient or situation. Similarly, the USPSTF notes that policy and coverage decisions involve considerations in addition to the evidence of clinical benefits and harms. Published by JAMA®—Journal of the American Medical Association under arrangement with the Agency for Healthcare Research and Quality (AHRQ). ©2022 AMA and United States Government, as represented by the Secretary of the Department of Health and Human Services (HHS), by assignment from the members of the United States Preventive Services Task Force (USPSTF). All rights reserved.</p>            <a class="article-section-id-anchor" id="248567017"></a>
                        <div class="h3 cb section-type-references  ">

                            <div class="heading-text thm-col sb-sc">
                                References
                            </div>
                        </div>
<div class="references"><div class="reference"><a class="reference-number" id="jus220018r1">1.</a><div class="reference-content">Heron
         M﻿.  Deaths: leading causes for 2017. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Natl Vital Stat Rep</i>. 2019;68(6):1-77.<a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32501203" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Deaths%3A%20leading%20causes%20for%202017.&amp;author=M%20Heron&amp;publication_year=2019&amp;journal=Natl%20Vital%20Stat%20Rep&amp;volume=68&amp;pages=1-77" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jus220018r2">2.</a><div class="reference-content">Xu
         J﻿, Murphy
         SL﻿, Kockanek
         KD﻿, Arias
         E﻿.  Mortality in the United States, 2018. ﻿ <i xmlns:helper="urn:XsltStringHelper"> NCHS Data Brief</i>. 2020;(355):1-8.<a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32487294" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Mortality%20in%20the%20United%20States%2C%202018.&amp;author=J%20Xu&amp;author=SL%20Murphy&amp;author=KD%20Kockanek&amp;author=E%20Arias&amp;publication_year=2020&amp;journal=NCHS%20Data%20Brief&amp;volume=&amp;pages=1-8" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jus220018r3">3.</a><div class="reference-content">Virani
         SS﻿, Alonso
         A﻿, Benjamin
         EJ﻿, 
     et al; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee.  Heart disease and stroke statistics—2020 update: a report from the American Heart Association. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Circulation</i>. 2020;141(9):e139-e596. doi:<a href="http://dx.doi.org/10.1161/CIR.0000000000000757">10.1161/CIR.0000000000000757</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/31992061" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Heart%20disease%20and%20stroke%20statistics%E2%80%942020%20update%3A%20a%20report%20from%20the%20American%20Heart%20Association.&amp;author=SS%20Virani&amp;author=A%20Alonso&amp;author=EJ%20Benjamin&amp;publication_year=2020&amp;journal=Circulation&amp;volume=141&amp;pages=e139-e596" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1161/CIR.0000000000000757" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1161/CIR.0000000000000757" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r4">4.</a><div class="reference-content">Virani
         SS﻿, Alonso
         A﻿, Aparicio
         HJ﻿, 
     et al; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee.  Heart disease and stroke statistics—2021 update: a report from the American Heart Association. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Circulation</i>. 2021;143(8):e254-e743. doi:<a href="http://dx.doi.org/10.1161/CIR.0000000000000950">10.1161/CIR.0000000000000950</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/33501848" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Heart%20disease%20and%20stroke%20statistics%E2%80%942021%20update%3A%20a%20report%20from%20the%20American%20Heart%20Association.&amp;author=SS%20Virani&amp;author=A%20Alonso&amp;author=HJ%20Aparicio&amp;publication_year=2021&amp;journal=Circulation&amp;volume=143&amp;pages=e254-e743" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1161/CIR.0000000000000950" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1161/CIR.0000000000000950" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r5">5.</a><div class="reference-content">US Preventive Services Task Force. Procedure Manual. Updated May 2021. Accessed February 3, 2022. <a href="https://uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual">https://uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual</a></div></div><div class="reference"><a class="reference-number" id="jus220018r6">6.</a><div class="reference-content">Goff
         DC
         Jr﻿, Lloyd-Jones
         DM﻿, Bennett
         G﻿, 
     et al.  2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Am Coll Cardiol</i>. 2014;63(25, pt B):2935-2959. doi:<a href="http://dx.doi.org/10.1016/j.jacc.2013.11.005">10.1016/j.jacc.2013.11.005</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/24239921" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=2013%20ACC%2FAHA%20guideline%20on%20the%20assessment%20of%20cardiovascular%20risk%3A%20a%20report%20of%20the%20American%20College%20of%20Cardiology%2FAmerican%20Heart%20Association%20Task%20Force%20on%20Practice%20Guidelines.&amp;author=DC%20Goff&amp;author=DM%20Lloyd-Jones&amp;author=G%20Bennett&amp;publication_year=2014&amp;journal=J%20Am%20Coll%20Cardiol&amp;volume=63&amp;pages=2935-2959" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/j.jacc.2013.11.005" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/j.jacc.2013.11.005" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r7">7.</a><div class="reference-content">DeFilippis
         AP﻿, Young
         R﻿, Carrubba
         CJ﻿, 
     et al.  An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Ann Intern Med</i>. 2015;162(4):266-275. doi:<a href="http://dx.doi.org/10.7326/M14-1281">10.7326/M14-1281</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/25686167" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=An%20analysis%20of%20calibration%20and%20discrimination%20among%20multiple%20cardiovascular%20risk%20scores%20in%20a%20modern%20multiethnic%20cohort.&amp;author=AP%20DeFilippis&amp;author=R%20Young&amp;author=CJ%20Carrubba&amp;publication_year=2015&amp;journal=Ann%20Intern%20Med&amp;volume=162&amp;pages=266-275" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.7326/M14-1281" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.7326/M14-1281" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r8">8.</a><div class="reference-content">Cook
         NR﻿, Ridker
         PM﻿.  Calibration of the pooled cohort equations for atherosclerotic cardiovascular disease: an update. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Ann Intern Med</i>. 2016;165(11):786-794. doi:<a href="http://dx.doi.org/10.7326/M16-1739">10.7326/M16-1739</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/27723890" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Calibration%20of%20the%20pooled%20cohort%20equations%20for%20atherosclerotic%20cardiovascular%20disease%3A%20an%20update.&amp;author=NR%20Cook&amp;author=PM%20Ridker&amp;publication_year=2016&amp;journal=Ann%20Intern%20Med&amp;volume=165&amp;pages=786-794" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.7326/M16-1739" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.7326/M16-1739" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r9">9.</a><div class="reference-content">Rana
         JS﻿, Tabada
         GH﻿, Solomon
         MD﻿, 
     et al.  Accuracy of the atherosclerotic cardiovascular risk equation in a large contemporary, multiethnic population. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Am Coll Cardiol</i>. 2016;67(18):2118-2130. doi:<a href="http://dx.doi.org/10.1016/j.jacc.2016.02.055">10.1016/j.jacc.2016.02.055</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/27151343" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Accuracy%20of%20the%20atherosclerotic%20cardiovascular%20risk%20equation%20in%20a%20large%20contemporary%2C%20multiethnic%20population.&amp;author=JS%20Rana&amp;author=GH%20Tabada&amp;author=MD%20Solomon&amp;publication_year=2016&amp;journal=J%20Am%20Coll%20Cardiol&amp;volume=67&amp;pages=2118-2130" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/j.jacc.2016.02.055" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/j.jacc.2016.02.055" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r10">10.</a><div class="reference-content">Dalton
         JE﻿, Perzynski
         AT﻿, Zidar
         DA﻿, 
     et al.  Accuracy of cardiovascular risk prediction varies by neighborhood socioeconomic position: a retrospective cohort study. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Ann Intern Med</i>. 2017;167(7):456-464. doi:<a href="http://dx.doi.org/10.7326/M16-2543">10.7326/M16-2543</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/28847012" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Accuracy%20of%20cardiovascular%20risk%20prediction%20varies%20by%20neighborhood%20socioeconomic%20position%3A%20a%20retrospective%20cohort%20study.&amp;author=JE%20Dalton&amp;author=AT%20Perzynski&amp;author=DA%20Zidar&amp;publication_year=2017&amp;journal=Ann%20Intern%20Med&amp;volume=167&amp;pages=456-464" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.7326/M16-2543" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.7326/M16-2543" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r11">11.</a><div class="reference-content">Colantonio
         LD﻿, Richman
         JS﻿, Carson
         AP﻿, 
     et al.  Performance of the atherosclerotic cardiovascular disease pooled cohort risk equations by social deprivation status. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Am Heart Assoc</i>. 2017;6(3):e005676. doi:<a href="http://dx.doi.org/10.1161/JAHA.117.005676">10.1161/JAHA.117.005676</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/28314800" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Performance%20of%20the%20atherosclerotic%20cardiovascular%20disease%20pooled%20cohort%20risk%20equations%20by%20social%20deprivation%20status.&amp;author=LD%20Colantonio&amp;author=JS%20Richman&amp;author=AP%20Carson&amp;publication_year=2017&amp;journal=J%20Am%20Heart%20Assoc&amp;volume=6&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1161/JAHA.117.005676" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1161/JAHA.117.005676" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r12">12.</a><div class="reference-content">US Preventive Services Task Force.  Collaboration and shared decision-making between patients and clinicians in preventive health care decisions and US Preventive Services Task Force recommendations. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2022;327(12):1171-1176. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2022.3267">10.1001/jama.2022.3267</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/35315879" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Collaboration%20and%20shared%20decision-making%20between%20patients%20and%20clinicians%20in%20preventive%20health%20care%20decisions%20and%20US%20Preventive%20Services%20Task%20Force%20recommendations.&amp;publication_year=2022&amp;journal=JAMA&amp;volume=327&amp;pages=1171-1176" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2022.3267" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2022.3267" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r13">13.</a><div class="reference-content">Chou
         R﻿, Cantor
         A﻿, Dana
         T﻿, 
     et al. <i xmlns:helper="urn:XsltStringHelper"> Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: A Systematic Review for the US Preventive Services Task Force. Evidence Synthesis No. 219</i>.  Agency for Healthcare Research and Quality; 2022. AHRQ publication 22-05291-EF-1.</div></div><div class="reference"><a class="reference-number" id="jus220018r14">14.</a><div class="reference-content">Dorsch
         MP﻿, Lester
         CA﻿, Ding
         Y﻿, Joseph
         M﻿, Brook
         RD﻿.  Effects of race on statin prescribing for primary prevention with high atherosclerotic cardiovascular disease risk in a large healthcare system. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Am Heart Assoc</i>. 2019;8(22):e014709. doi:<a href="http://dx.doi.org/10.1161/JAHA.119.014709">10.1161/JAHA.119.014709</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/31707943" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Effects%20of%20race%20on%20statin%20prescribing%20for%20primary%20prevention%20with%20high%20atherosclerotic%20cardiovascular%20disease%20risk%20in%20a%20large%20healthcare%20system.&amp;author=MP%20Dorsch&amp;author=CA%20Lester&amp;author=Y%20Ding&amp;author=M%20Joseph&amp;author=RD%20Brook&amp;publication_year=2019&amp;journal=J%20Am%20Heart%20Assoc&amp;volume=8&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1161/JAHA.119.014709" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1161/JAHA.119.014709" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r15">15.</a><div class="reference-content">Schroff
         P﻿, Gamboa
         CM﻿, Durant
         RW﻿, Oikeh
         A﻿, Richman
         JS﻿, Safford
         MM﻿.  Vulnerabilities to health disparities and statin use in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Am Heart Assoc</i>. 2017;6(9):e005449. doi:<a href="http://dx.doi.org/10.1161/JAHA.116.005449">10.1161/JAHA.116.005449</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/28847913" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Vulnerabilities%20to%20health%20disparities%20and%20statin%20use%20in%20the%20REGARDS%20%28Reasons%20for%20Geographic%20and%20Racial%20Differences%20in%20Stroke%29%20study.&amp;author=P%20Schroff&amp;author=CM%20Gamboa&amp;author=RW%20Durant&amp;author=A%20Oikeh&amp;author=JS%20Richman&amp;author=MM%20Safford&amp;publication_year=2017&amp;journal=J%20Am%20Heart%20Assoc&amp;volume=6&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1161/JAHA.116.005449" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1161/JAHA.116.005449" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r16">16.</a><div class="reference-content">Gamboa
         CM﻿, Colantonio
         LD﻿, Brown
         TM﻿, Carson
         AP﻿, Safford
         MM﻿.  Race-sex differences in statin use and low-density lipoprotein cholesterol control among people with diabetes mellitus in the Reasons for Geographic and Racial Differences in Stroke study. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Am Heart Assoc</i>. 2017;6(5):e004264. doi:<a href="http://dx.doi.org/10.1161/JAHA.116.004264">10.1161/JAHA.116.004264</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/28490523" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Race-sex%20differences%20in%20statin%20use%20and%20low-density%20lipoprotein%20cholesterol%20control%20among%20people%20with%20diabetes%20mellitus%20in%20the%20Reasons%20for%20Geographic%20and%20Racial%20Differences%20in%20Stroke%20study.&amp;author=CM%20Gamboa&amp;author=LD%20Colantonio&amp;author=TM%20Brown&amp;author=AP%20Carson&amp;author=MM%20Safford&amp;publication_year=2017&amp;journal=J%20Am%20Heart%20Assoc&amp;volume=6&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1161/JAHA.116.004264" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1161/JAHA.116.004264" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r17">17.</a><div class="reference-content">Gu
         A﻿, Kamat
         S﻿, Argulian
         E﻿.  Trends and disparities in statin use and low-density lipoprotein cholesterol levels among US patients with diabetes, 1999-2014. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetes Res Clin Pract</i>. 2018;139:1-10. doi:<a href="http://dx.doi.org/10.1016/j.diabres.2018.02.019">10.1016/j.diabres.2018.02.019</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/29476887" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Trends%20and%20disparities%20in%20statin%20use%20and%20low-density%20lipoprotein%20cholesterol%20levels%20among%20US%20patients%20with%20diabetes%2C%201999-2014.&amp;author=A%20Gu&amp;author=S%20Kamat&amp;author=E%20Argulian&amp;publication_year=2018&amp;journal=Diabetes%20Res%20Clin%20Pract&amp;volume=139&amp;pages=1-10" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/j.diabres.2018.02.019" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/j.diabres.2018.02.019" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r18">18.</a><div class="reference-content">Wall
         HK﻿, Ritchey
         MD﻿, Gillespie
         C﻿, Omura
         JD﻿, Jamal
         A﻿, George
         MG﻿.  Vital Signs: prevalence of key cardiovascular disease risk factors for Million Hearts 2022—United States, 2011-2016. ﻿ <i xmlns:helper="urn:XsltStringHelper"> MMWR Morb Mortal Wkly Rep</i>. 2018;67(35):983-991. doi:<a href="http://dx.doi.org/10.15585/mmwr.mm6735a4">10.15585/mmwr.mm6735a4</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/30188885" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Vital%20Signs%3A%20prevalence%20of%20key%20cardiovascular%20disease%20risk%20factors%20for%20Million%20Hearts%202022%E2%80%94United%20States%2C%202011-2016.&amp;author=HK%20Wall&amp;author=MD%20Ritchey&amp;author=C%20Gillespie&amp;author=JD%20Omura&amp;author=A%20Jamal&amp;author=MG%20George&amp;publication_year=2018&amp;journal=MMWR%20Morb%20Mortal%20Wkly%20Rep&amp;volume=67&amp;pages=983-991" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.15585/mmwr.mm6735a4" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.15585/mmwr.mm6735a4" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r19">19.</a><div class="reference-content">National Center for Health Statistics. Health, United States, 2019: Table 7: Leading Causes of Death and Numbers of Deaths, by Age: United States, 1980 and 2018. Accessed February 3, 2022. <a href="https://www.cdc.gov/nchs/data/hus/2019/007-508.pdf">https://www.cdc.gov/nchs/data/hus/2019/007-508.pdf</a></div></div><div class="reference"><a class="reference-number" id="jus220018r20">20.</a><div class="reference-content">Ridker
         PM﻿, Danielson
         E﻿, Fonseca
         FA﻿, 
     et al; JUPITER Study Group.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. ﻿ <i xmlns:helper="urn:XsltStringHelper"> N Engl J Med</i>. 2008;359(21):2195-2207. doi:<a href="http://dx.doi.org/10.1056/NEJMoa0807646">10.1056/NEJMoa0807646</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/18997196" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Rosuvastatin%20to%20prevent%20vascular%20events%20in%20men%20and%20women%20with%20elevated%20C-reactive%20protein.&amp;author=PM%20Ridker&amp;author=E%20Danielson&amp;author=FA%20Fonseca&amp;publication_year=2008&amp;journal=N%20Engl%20J%20Med&amp;volume=359&amp;pages=2195-2207" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1056/NEJMoa0807646" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1056/NEJMoa0807646" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r21">21.</a><div class="reference-content">Ridker
         PM﻿, Pradhan
         A﻿, MacFadyen
         JG﻿, Libby
         P﻿, Glynn
         RJ﻿.  Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet</i>. 2012;380(9841):565-571. doi:<a href="http://dx.doi.org/10.1016/S0140-6736(12)61190-8">10.1016/S0140-6736(12)61190-8</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/22883507" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Cardiovascular%20benefits%20and%20diabetes%20risks%20of%20statin%20therapy%20in%20primary%20prevention%3A%20an%20analysis%20from%20the%20JUPITER%20trial.&amp;author=PM%20Ridker&amp;author=A%20Pradhan&amp;author=JG%20MacFadyen&amp;author=P%20Libby&amp;author=RJ%20Glynn&amp;publication_year=2012&amp;journal=Lancet&amp;volume=380&amp;pages=565-571" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S0140-6736(12)61190-8" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S0140-6736(12)61190-8" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r22">22.</a><div class="reference-content">Panozzo
         CA﻿, Curtis
         LH﻿, Marshall
         J﻿, 
     et al.  Incidence of statin use in older adults with and without cardiovascular disease and diabetes mellitus, January 2008-March 2018. ﻿ <i xmlns:helper="urn:XsltStringHelper"> PLoS One</i>. 2019;14(12):e0223515. doi:<a href="http://dx.doi.org/10.1371/journal.pone.0223515">10.1371/journal.pone.0223515</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/31805056" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Incidence%20of%20statin%20use%20in%20older%20adults%20with%20and%20without%20cardiovascular%20disease%20and%20diabetes%20mellitus%2C%20January%202008-March%202018.&amp;author=CA%20Panozzo&amp;author=LH%20Curtis&amp;author=J%20Marshall&amp;publication_year=2019&amp;journal=PLoS%20One&amp;volume=14&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1371/journal.pone.0223515" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1371/journal.pone.0223515" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r23">23.</a><div class="reference-content">US Preventive Services Task Force.  Aspirin use to prevent cardiovascular disease: US Preventive Services Task Force recommendation statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2022;327(16):1577-1584. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2022.4983">10.1001/jama.2022.4983</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/35471505" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Aspirin%20use%20to%20prevent%20cardiovascular%20disease%3A%20US%20Preventive%20Services%20Task%20Force%20recommendation%20statement.&amp;publication_year=2022&amp;journal=JAMA&amp;volume=327&amp;pages=1577-1584" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2022.4983" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2022.4983" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r24">24.</a><div class="reference-content">US Preventive Services Task Force.  Screening for hypertension in adults: US Preventive Services Task Force reaffirmation recommendation statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2021;325(16):1650-1656. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2021.4987">10.1001/jama.2021.4987</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/33904861" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Screening%20for%20hypertension%20in%20adults%3A%20US%20Preventive%20Services%20Task%20Force%20reaffirmation%20recommendation%20statement.&amp;publication_year=2021&amp;journal=JAMA&amp;volume=325&amp;pages=1650-1656" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2021.4987" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2021.4987" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r25">25.</a><div class="reference-content">US Preventive Services Task Force.  Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force recommendation statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2021;326(8):736-743. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2021.12531">10.1001/jama.2021.12531</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/34427594" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Screening%20for%20prediabetes%20and%20type%202%20diabetes%3A%20US%20Preventive%20Services%20Task%20Force%20recommendation%20statement.&amp;publication_year=2021&amp;journal=JAMA&amp;volume=326&amp;pages=736-743" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2021.12531" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2021.12531" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r26">26.</a><div class="reference-content">US Preventive Services Task Force.  Interventions for tobacco smoking cessation in adults, including pregnant persons: US Preventive Services Task Force recommendation statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2021;325(3):265-279. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2020.25019">10.1001/jama.2020.25019</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/33464343" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Interventions%20for%20tobacco%20smoking%20cessation%20in%20adults%2C%20including%20pregnant%20persons%3A%20US%20Preventive%20Services%20Task%20Force%20recommendation%20statement.&amp;publication_year=2021&amp;journal=JAMA&amp;volume=325&amp;pages=265-279" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2020.25019" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2020.25019" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r27">27.</a><div class="reference-content">US Preventive Services Task Force.  Behavioral counseling interventions to promote a healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: US Preventive Services Task Force recommendation statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2020;324(20):2069-2075. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2020.21749">10.1001/jama.2020.21749</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/33231670" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Behavioral%20counseling%20interventions%20to%20promote%20a%20healthy%20diet%20and%20physical%20activity%20for%20cardiovascular%20disease%20prevention%20in%20adults%20with%20cardiovascular%20risk%20factors%3A%20US%20Preventive%20Services%20Task%20Force%20recommendation%20statement.&amp;publication_year=2020&amp;journal=JAMA&amp;volume=324&amp;pages=2069-2075" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2020.21749" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2020.21749" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r28">28.</a><div class="reference-content">US Preventive Services Task Force.  Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults without cardiovascular risk factors: US Preventive Services Task Force recommendation statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2017;318(2):167-174. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2017.7171">10.1001/jama.2017.7171</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/28697260" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Behavioral%20counseling%20to%20promote%20a%20healthful%20diet%20and%20physical%20activity%20for%20cardiovascular%20disease%20prevention%20in%20adults%20without%20cardiovascular%20risk%20factors%3A%20US%20Preventive%20Services%20Task%20Force%20recommendation%20statement.&amp;publication_year=2017&amp;journal=JAMA&amp;volume=318&amp;pages=167-174" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2017.7171" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2017.7171" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r29">29.</a><div class="reference-content">US Preventive Services Task Force.  Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force recommendation statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2018;320(11):1163-1171. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2018.13022">10.1001/jama.2018.13022</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/30326502" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Behavioral%20weight%20loss%20interventions%20to%20prevent%20obesity-related%20morbidity%20and%20mortality%20in%20adults%3A%20US%20Preventive%20Services%20Task%20Force%20recommendation%20statement.&amp;publication_year=2018&amp;journal=JAMA&amp;volume=320&amp;pages=1163-1171" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2018.13022" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2018.13022" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r30">30.</a><div class="reference-content">US Preventive Services Task Force.  Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2016;316(19):1997-2007. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2016.15450">10.1001/jama.2016.15450</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/27838723" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Statin%20use%20for%20the%20primary%20prevention%20of%20cardiovascular%20disease%20in%20adults%3A%20US%20Preventive%20Services%20Task%20Force%20recommendation%20statement.&amp;publication_year=2016&amp;journal=JAMA&amp;volume=316&amp;pages=1997-2007" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2016.15450" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2016.15450" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r31">31.</a><div class="reference-content">Chou
         R﻿, Cantor
         A﻿, Dana
         T﻿, 
     et al.  Statin use for the primary prevention of cardiovascular disease in adults: updated evidence report and systematic review for the US Preventive Services Task Force. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. Published August 23, 2022. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2022.12138">10.1001/jama.2022.12138</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Statin%20use%20for%20the%20primary%20prevention%20of%20cardiovascular%20disease%20in%20adults%3A%20updated%20evidence%20report%20and%20systematic%20review%20for%20the%20US%20Preventive%20Services%20Task%20Force.&amp;author=R%20Chou&amp;author=A%20Cantor&amp;author=T%20Dana&amp;publication_year=2022&amp;journal=JAMA&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jus220018r32">32.</a><div class="reference-content">Shepherd
         J﻿, Blauw
         GJ﻿, Murphy
         MB﻿, 
     et al; PROSPER Study Group.  Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet</i>. 2002;360(9346):1623-1630. doi:<a href="http://dx.doi.org/10.1016/S0140-6736(02)11600-X">10.1016/S0140-6736(02)11600-X</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/12457784" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Pravastatin%20in%20elderly%20individuals%20at%20risk%20of%20vascular%20disease%20%28PROSPER%29%3A%20a%20randomised%20controlled%20trial.&amp;author=J%20Shepherd&amp;author=GJ%20Blauw&amp;author=MB%20Murphy&amp;publication_year=2002&amp;journal=Lancet&amp;volume=360&amp;pages=1623-1630" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S0140-6736(02)11600-X" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S0140-6736(02)11600-X" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r33">33.</a><div class="reference-content">Shepherd
         J﻿, Cobbe
         SM﻿, Ford
         I﻿, 
     et al; West of Scotland Coronary Prevention Study Group.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. ﻿ <i xmlns:helper="urn:XsltStringHelper"> N Engl J Med</i>. 1995;333(20):1301-1307. doi:<a href="http://dx.doi.org/10.1056/NEJM199511163332001">10.1056/NEJM199511163332001</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/7566020" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Prevention%20of%20coronary%20heart%20disease%20with%20pravastatin%20in%20men%20with%20hypercholesterolemia.&amp;author=J%20Shepherd&amp;author=SM%20Cobbe&amp;author=I%20Ford&amp;publication_year=1995&amp;journal=N%20Engl%20J%20Med&amp;volume=333&amp;pages=1301-1307" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1056/NEJM199511163332001" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1056/NEJM199511163332001" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r34">34.</a><div class="reference-content">Han
         BH﻿, Sutin
         D﻿, Williamson
         JD﻿, 
     et al; ALLHAT Collaborative Research Group.  Effect of statin treatment vs usual care on primary cardiovascular prevention among older adults: the ALLHAT-LLT randomized clinical trial. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA Intern Med</i>. 2017;177(7):955-965. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jamainternmed.2017.1442">10.1001/jamainternmed.2017.1442</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/28531241" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20statin%20treatment%20vs%20usual%20care%20on%20primary%20cardiovascular%20prevention%20among%20older%20adults%3A%20the%20ALLHAT-LLT%20randomized%20clinical%20trial.&amp;author=BH%20Han&amp;author=D%20Sutin&amp;author=JD%20Williamson&amp;publication_year=2017&amp;journal=JAMA%20Intern%20Med&amp;volume=177&amp;pages=955-965" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jamainternmed.2017.1442" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jamainternmed.2017.1442" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r35">35.</a><div class="reference-content">ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.  Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2002;288(23):2998-3007. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.288.23.2998">10.1001/jama.288.23.2998</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/12479764" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Major%20outcomes%20in%20moderately%20hypercholesterolemic%2C%20hypertensive%20patients%20randomized%20to%20pravastatin%20vs%20usual%20care%3A%20the%20Antihypertensive%20and%20Lipid-Lowering%20Treatment%20to%20Prevent%20Heart%20Attack%20Trial%20%28ALLHAT-LLT%29.&amp;publication_year=2002&amp;journal=JAMA&amp;volume=288&amp;pages=2998-3007" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.288.23.2998" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.288.23.2998" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r36">36.</a><div class="reference-content">Macedo
         AF﻿, Taylor
         FC﻿, Casas
         JP﻿, Adler
         A﻿, Prieto-Merino
         D﻿, Ebrahim
         S﻿.  Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis. ﻿ <i xmlns:helper="urn:XsltStringHelper"> BMC Med</i>. 2014;12(51):51. doi:<a href="http://dx.doi.org/10.1186/1741-7015-12-51">10.1186/1741-7015-12-51</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/24655568" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Unintended%20effects%20of%20statins%20from%20observational%20studies%20in%20the%20general%20population%3A%20systematic%20review%20and%20meta-analysis.&amp;author=AF%20Macedo&amp;author=FC%20Taylor&amp;author=JP%20Casas&amp;author=A%20Adler&amp;author=D%20Prieto-Merino&amp;author=S%20Ebrahim&amp;publication_year=2014&amp;journal=BMC%20Med&amp;volume=12&amp;pages=51" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1186/1741-7015-12-51" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1186/1741-7015-12-51" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r37">37.</a><div class="reference-content">Jick
         SS﻿, Bradbury
         BD﻿.  Statins and newly diagnosed diabetes. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Br J Clin Pharmacol</i>. 2004;58(3):303-309. doi:<a href="http://dx.doi.org/10.1111/j.1365-2125.2004.02142.x">10.1111/j.1365-2125.2004.02142.x</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/15327590" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Statins%20and%20newly%20diagnosed%20diabetes.&amp;author=SS%20Jick&amp;author=BD%20Bradbury&amp;publication_year=2004&amp;journal=Br%20J%20Clin%20Pharmacol&amp;volume=58&amp;pages=303-309" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1111/bcp.2004.58.issue-3" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1111/bcp.2004.58.issue-3" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r38">38.</a><div class="reference-content">Culver
         AL﻿, Ockene
         IS﻿, Balasubramanian
         R﻿, 
     et al.  Statin use and risk of diabetes mellitus in postmenopausal women in the Women’s Health Initiative. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Arch Intern Med</i>. 2012;172(2):144-152. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/archinternmed.2011.625">10.1001/archinternmed.2011.625</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/22231607" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Statin%20use%20and%20risk%20of%20diabetes%20mellitus%20in%20postmenopausal%20women%20in%20the%20Women%E2%80%99s%20Health%20Initiative.&amp;author=AL%20Culver&amp;author=IS%20Ockene&amp;author=R%20Balasubramanian&amp;publication_year=2012&amp;journal=Arch%20Intern%20Med&amp;volume=172&amp;pages=144-152" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/archinternmed.2011.625" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/archinternmed.2011.625" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r39">39.</a><div class="reference-content">Porath
         A﻿, Arbelle
         JE﻿, Fund
         N﻿, Cohen
         A﻿, Mosseri
         M﻿.  Statin therapy: diabetes mellitus risk and cardiovascular benefit in primary prevention. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Isr Med Assoc J</i>. 2018;20(8):480-485.<a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/30084572" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Statin%20therapy%3A%20diabetes%20mellitus%20risk%20and%20cardiovascular%20benefit%20in%20primary%20prevention.&amp;author=A%20Porath&amp;author=JE%20Arbelle&amp;author=N%20Fund&amp;author=A%20Cohen&amp;author=M%20Mosseri&amp;publication_year=2018&amp;journal=Isr%20Med%20Assoc%20J&amp;volume=20&amp;pages=480-485" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jus220018r40">40.</a><div class="reference-content">Yusuf
         S﻿, Bosch
         J﻿, Dagenais
         G﻿, 
     et al; HOPE-3 Investigators.  Cholesterol lowering in intermediate-risk persons without cardiovascular disease. ﻿ <i xmlns:helper="urn:XsltStringHelper"> N Engl J Med</i>. 2016;374(21):2021-2031. doi:<a href="http://dx.doi.org/10.1056/NEJMoa1600176">10.1056/NEJMoa1600176</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/27040132" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Cholesterol%20lowering%20in%20intermediate-risk%20persons%20without%20cardiovascular%20disease.&amp;author=S%20Yusuf&amp;author=J%20Bosch&amp;author=G%20Dagenais&amp;publication_year=2016&amp;journal=N%20Engl%20J%20Med&amp;volume=374&amp;pages=2021-2031" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1056/NEJMoa1600176" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1056/NEJMoa1600176" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r41">41.</a><div class="reference-content">US Preventive Services Task Force.  Risk assessment for cardiovascular disease with nontraditional risk factors: US Preventive Services Task Force recommendation statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2018;320(3):272-280. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2018.8359">10.1001/jama.2018.8359</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/29998297" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Risk%20assessment%20for%20cardiovascular%20disease%20with%20nontraditional%20risk%20factors%3A%20US%20Preventive%20Services%20Task%20Force%20recommendation%20statement.&amp;publication_year=2018&amp;journal=JAMA&amp;volume=320&amp;pages=272-280" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2018.8359" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2018.8359" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r42">42.</a><div class="reference-content">Grundy
         SM﻿, Stone
         NJ﻿, Bailey
         AL﻿, 
     et al.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Circulation</i>. 2019;139:e1082–1143.  doi:<a href="http://dx.doi.org/10.1161/CIR.0000000000000625">10.1161/CIR.0000000000000625</a>﻿ <a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/30879355" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=2018%20AHA%2FACC%2FAACVPR%2FAAPA%2FABC%2FACPM%2FADA%2FAGS%2FAPhA%2FASPC%2FNLA%2FPCNA%20guideline%20on%20the%20management%20of%20blood%20cholesterol%3A%20a%20report%20of%20the%20American%20College%20of%20Cardiology%2FAmerican%20Heart%20Association%20Task%20Force%20on%20Clinical%20Practice%20Guidelines.&amp;author=SM%20Grundy&amp;author=NJ%20Stone&amp;author=AL%20Bailey&amp;publication_year=2019&amp;journal=Circulation&amp;volume=139&amp;pages=e1082-1143" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1161/CIR.0000000000000625" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1161/CIR.0000000000000625" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r43">43.</a><div class="reference-content">Arnett
         DK﻿, Blumenthal
         RS﻿, Albert
         MA﻿, 
     et al.  2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Circulation</i>. 2019;140(11):e596-e646. doi:<a href="http://dx.doi.org/10.1161/CIR.0000000000000678">10.1161/CIR.0000000000000678</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/30879355" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=2019%20ACC%2FAHA%20guideline%20on%20the%20primary%20prevention%20of%20cardiovascular%20disease%3A%20a%20report%20of%20the%20American%20College%20of%20Cardiology%2FAmerican%20Heart%20Association%20Task%20Force%20on%20Clinical%20Practice%20Guidelines.&amp;author=DK%20Arnett&amp;author=RS%20Blumenthal&amp;author=MA%20Albert&amp;publication_year=2019&amp;journal=Circulation&amp;volume=140&amp;pages=e596-e646" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1161/CIR.0000000000000678" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1161/CIR.0000000000000678" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus220018r44">44.</a><div class="reference-content">Department of Veterans Affairs, Department of Defense. VA/DoD Clinical Practice Guideline for the Management of Dyslipidemia for Cardiovascular Risk Reduction. Published 2014. Accessed February 3, 2022. <a href="https://www.healthquality.va.gov/guidelines/CD/lipids/VADoDDyslipidemiaCPG2014.pdf">https://www.healthquality.va.gov/guidelines/CD/lipids/VADoDDyslipidemiaCPG2014.pdf</a></div></div></div>

</div>
 
    </div>

        <div class="movable-ad bta">
    <div class="widget-WidgetLoader widget-instance-AMA_AdTag_textbreak_bta_dual">
        
    <div class="SCM-SharedWidgets-AsyncAdLoader" data-url="/AMA/AdTag/AMA_AdTag_textbreak_bta_dual" data-params="{&quot;parameters&quot;:{&quot;siteName&quot;:&quot;jama&quot;,&quot;siteId&quot;:3,&quot;journalId&quot;:67,&quot;adDisplay&quot;:8,&quot;adSection&quot;:&quot;textbreak&quot;,&quot;adPosition&quot;:&quot;bta&quot;,&quot;fromGoogle&quot;:false},&quot;dynamicParameters&quot;:{}}"></div>
 
    </div>

        </div>
    </div> 

</div> 

<div class="hidden-jobs-ad hide">
    <div class="widget-WidgetLoader widget-instance-AMA_JobsAd">
        
<div class="SCM-SharedWidgets-AsyncJobsAdLoader" data-url="/AMA/JobsAd/AMA_JobsAd" data-params="{&quot;parameters&quot;:{&quot;SiteId&quot;:3},&quot;dynamicParameters&quot;:{&quot;localParams&quot;:&quot;[REPLACE_WITH_LOCAL]&quot;}}"></div>
 
    </div>

</div>



<script>
                var App = App || {};
                App.ArticleSplitScreen = App.ArticleSplitScreen || {};
                App.ArticleSplitScreen.siteName = 'jama';
                App.ArticleSplitScreen.siteId = 3;
                App.ArticleSplitScreen.journalId = 67;
                App.ArticleSplitScreen.adDisplay = 'ArticleContentsSkyBox';
                App.ArticleSplitScreen.adSection = "scholarly";
                App.ArticleSplitScreen.adPosition = "contab";
                App.ArticleSplitScreen.controlId = "AMA_AdTag_Contents_Skybox";
                App.ArticleSplitScreen.fromGoogle = "False";
                App.ArticleSplitScreen.slotLocationOverride = "50";

</script> 
    </div>


 
    </div>

    </section>


    <section id="secFooterControl" class="master-footer">
        

        <script>
            var App = App || {};

            function scmByClass(className) {
                return document.getElementsByClassName(className);
            }

            function scmById(id) {
                return document.getElementById(id);
            }

            function scmquery(selector) {
                return document.querySelector(selector);
            }

            function queryAll(selector) {
                return document.querySelectorAll(selector);
            }

            function isTrueString(string) {
                if (typeof string === 'string') {
                    return string.toLowerCase() === 'true';
                }

                return undefined;
            }

            function updateViewportDimensions() {
                var w = window, d = document, e = d.documentElement, g = d.getElementsByTagName('body')[0], x = w.innerWidth || e.clientWidth || g.clientWidth, y = w.innerHeight || e.clientHeight || g.clientHeight;
                return { width: x, height: y };
            }

            var viewport = updateViewportDimensions();

            var debounce = function (func, wait, immediate) {
                var timeout;
                return function () {
                    var context = this, args = arguments;
                    var later = function () {
                        timeout = null;
                        if (!immediate) func.apply(context, args);
                    };
                    var callNow = immediate && !timeout;
                    clearTimeout(timeout);
                    timeout = setTimeout(later, wait);
                    if (callNow) func.apply(context, args);
                };
            };

            (function (App) {
                App.mobileUpperBreakpoint = 767;
                App.mobileAltBreakpoint = 640;
                App.mobileMinBreakpoint = 547;
                App.tabletUpperBreakpoint = 1023;

                function setVariables() {
                    viewport = updateViewportDimensions();
                    App.isMobile = (viewport.width <= App.mobileUpperBreakpoint);
                    App.isMobileAlt = (viewport.width <= App.mobileAltBreakpoint);
                    App.isTablet = (viewport.width > App.mobileUpperBreakpoint && viewport.width <= App.tabletUpperBreakpoint);
                    App.isTabletDown = (viewport.width <= App.tabletUpperBreakpoint);
                    App.isDesktop = (viewport.width > App.tabletUpperBreakpoint);
                    App.activeViewport = App.isMobile ? 'small' : App.isTablet ? 'med' : 'large';
                }

                setVariables();

                App.cachedViewport = App.isMobile ? 'small' : App.isTablet ? 'med' : 'large';
                App.isAnyArticle = !!(scmByClass('widget-ArticleFullView').length || scmByClass('pg_abstract').length
                    || scmByClass('widget-MagazineView').length || scmByClass('widget-ChannelsMagazineView').length);
                App.isSplitScreen = !!scmByClass('widget-ArticleFullView').length;
                App.isAbstract = !!scmByClass('pg_abstract').length;
                App.isMag = !!(scmByClass('widget-MagazineView').length);
                App.isChannel = !!(scmByClass('channel-site').length);
                App.isChannelMag = !!(scmByClass('widget-ChannelsMagazineView').length);
                App.isFreeArticle = !!(scmquery('.widget-ArticleTopInfo .free-access') ||
                                        scmquery('.widget-ArticleTopInfo .open-access') ||
                                        scmquery('.widget-ArticleTopInfo .icon-free') || 
                                        scmquery('.widget-ChannelsMagazineView .free-access'));
                App.isTollFreeAccess = false;
                App.isIssue = !!scmByClass('pg_issue').length || !!scmByClass('pg_newonline').length || !!scmByClass('pg_currentissue').length || !!scmByClass('pg_pastissues').length;
                App.isNewOnline = !!scmByClass('pg_newonline').length;
                App.isCurrentIssue = !!scmByClass('pg_currentissue').length;
                App.isPastIssues = !!scmByClass('pg_pastissues').length;
                App.isJournal = !!scmByClass('pg_journal').length;
                App.isNetworkHome = !!scmByClass('pg_index').length;
                App.isSearch = !!scmByClass('pg_searchresults').length;
                App.isAdvancedSearch = !!scmByClass('pg_advancedsearch').length;
                App.isPlayer= !!scmByClass('pg_multimediaplayer').length;
                App.isSelfServe = !!scmByClass('pg_sspage').length;
                App.isCmsPage = !!scmByClass('pg_cmspage').length; 
                App.isMyAccount = !!scmByClass('pg_myaccount').length;
                App.supportsFlexbox = !!scmByClass('flexbox').length;
                App.isCollection = !!scmByClass('pg_collection').length;
                App.isPaidUser = isTrueString(scmById('hfAppIsPaidUser').getAttribute('value'));
                App.isMember = isTrueString(scmById('hfAppIsMember').getAttribute('value'));
                App.isIndividual = isTrueString(scmById('hfAppIsIndividual').getAttribute('value'));
                App.hasAccess = isTrueString(scmById('hfAppHasAccess').getAttribute('value'));
                App.isReferredFromGoogle = isTrueString(scmById('hfAppIsReferredFromGoogle').getAttribute('value'));
                var subscribedTo = scmById('hfAppSubscribedTo').getAttribute('value');
                App.userSubscribedTo = subscribedTo ? subscribedTo.split(',') : undefined;
                App.isLucy = isTrueString(scmById('hfAppIsLucy').getAttribute('value'));
                App.currentJournalCount = 26;
                App.isChannelPage = !!(scmByClass('channels-page'));
                App.updateAppVariables = debounce(function () {
                    setVariables();
                }, 50, false);
            })(App);
        </script>
        

        
<div class="footer-ad-wrapper">
    <div id="BodyContent_Footer_divAds" class="footer-ad desktop-only">
        
            <div class="widget-WidgetLoader widget-instance-AMA_AdTag_AnchorboardAd_btf">
        
    <div class="SCM-SharedWidgets-AsyncAdLoader" data-url="/AMA/AdTag/AMA_AdTag_AnchorboardAd_btf" data-params="{&quot;parameters&quot;:{&quot;siteName&quot;:&quot;jama&quot;,&quot;siteId&quot;:3,&quot;journalId&quot;:67,&quot;adDisplay&quot;:11,&quot;adSection&quot;:&quot;scholarly&quot;,&quot;adPosition&quot;:&quot;btf&quot;,&quot;fromGoogle&quot;:false},&quot;dynamicParameters&quot;:{&quot;localParams&quot;:&quot;[REPLACE_WITH_LOCAL]&quot;}}"></div>
 
    </div>
</div>
</div>

 
 <div class="ad-riser-wrap desktop-only">
     <div class="ad-riser--dismiss t-c">X</div>
         <div class="widget-WidgetLoader widget-instance-AMA_AdTag_Riser">
        
    <div class="SCM-SharedWidgets-AsyncAdLoader" data-url="/AMA/AdTag/AMA_AdTag_Riser" data-params="{&quot;parameters&quot;:{&quot;siteName&quot;:&quot;jama&quot;,&quot;siteId&quot;:3,&quot;journalId&quot;:67,&quot;adDisplay&quot;:12,&quot;adSection&quot;:&quot;scholarly&quot;,&quot;adPosition&quot;:&quot;Riser&quot;,&quot;fromGoogle&quot;:false},&quot;dynamicParameters&quot;:{&quot;localParams&quot;:&quot;[REPLACE_WITH_LOCAL]&quot;}}"></div>
 
    </div>

 </div>


<div class="footer-wrap">
    
    <footer class="footer" id="footer">
        
        <div id="footer-microsite" class="footer-microsite">
            



    <input type="hidden" class="SelfServeContentId" value="v2_Footer_Left" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<style type="text/css">
    @media (min-width: 1024px) {.split-screen .footer-microsite-contents {border-bottom:0 !important;}}
    .footer-microsite-contents {margin-bottom:1em;width:100%;}
    .footer-network-other .link-apps:before {width: 23px;}
    .footer-network-other .link-institutions-librarians:before {width: 23px;}
    .jn-ss-footer-border-top {border-top:1px solid #555;padding-top:15px;}
    .jn-ss-footer-border-bottom {border-bottom:1px solid #555;padding-bottom:10px;padding-right:3px;}
</style>
<div class="footer-heading-wrap">
<h3 id="BodyContent_Footer_h3SiteName" class="footer-heading is-b footer-microsite-heading" data-mobile-tog-target=".footer-microsite-links-wrap">JAMA</h3>
</div>
<div class="footer-microsite-links-wrap">
<div class="footer-microsite-contents  jn-ss-footer-border-bottom">
<h4 id="BodyContent_Footer_ContentHeader" class="footer-subheading">Content</h4>
<a href="/journals/jama">Home</a>
<a href="/journals/jama/newonline">New Online</a>
<a href="/journals/jama/currentissue">Current Issue</a>
</div>
<div class="footer-microsite-contents  jn-ss-footer-border-bottom">
<h4 class="footer-subheading">Podcasts</h4>
<a href="/journals/jama/pages/covid-19-interviews#audio">Coronavirus (COVID-19)&nbsp;Q&amp;A</a>
<a href="/journals/jama/pages/jama-clinical-reviews">Clinical Reviews</a>
<a href="/journals/jama/pages/jama-editors-summary">Editors' Summary</a>
<a href="/journals/jama/pages/jama-medical-news">Medical News</a>
<a href="/journals/jama/pages/jama-author-interviews">Author Interviews</a>
<a href="/journals/jama/pages/jamaevidence-jama-guide-to-statistics-and-methods">JAMAevidence: <em>JAMA Guide to Statistics and Methods</em></a>
<a href="/journals/jama/pages/jamaevidence-the-rational-clinical-examination">JAMAevidence: The Rational Clinical Examination</a>
<a href="/journals/jama/pages/jamaevidence-users-guides-to-the-medical-literature">JAMAevidence: Users' Guides to the Medical Literature</a>
</div>
<div class="footer-microsite-services cf">
<h4 id="BodyContent_Footer_ServiceHeader" class="footer-subheading">Journal Information</h4>
<a href="/journals/jama/pages/for-authors">For Authors</a>
<a href="/journals/jama/pages/jama-editors">JAMA Editors</a>
<a href="/journals/jama/editors-and-publishers">Editors &amp; Publishers</a>
<a href="/pages/rss">RSS</a>
<a href="/journals/jama/pages/contact-us">Contact Us</a>
</div>
<div class="footer-network-other  jn-ss-footer-border-bottom">
<a href="https://edhub.ama-assn.org/jn-learning" class="link-network-other is-b link-learning">JN Learning / CME</a>
<a href="https://store.jamanetwork.com" class="link-network-other is-b link-store" target="_blank">Store</a>
<a href="/pages/apps" class="link-network-other is-b link-mobile" target="_blank">Apps</a>
<a href="https://careers.jamanetwork.com/" class="link-network-other is-b link-jobs" target="_blank">Jobs</a>
<a href="/pages/resources-for-librarians" class="link-network-other is-b link-institutions-librarians" target="_blank">Institutions</a>
<a href="/pages/reprints-and-permissions" class="link-network-other is-b link-reprints-permissions">Reprints &amp; Permissions</a>
</div>
<div id="BodyContent_Footer_divSubscribe" class="footer-microsite-subscribe">
<img src="//cdn.jamanetwork.com/UI/app/img/covers/jama.jpg" class="subscribe-image" alt="Journal Cover">
<div class="subscribe-meta">
<h4 class="subscribe-heading footer-subheading">Subscribe</h4>
<a href="https://store.jamanetwork.com/productDetails.aspx?productcodeID=64" class="subscribe-submit btn">Go</a>
</div>
</div>
</div>





        </div>

        
        <div id="footer-network" class="footer-network">
            



    <input type="hidden" class="SelfServeContentId" value="v2_Footer_Middle" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<style type="text/css">
    .footer-network-sites {width: 62.85542%;}
    .footer-network-info {width: 35.93976%}
    .jn-ss-subheading-mt {margin-top: 1.5em;}
    .jn-registered:after {content: "\00AE";font-size: 50%;vertical-align: top;}
    .jn-trademark:after {content: "\2122";font-size: 50%;vertical-align: top;}
</style>
<div class="footer-heading-wrap">
<h3 class="footer-heading is-b jn-registered" data-mobile-tog-target=".footer-network-links-wrap"><strong>JAMA</strong> Network</h3>
</div>
<div class="footer-network-links-wrap">
<div class="footer-network-sites">
<div class="internal">
<h4 id="BodyContent_Footer_JournalHeader" class="footer-subheading">Publications</h4>
<a href="/journals/jama">JAMA</a>
<a href="/journals/jamanetworkopen" target="_blank">JAMA Network Open</a>
<a href="/journals/jamacardiology">JAMA Cardiology</a>
<a href="/journals/jamadermatology">JAMA Dermatology</a>
<a href="/journals/jama-health-forum">JAMA Health Forum</a>
<a href="/journals/jamainternalmedicine">JAMA Internal Medicine</a>
<a href="/journals/jamaneurology">JAMA Neurology</a>
<a href="/journals/jamaoncology">JAMA Oncology</a>
<a href="/journals/jamaophthalmology">JAMA Ophthalmology</a>
<a href="/journals/jamaotolaryngology">JAMA Otolaryngology–Head &amp; Neck Surgery</a>
<a href="/journals/jamapediatrics">JAMA Pediatrics</a>
<a href="/journals/jamapsychiatry">JAMA Psychiatry</a>
<a href="/journals/jamasurgery">JAMA Surgery</a>
<a href="/journals/archneurpsyc">Archives of Neurology &amp; Psychiatry (1919-1959)</a>
</div>
<div class="external">
<h4 class="footer-subheading">Sites</h4>
<div id="BodyContent_Footer_ssFooterSiteMenu">
<div class="selfServe">
<a target="_blank" href="https://sites.jamanetwork.com/art-and-images-in-psychiatry/">Art and Images in Psychiatry</a>
<a target="_blank" href="/channels/ai">Artificial Intelligence (AI) Resource Center</a>
<a target="_blank" href="/journals/jama/pages/2023-most-viewed-jama">Best of the JAMA Network</a>
<a target="_blank" href="/channels/caring-for-the-critically-ill-patient">Caring for the Critically Ill Patient</a>
<a target="_blank" href="/journals/jama/pages/crosswords">Clinical Crosswords from JAMA</a>
<a target="_blank" href="/journals/jama/pages/coronavirus-alert">Coronavirus Resource Center</a>
<a target="_blank" href="https://ebm.jamanetwork.com/index.html">Evidence-Based Medicine: An Oral History</a>
<a target="_blank" href="/pages/fishbein-fellowship">Fishbein Fellowship</a>
<a target="_blank" href="/channels/genomics/">Genomics and Precision Health</a>
<a target="_blank" href="/channels/hypertension">Hypertension</a>
<a target="_blank" href="/channels/health-forum/archive">JAMA Forum Archive</a>
<a target="_blank" href="https://sites.jamanetwork.com/audio">JAMA Network Audio</a>
<a target="_blank" href="/pages/video">JAMA Network Video</a>
<a target="_blank" href="/pages/conferences">JAMA Network Conferences </a>
<a target="_blank" href="/pages/jama-summit">JAMA Summit </a>
<a target="_blank" href="/journals/jamasurgery/pages/statistics-and-methods">JAMA Surgery Guide to Statistics and Methods</a>
<a target="_blank" href="/channels/medical-news">Medical News</a>
<a target="_blank" href="/channels/monkeypox">Mpox (Monkeypox)</a>
<a target="_blank" href="https://sites.jamanetwork.com/research-ethics/">Research Ethics</a>
<a target="_blank" href="/pages/collections">Topics and Collections</a>
<a target="_blank" href="/pages/visual-abstracts">Visual Abstracts</a>
<a target="_blank" href="/channels/war">War and Health</a>
<a target="_blank" href="/channels/womens-health">Women's Health</a>
<h4 class="footer-subheading jn-ss-subheading-mt">Featured Articles</h4>
<a href="/journals/jama/fullarticle/2799240">Antiretroviral Drugs for HIV Treatment and Prevention in Adults - 2022 IAS-USA Recommendations</a>
<a href="/journals/jama/fullarticle/2781397">CONSERVE 2021 Guidelines for Reporting Trials Modified for the COVID-19 Pandemic</a>
<a href="/journals/jama/fullarticle/2808296">Creation and Adoption of Large Language Models in&nbsp;Medicine</a>
<a href="/journals/jamaoncology/fullarticle/2787350">Global Burden of Cancer, 2010-2019</a>
<a href="/journals/jama/fullarticle/2797443">Global Burden of Long COVID</a>
<a href="/journals/jamadermatology/fullarticle/2790344">Global Burden of Melanoma</a>
<a href="/journals/jamadermatology/fullarticle/2787350">Global Burden of Skin Diseases, 1990-2017</a>
<a href="/journals/jamaneurology/fullarticle/2793874">Global Disparities in Parkinson Disease</a>
<a href="/journals/jama/fullarticle/2799547">Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension</a>
<a href="/journals/jamapsychiatry/fullarticle/2799486">Mass Violence and the Complex Spectrum of Mental Illness and Mental Functioning</a>
<a href="/journals/jamapsychiatry/fullarticle/2793903">Neuropsychiatry Sequelae of COVID-19</a>
<a href="/journals/jamaneurology/fullarticle/2810313">A New Framework for Dementia Nomenclature</a>
<a href="/journals/jama/fullarticle/2800656">Organization and Performance of US Health Systems</a>
<a href="/journals/jama-health-forum/fullarticle/2791195">Pharmacy Benefit Managers: History, Business Practices, Economics, and Policy</a>
<a href="/journals/jama-health-forum/fullarticle/2791195">Promoting EDI in Genetics Research</a>
<a href="/journals/jamacardiology/fullarticle/2781972">PTSD and Cardiovascular Disease</a>
<a href="/journals/jama/fullarticle/2810754">Red Blood Cell Transfusion: 2023 AABB International Guidelines</a>
<a href="/journals/jamapediatrics/fullarticle/2797600">Reimagining Children’s Rights in the US</a>
<a href="/journals/jama/fullarticle/2794049">Spirituality in Serious Illness and Health</a>
<a href="/journals/jama/fullarticle/2796374">The US Medicaid Program: Coverage, Financing, Reforms, and Implications for Health Equity</a>
<h4 class="footer-subheading jn-ss-subheading-mt">USPSTF Recommendation Statements</h4>
<a href="/journals/jama/fullarticle/2779985">Screening for Colorectal Cancer</a>
<a href="/journals/jama/fullarticle/2779190">Screening for Hypertension</a>
<a href="/journals/jama/fullarticle/2777244">Screening for Lung Cancer</a>
<a href="/journals/jama/fullarticle/2796244">Screening for Prediabetes and Type 2 Diabetes In Children</a>
<a href="/journals/jama/fullarticle/2783414">Screening for Prediabetes and Type 2 Diabetes In Adults</a>
<a href="/journals/jama/fullarticle/2795521">Statins for Primary Prevention of Cardiovascular Disease</a>
<a href="/journals/jama/fullarticle/2793446">Vitamin and Mineral Supplements for Primary Prevention of of Cardiovascular Disease and Cancer</a>
<h4 class="footer-subheading jn-ss-subheading-mt">Blogs</h4>
<a target="_blank" href="https://amastyleinsider.com/">AMA Style Insider</a>
</div>
</div>
</div>
</div>
<div id="footer-network-info" class="footer-network-info">
<div class="information-for-links">
<h4 id="BodyContent_Footer_InfoHeader" class="footer-subheading">Information</h4>
<a href="/pages/for-authors">For Authors</a>
<a href="/pages/resources-for-librarians">For Institutions &amp; Librarians</a>
<a href="/pages/advertisers">For Advertisers</a>
<a href="/pages/subscription-agents">For Subscription Agents</a>
<a href="https://careers.jamanetwork.com/" target="_blank">For Employers &amp; Job Seekers</a>
<a href="https://media.jamanetwork.com" rel="nofollow" target="_blank">For the Media</a>
<a href="/pages/equity-diversity-inclusion">Equity, Diversity, Inclusion</a>
<a href="/pages/commenting-policy">Online Commenting Policy</a>
<a href="/pages/access-at-jama-network">Public Access and Open Access Policy</a>
<a href="/pages/offensive-content-statement">Statement on Potentially Offensive Content</a>
</div>
<div class="services-links">
<h4 id="BodyContent_Footer_JAMANetworkProductsHeader" class="footer-subheading">JAMA Network Products</h4>
<a href="http://www.amamanualofstyle.com/" class="footer-service-link" target="_blank">AMA Manual of Style</a>
<a href="https://jamaevidence.mhmedical.com/" class="footer-service-link" target="_blank"><span class="jn-registered">JAMAevidence</span></a>
<a href="http://www.peerreviewcongress.org/" class="footer-service-link" target="_blank">Peer Review Congress</a>
</div>
<div class="learning-links">
<h4 id="BodyContent_Footer_LearningHeader" class="footer-subheading">JN Learning</h4>
<a href="https://edhub.ama-assn.org/jn-learning">Home</a>
<a href="https://edhub.ama-assn.org/jn-learning/state-cme">State CME</a>
<a href="https://edhub.ama-assn.org/jn-learning/pages/clinical-challenge-courses">Clinical Challenge CME</a>
<a href="https://edhub.ama-assn.org/jn-learning/course/288 ">Atrial Fibrillation Course</a>
<a href="https://edhub.ama-assn.org/jn-learning/course/294 ">Women's Health Course</a>
<a target="_blank" href="https://edhub.ama-assn.org/pages/auto-credit-reporting">CME / MOC Reporting Preferences</a>
<a href="https://edhub.ama-assn.org/jn-learning/pages/about-cme">About CME &amp; MOC</a>
</div>
</div>
</div>





        </div>
        
        <div id="footer-resources-wrap" class="footer-resources-wrap">
            



    <input type="hidden" class="SelfServeContentId" value="v2_Footer_Right" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<style type="text/css">
    .footer-resources-wrap .footer-subheading {color: grey;display:block !important;font-size: 1.17647em;font-weight: 400;text-transform: uppercase;}
</style>
<div class="footer-heading-wrap">
<h3 class="footer-heading is-b footer-resources-heading" data-mobile-tog-target=".footer-resources">Help</h3>
</div>
<div class="footer-resources">
<a href="https://store.jamanetwork.com" class="footer-service-link" target="_blank">Subscriptions &amp; Renewals</a>
<a href="https://jamanetwork.com/oauthsignin?return_url=http%3A%2F%2Fjamanetwork.com%2Fmyaccount%23my-alerts" class="footer-service-link" rel="nofollow">Manage Emails</a>
<a href="https://jamanetwork.com/oauthsignin?return_url=http%3A%2F%2Fjamanetwork.com%2Fmyaccount%23my-profile" class="footer-service-link" rel="nofollow">Update My Address</a>
<a href="https://support.jamanetwork.com/hc/en-us" class="footer-service-link">Support Center</a>
<a href="/myaccount " class="footer-service-link">My Account</a>
<h4 class="footer-subheading jn-ss-subheading-mt">JAMA Career Center</h4>
<a href="https://careers.jamanetwork.com/" class="footer-service-link" target="_blank">Physician Job Listings</a>
</div>








    <input type="hidden" class="SelfServeContentId" value="v2_Footer_Socials" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<style type="text/css">
    .widget-instance-AMA_Journal_Home_Socials .iconsocial {display: inline-block !important;width: 34px;height: 34px;min-width: unset !important;margin: 0 2px !important;background-color: #fff;border-radius: 20px;border: 1px solid #191919;vertical-align: middle;}
    .widget-instance-AMA_Journal_Home_Socials .iconsocial.instagram {background-image: url(https://cdn.jamanetwork.com/ImageLibrary/JamaNetwork/social/instagram-icon-black.svg);background-position: 7px 7px;background-repeat: no-repeat;background-size: 18px;}
    .widget-instance-AMA_Journal_Home_Socials .iconsocial.instagram:hover, .widget-instance-AMA_Journal_Home_Socials .iconsocial.instagram:focus {background-image: url(https://cdn.jamanetwork.com/ImageLibrary/JamaNetwork/social/instagram-icon-fill.png);border-color: #C13584;}
    .footer-resources-wrap .iconsocial {display: inline-block !important;width: 32px;height: 32px;min-width: unset !important;margin: 0 2px 0 3px !important;background-color: #fff;border-radius: 20px;border: 1px solid #191919;vertical-align: middle;}
    .footer-resources-wrap .iconsocial.instagram {background-image: url(https://cdn.jamanetwork.com/ImageLibrary/JamaNetwork/social/instagram-icon-black.svg);background-position: 6px 6px;background-repeat: no-repeat;background-size: 18px;}
    .footer-resources-wrap .iconsocial.instagram:hover, .footer-resources-wrap .iconsocial.instagram:focus {background-color: #C13584;border-color: #191919;}
    #load-instagram-image { background: url(https://cdn.jamanetwork.com/ImageLibrary/JamaNetwork/social/instagram-icon-fill.png) no-repeat -9999px -9999px; }
</style>
<div id="BodyContent_Footer_divSocial" class="social-links footer-social-links">
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://www.facebook.com/JAMAJournal/" class="social-link is-b facebook"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://twitter.com/JAMA_current" class="social-link is-b twitter"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://www.instagram.com/jamanetwork/?hl=en" class="iconsocial instagram"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://www.linkedin.com/company/jamanetwork/" class="social-link is-b linked-in"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://www.youtube.com/jamanetwork" class="social-link is-b you-tube"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://www.pinterest.com/jamanetwork/" class="social-link is-b pinterest"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="/rss/site_3/67.xml" class="social-link is-b rss"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://jamanetwork.com/journals/jama/pages/jama-editors-summary" class="social-link is-b podcast"></a>
<div id="load-instagram-image">&nbsp;</div>
</div>




<div id="BodyContent_Footer_divEmailUpdate" class="footer-email-updates">
                
                    <div class="widget-EmailListSignUp widget-instance-AMAv2_EmailListSignUp_Footer">
        <div class="email-signup">
    
    <div class="email-signup--text sb-pc">Get the latest from JAMA</div>
    <div class="email-signup--input-wrap is-b">
        <input type="text" name="email" class="email-signup--input" placeholder="Email address" title="Email address" />
        <a rel="nofollow" href="javascript:;" class="email-signup--submit sb-sc btn">Sign Up</a>
    </div>
    <div class="email-signup--link"> <a class="email-signup--privacy" href="/pages/privacy-policy">Privacy Policy</a> | <a class="email-signup--terms" href="/pages/terms-of-use">Terms of Use</a></div>
    <div class="email-signup--user-message"></div>
</div> 
    </div>
</div>
        </div>

        
        <div class="footer-bar" itemscope itemtype="https://schema.org/Organization">
            



    <input type="hidden" class="SelfServeContentId" value="v2_Footer_Bottom_Bar" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<style type="text/css">
    .nav-journals a.theme-jama-health-forum:before {background: #133763;}
    .jn-bottom-bar {color: #fff; float: left;font-size: 10px;padding: 13px 20px;width: 33.33%;}
    .jn-bottom-bar p {line-height: 2;}
    @media (max-width: 900px) {.jn-bottom-bar {float: none;width: 100%;}}
    .jn-footer-copyright {font-size:12px;line-height:1.5;margin-bottom:10px;}
    .jn-footer-pipe {margin:0 10px;}
    .footer-bar-jn-logo img {width: 230px;}
    @media (max-width: 900px) {.footer-bar-jn-logo img {width: 200px;}}
    [data-thm=umb] .jobs-ad--text h6 {color: #d71635 !important;}
    [data-thm=jama] .jobs-ad--text h6 {color: #d71635 !important;}
    [data-thm=jaman] .jobs-ad--text h6 {color: #ed0973 !important;}
    [data-thm=cardi] .jobs-ad--text h6 {color: #be1e32 !important;}
    [data-thm=derm] .jobs-ad--text h6 {color: #006f3b !important;}
    [data-thm=faci] .jobs-ad--text h6 {color: #ed1c24 !important;}
    [data-thm=jama-] .jobs-ad--text h6 {color: #fb5252 !important;}
    [data-thm=intem] .jobs-ad--text h6 {color: #006e96 !important;}
    [data-thm=neur] .jobs-ad--text h6 {color: #981b1e !important;}
    [data-thm=oncol] .jobs-ad--text h6 {color: #3b923f !important;}
    [data-thm=ophth] .jobs-ad--text h6 {color: #66bc29 !important;}
    [data-thm=otol] .jobs-ad--text h6 {color: #34b6e4 !important;}
    [data-thm=peds] .jobs-ad--text h6 {color: #0084c0 !important;}
    [data-thm=psych] .jobs-ad--text h6 {color: #005276 !important;}
    [data-thm=surg] .jobs-ad--text h6 {color: #f47920 !important;}
    .blockquote .para {margin: 0 0 1em 1em;}
    .jn-footer-copyright {display: block;}
    .inline-block {display: inline-block;}
    #selfserve-maintenance {display:block;margin:20px 0;max-height:none !important;min-height:200px;visibility:visible;}
</style>
<a class="footer-bar-jn-logo d-b no-mw mb1" href="/" title="JAMA Network Home"><img class="mw-100" src="https://cdn.jamanetwork.com/ImageLibrary/global/jn-signature-reversed-r.svg?versionId=81373" alt="Jama Network Logo"></a>
<div class="jn-bottom-bar">
<p>
<span class="jn-footer-copyright">© 2024 American Medical Association. <span class="inline-block">All rights reserved,</span> including those for text and data mining, AI training, <span class="inline-block">and similar technologies.</span></span>
<span class="inline-block"><a href="https://www.ama-assn.org/about/terms-use" rel="nofollow" class="p0">Terms of Use</a><span class="jn-footer-pipe">|</span></span>
<span class="inline-block"><a href="https://www.ama-assn.org/about/privacy-policy" rel="nofollow" class="p0">Privacy Policy</a><span class="jn-footer-pipe">|</span></span>
<span class="inline-block"><a href="https://www.ama-assn.org/about/accessibility-statement" rel="nofollow" class="p0">Accessibility Statement</a><span class="jn-footer-pipe">|</span></span>
<span class="inline-block"><a onclick="OneTrust.ToggleInfoDisplay()" rel="nofollow" class="p0" id="CookieFooter">Cookie Settings</a></span>
</p>
</div>
<!-- 
	#selfserve-maintenance {display:block;margin:20px 0;max-height:none !important;min-height:200px;visibility:visible;}
	-->





            <a class="footer-bar-sis no-mw relative nudge-down" href="https://www.silverchair.com" target="_blank"><img class="footer-bar-sis-img mt05 mw-100" width="600" height="70" src="//cdn.jamanetwork.com/UI/app/img/powered.png" alt="Silverchair Logo" /></a>
        </div>
    </footer>

</div>
<div class="ss-ui-only">
        <div class="widget-SelfServeContent widget-instance-AMA_SS_UI_Only">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SsUiOnly" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

.


</div>

 
    </div>

</div>

    </section>


        

        
        
        <div id="revealModal" class="reveal-modal" data-reveal>
            <div id="revealContent"></div>
            <a class="close-reveal-modal icon-close"></a>
        </div>

        
        <div class="artmet-modal" id="MetricsModal">
            <div class="artmet-modal-contents">
                <a class="artmet-close-modal">&#215;</a>
            </div>
        </div>

        
        
    


            <div class="widget-SigninModals widget-instance-AMA_SigninModals">
        <div class="js-modal-no-access-reveal no-access reveal-modal modal tiny" data-reveal>
    <div class="modal--box">
        <div class="modal--title">Access your subscriptions</div>
        <hr />
                <button type="button" role="button" class="modal--btn js-btn-signin-personal" data-oauth-signin-url="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2795521">
            Sign in<span class="fw-normal"> | personal account</span>
        </button>

            <div class="widget-AmaAdvancedSeamlessAccess widget-instance-AMA_NoAccess_AdvancedSeamlessAccessButton">
        <div class="seamless-access-button--wrap">
    <button class="d-flex sa-button align-items-center" role="button" type="button">
        <div class="sa-button-logo-wrap">
            <img src="//cdn.jamanetwork.com/UI/app/svg/seamless-access.svg" class="sa-button-logo" alt="Seamless Access Logo" />
        </div>
        <div class="d-flex justify-content-center align-items-center sa-button-text text-truncate">
            <div class="sa-button-text-primary text-truncate">Access through your institution</div>
        </div>
    </button>
    <div class="sa-access-text text-truncate hide">
        <div class="sa-cta-access"><span>Add or change institution</span></div>
    </div>
</div>
 
    </div>

    <div class="widget-SelfServeContent widget-instance-AMA_NoAccess_SigninModal_CreateAccount">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_CreateAccount" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Free access to newly published articles</div>
<hr>
<button class="modal--btn js-btn-create-personal-account" type="button" role="button">
<div class="text-truncate">Create a free personal account</div>
</button>
<div class="modal--btn-desc">To register for email alerts, access free PDF, and more</div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_CreateAccount</div>-->


</div>

 
    </div>
            <div class="widget-SelfServeContent widget-instance-AMA_NoAccess_SigninModal_PurchaseOptions_NoAccessAndPaidPDF">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_PurchaseOptions_NoAccessAndPaidPDF" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Purchase access</div>
<hr>
<button class="modal--btn js-btn-subscribe-journal" type="button" role="button">
<div class="text-truncate">Subscribe to journal</div>
</button>
<div class="modal--btn-desc">Get full journal access for 1 year</div>
<button class="modal--btn js-btn-purchase-article" type="button" role="button">
<div class="text-truncate">Buy article</div>
</button>
<div class="modal--btn-desc">Get unlimited access and a printable PDF ($40.00)—<br>
<em>Sign in or create a free account</em></div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_PurchaseOptions_NoAccessAndPaidPDF</div>-->


</div>

 
    </div>

            <div class="widget-DeepDyve widget-instance-AMA_NoAccess_DeepDyve">
                <button type="button" role="button" class="modal--btn js-deepdyve-link hiddenRentalLink" data-deepdyveurl="https://www.deepdyve.com/doc-view?docId=10.1001/jama.2022.13044&amp;fieldName=journal_doi&amp;affiliateId=JAMA" data-doi="10.1001/jama.2022.13044" data-fieldname="journal_doi" 
                data-issneissn="0098-7484" data-affiliate="JAMA">Rent article</button>
        <div class="modal--btn-desc js-deepdyve-desc hiddenRentalLink">Rent this article from DeepDyve</div>
 
    </div>

    </div>
        <a class="close-reveal-modal icon-close"></a>

</div>

<div class="js-modal-paid-pdf-reveal no-access reveal-modal modal tiny" data-reveal>
    <div class="modal--box">
        <div class="modal--title">Access your subscriptions</div>
        <hr />
                <button type="button" role="button" class="modal--btn js-btn-signin-personal" data-oauth-signin-url="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2795521">
            Sign in<span class="fw-normal"> | personal account</span>
        </button>

            <div class="widget-AmaAdvancedSeamlessAccess widget-instance-AMA_PaidPdf_AdvancedSeamlessAccessButton">
        <div class="seamless-access-button--wrap">
    <button class="d-flex sa-button align-items-center" role="button" type="button">
        <div class="sa-button-logo-wrap">
            <img src="//cdn.jamanetwork.com/UI/app/svg/seamless-access.svg" class="sa-button-logo" alt="Seamless Access Logo" />
        </div>
        <div class="d-flex justify-content-center align-items-center sa-button-text text-truncate">
            <div class="sa-button-text-primary text-truncate">Access through your institution</div>
        </div>
    </button>
    <div class="sa-access-text text-truncate hide">
        <div class="sa-cta-access"><span>Add or change institution</span></div>
    </div>
</div>
 
    </div>

    <div class="widget-SelfServeContent widget-instance-AMA_PaidPdf_SigninModal_CreateAccount">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_CreateAccount" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Free access to newly published articles</div>
<hr>
<button class="modal--btn js-btn-create-personal-account" type="button" role="button">
<div class="text-truncate">Create a free personal account</div>
</button>
<div class="modal--btn-desc">To register for email alerts, access free PDF, and more</div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_CreateAccount</div>-->


</div>

 
    </div>
            <div class="widget-SelfServeContent widget-instance-AMA_PaidPdf_SigninModal_PurchaseOptions_NoAccessAndPaidPDF">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_PurchaseOptions_NoAccessAndPaidPDF" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Purchase access</div>
<hr>
<button class="modal--btn js-btn-subscribe-journal" type="button" role="button">
<div class="text-truncate">Subscribe to journal</div>
</button>
<div class="modal--btn-desc">Get full journal access for 1 year</div>
<button class="modal--btn js-btn-purchase-article" type="button" role="button">
<div class="text-truncate">Buy article</div>
</button>
<div class="modal--btn-desc">Get unlimited access and a printable PDF ($40.00)—<br>
<em>Sign in or create a free account</em></div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_PurchaseOptions_NoAccessAndPaidPDF</div>-->


</div>

 
    </div>

            <div class="widget-DeepDyve widget-instance-AMA_PaidPDF_DeepDyve">
                <button type="button" role="button" class="modal--btn js-deepdyve-link hiddenRentalLink" data-deepdyveurl="https://www.deepdyve.com/doc-view?docId=10.1001/jama.2022.13044&amp;fieldName=journal_doi&amp;affiliateId=JAMA" data-doi="10.1001/jama.2022.13044" data-fieldname="journal_doi" 
                data-issneissn="0098-7484" data-affiliate="JAMA">Rent article</button>
        <div class="modal--btn-desc js-deepdyve-desc hiddenRentalLink">Rent this article from DeepDyve</div>
 
    </div>

    </div>
        <a class="close-reveal-modal icon-close"></a>

</div>

<div class="js-modal-free-pdf-reveal no-access reveal-modal modal tiny" data-reveal>
    <div class="modal--box">
        <div class="modal--title">Sign in to access free PDF</div>
        <hr />
                <button type="button" role="button" class="modal--btn js-btn-signin-personal" data-oauth-signin-url="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2795521">
            Sign in<span class="fw-normal"> | personal account</span>
        </button>

            <div class="widget-AmaAdvancedSeamlessAccess widget-instance-AMA_FreePdf_AdvancedSeamlessAccessButton">
        <div class="seamless-access-button--wrap">
    <button class="d-flex sa-button align-items-center" role="button" type="button">
        <div class="sa-button-logo-wrap">
            <img src="//cdn.jamanetwork.com/UI/app/svg/seamless-access.svg" class="sa-button-logo" alt="Seamless Access Logo" />
        </div>
        <div class="d-flex justify-content-center align-items-center sa-button-text text-truncate">
            <div class="sa-button-text-primary text-truncate">Access through your institution</div>
        </div>
    </button>
    <div class="sa-access-text text-truncate hide">
        <div class="sa-cta-access"><span>Add or change institution</span></div>
    </div>
</div>
 
    </div>

    <div class="widget-SelfServeContent widget-instance-AMA_FreePdf_SigninModal_CreateAccount">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_CreateAccount" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Free access to newly published articles</div>
<hr>
<button class="modal--btn js-btn-create-personal-account" type="button" role="button">
<div class="text-truncate">Create a free personal account</div>
</button>
<div class="modal--btn-desc">To register for email alerts, access free PDF, and more</div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_CreateAccount</div>-->


</div>

 
    </div>
    </div>
        <a class="close-reveal-modal icon-close"></a>

</div>

<div class="js-modal-save-search-reveal no-access reveal-modal modal tiny" data-reveal>
    <div class="modal--box">
        <div class="modal--title">Save your search</div>
        <hr />
                <button type="button" role="button" class="modal--btn js-btn-signin-personal" data-oauth-signin-url="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2795521">
            Sign in<span class="fw-normal"> | personal account</span>
        </button>

    <div class="widget-SelfServeContent widget-instance-AMA_SaveSearch_SigninModal_CreateAccount">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_CreateAccount" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Free access to newly published articles</div>
<hr>
<button class="modal--btn js-btn-create-personal-account" type="button" role="button">
<div class="text-truncate">Create a free personal account</div>
</button>
<div class="modal--btn-desc">To register for email alerts, access free PDF, and more</div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_CreateAccount</div>-->


</div>

 
    </div>
            <div class="widget-SelfServeContent widget-instance-AMA_SigninModal_PurchaseOptions_SaveSearch">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_PurchaseOptions_SaveSearch" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Purchase access</div>
		<hr />
		<button class="modal--btn js-btn-subscribe-now">Subscribe now</button>
		<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_PurchaseOptions_SaveSearch</div>-->


</div>

 
    </div>

    </div>
        <a class="close-reveal-modal icon-close"></a>

</div>

<div class="js-modal-follow-collection-reveal no-access reveal-modal modal tiny" data-reveal>
    <div class="modal--box">
        <div class="modal--title">Customize your interests</div>
        <hr />
                <button type="button" role="button" class="modal--btn js-btn-signin-personal" data-oauth-signin-url="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2795521">
            Sign in<span class="fw-normal"> | personal account</span>
        </button>

    <div class="widget-SelfServeContent widget-instance-AMA_FollowCollection_SigninModal_CreateAccount">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_CreateAccount" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Free access to newly published articles</div>
<hr>
<button class="modal--btn js-btn-create-personal-account" type="button" role="button">
<div class="text-truncate">Create a free personal account</div>
</button>
<div class="modal--btn-desc">To register for email alerts, access free PDF, and more</div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_CreateAccount</div>-->


</div>

 
    </div>
            <div class="widget-SelfServeContent widget-instance-AMA_SigninModal_PurchaseOptions_FollowCollection">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_PurchaseOptions_FollowCollection" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--sub-title">Create a personal account or sign in to:</div>
		<ul>
			<li>Register for email alerts with links to free full-text articles</li>
			<li>Access PDFs of free articles</li>
			<li>Manage your interests</li>
			<li>Save searches and receive search alerts</li>
		<ul>
		<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_PurchaseOptions_FollowCollection</div>-->


</div>

 
    </div>

            <div class="modal--link-wrap">
        <a class="modal--link" href="/pages/privacy-policy" rel="nofollow">Privacy Policy</a>
    </div>

    </div>
        <a class="close-reveal-modal icon-close"></a>

</div>

<div class="js-modal-user-comment-reveal no-access reveal-modal modal tiny" data-reveal>
    <div class="modal--box">
        <div class="modal--title">Make a comment</div>
        <hr />
                <button type="button" role="button" class="modal--btn js-btn-signin-personal" data-oauth-signin-url="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2795521">
            Sign in<span class="fw-normal"> | personal account</span>
        </button>

    <div class="widget-SelfServeContent widget-instance-AMA_UserComment_SigninModal_CreateAccount">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_CreateAccount" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Free access to newly published articles</div>
<hr>
<button class="modal--btn js-btn-create-personal-account" type="button" role="button">
<div class="text-truncate">Create a free personal account</div>
</button>
<div class="modal--btn-desc">To register for email alerts, access free PDF, and more</div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_CreateAccount</div>-->


</div>

 
    </div>
            <div class="widget-SelfServeContent widget-instance-AMA_SigninModal_PurchaseOptions_UserComment">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_PurchaseOptions_UserComment" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--sub-title">Create a personal account or sign in to:</div>
		<ul>
			<li>Register for email alerts with links to free full-text articles</li>
			<li>Access PDFs of free articles</li>
			<li>Manage your interests</li>
			<li>Save searches and receive search alerts</li>
		<ul>
		<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_PurchaseOptions_UserComment</div>-->


</div>

 
    </div>

            <div class="modal--link-wrap">
        <a class="modal--link" href="/pages/privacy-policy" rel="nofollow">Privacy Policy</a>
    </div>

    </div>
        <a class="close-reveal-modal icon-close"></a>

</div>

<div class="hidden-true js-modal-page-data"
     data-store-url="https://store.jamanetwork.com"
     data-store-purchase-url="https://jamanetwork.com/oauthsignin?return_url=https://store.jamanetwork.com"
     data-store-subscribe-url="https://store.jamanetwork.com/index.aspx?productcode=64">
</div>






 
    </div>

        

        
        <script src="//cdn.jamanetwork.com/UI/app/vendor/jquery-2.2.4.min.js?v=638473295270790799"></script>
        <script>window.jQuery || document.write('<script src="/UI/app/vendor/jquery-2.2.4.min.js">\x3C/script>')</script>

        <script src="//cdn.jamanetwork.com/UI/app/dist/app.min.js?v=638488852374030681"></script>
        
    
    
    <script src="//cdn.jsdelivr.net/chartist.js/latest/chartist.min.js" type="text/javascript"></script>

    
    
        <script src="//d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script>
    
    <script defer src='//js.trendmd.com/trendmd.min.js' data-trendmdconfig='{"element":"#trendmd-suggestions"}'></script>
        <script type='text/javascript' src='https://platform-api.sharethis.com/js/sharethis.js#property=643701de45aa460012e1032e&amp;product=sop' async='async'></script>


    <script>
        var App = App || {};
        App.showCmePromo = false;
    </script>


    </form>
    

    
    
    <link rel="stylesheet" href="//cdn.jamanetwork.com/UI/app/scss/modules/_trendMD.css">
</body>
</html>

 contentType 9 text/html url 61 https://jamanetwork.com:443/journals/jama/fullarticle/2795521 responseCode 3 200 